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ABSTRACT 
Spinach as a source of carotenoids, folate and antioxidant activity 
PhD thesis by Jacqueline J.M. Castenmiller, Division of Human Nutrition and 
Epidemiology, Wageningen University, The Netherlands, 5 January 2000 
Fruits and vegetables are generally considered important contributors to a healthy 
diet and an increased intake of fruits and vegetables is related to a decreased risk 
of cancers, cardiovascular disease, and other diseases. In this thesis two aspects 
of spinach, a dark-green, leafy vegetable, are examined. The first aspect is the 
bioavailability of the carotenoids and folate present in spinach. The second aspect 
is the antioxidant activity of spinach consumption in humans and the antioxidant 
capacity of spinach products. The literature on carotenoid bioavailability and 
bioconversion was reviewed for each of the SLAMENGHI factors. These factors 
include: Species of carotenoid; molecular Linkage; Amount of carotenoid 
consumed in a meal; Matrix in which the carotenoid is incorporated; Effectors of 
absorption; Nutrient status of the host; Genetic factors; Host related factors; and 
Interactions. 
A dietary intervention study with 70 healthy human subjects divided over six 
treatment groups was conducted to examine the effect of the food matrix on the 
bioavailability of carotenoids and folate and to evaluate the effect of spinach 
intake on biomarkers of antioxidant activity. Four groups received a basic diet 
plus a spinach product (whole-leaf, minced, enzymatically liquefied, and liquefied 
spinach plus added dietary fibre), one group received the basic diet plus a 
carotenoid supplement of p-carotene, lutein and a small amount of zeaxanthin 
dissolved in oil, and one group received the basic diet only. Consumption of 
spinach (20 g/MJ), containing the carotenoids p-carotene and lutein, increased 
serum concentrations of p-carotene, lutein, a-carotene and retinol and decreased 
the serum concentration of lycopene compared with the control group. Compared 
with the synthetic carotenoid supplement, the relative bioavailability of p-carotene 
was low, 5.1-9.5%, but much higher for lutein, 45-55%. Serum p-carotene 
responses differed significantly between the whole-leaf and liquefied spinach 
groups and between the minced and liquefied spinach groups. The plasma folate 
response was significantly greater in the spinach groups compared with the 
control group. Intake of minced and liquefied spinach resulted in greater plasma 
folate responses than consumption of whole-leaf spinach. Thus, disruption of the 
food matrix (cell wall structure) and loss of cellular structure had an effect on the 
bioavailability of p-carotene and folate, whereas the bioavailability of lutein was 
not affected. Addition of dietary fibre to the liquefied spinach to compensate for 
the fibre that was broken down during liquefaction had no effect on serum 
carotenoid or plasma folate responses. 
Consumption of spinach or the carotenoid supplement resulted in an increased 
erythrocyte glutathione reductase activity, and decreased erythrocyte catalase 
activity and serum a-tocopherol concentration. These changes were related to 
serum lutein concentrations. The antioxidant capacity of the differently processed 
spinach products was determined in different oxidation systems. Corrected for the 
total phenolics content of the spinach, the whole-leaf spinach extract showed the 
strongest inhibition of hydroperoxide formation, followed by extracts from liquefied 
and minced spinach. The calculated amount of lutein in the spinach samples used 
(amounts were adjusted for the total phenolics content of spinach) was correlated 
with the inhibition of hydroperoxide formation. In a meatball model at 100 and 200 
g spinach/kg meat, whole-leaf and minced spinach were prooxidative (increased 
the formation of thiobarbituric acid-reactive substances); the liquefied spinach 
became antioxidative at 200 g/kg. Minced and liquefied spinach were 
antioxidatively active with respect to the mean inhibition of hexanal formation, 
whereas whole-leaf spinach showed prooxidant activity. 
In conclusion, the results of the studies described in this thesis demonstrated 
an effect of the food matrix on p-carotene and folate, but not on lutein, 
bioavailability and support the finding that p-carotene is not a good antioxidant in 
man or in foods, but indicate that lutein may play a role as antioxidant. 
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General introduction 
Chapter 1 
HEALTH EFFECTS OF FRUITS AND VEGETABLES 
Cancer and cardiovascular disease are major causes of chronic disease deaths 
and are thus major public health problems. Apart from genetic and environmental 
factors, life-style is considered to influence the aetiology of chronic diseases. Life-
style factors include diet, smoking, drinking and physical activity. Fruits and 
vegetables are generally considered important contributors to a healthy diet and, 
for some years now, health professionals have been advising the general public 
to increase their intake of fruits and vegetables to reduce the risk of specific 
cancers, cardiovascular disease, neural tube defects, and cataracts. Although the 
mechanisms are not fully understood, carotenoids, folic acid and dietary fibre 
appear to play important roles in the prevention of these diseases (Kushi et al. 
1995). 
Estimates have been made of the proportion of cancer cases and 
cardiovascular deaths that could be prevented by increasing fruit and vegetable 
consumption. For cancer incidence, the best estimate is 19% (7-28%); CHD 
mortality risk could be reduced by 20-40%, whereas stroke mortality could be 
reduced by 0-25% with high intake of fruits and vegetables (Klerk et al. 1998). 
Law & Morris (1998) have tried to quantify the relationship between fruits and 
vegetables consumption and the incidence of ischaemic heart disease. They 
conclude that the risk of ischaemic heart disease is about 15% lower at the 90th 
than at the 10th centile of fruit and vegetable consumption. 
A diet high in fruits and vegetables provides a variety of food components, 
which promote health. Table 1 lists a number of nutrients and nonnutrients 
present in fruits and vegetables. However, fruits and vegetables further contain 
natural substances that may have adverse effects on human health: nitrate, 
aflatoxin and other mycotoxins, and goitrogens. There may also be some adverse 
Table 1. Nutrients and nonnutrients in fruits and vegetables 
Nutrients Nonnutrients 
Carotenoids Dietary fibre 
Ascorbic acid Glucosinolates 
Fat-soluble vitamins such as tocopherols Phenols, including flavonoids 
B-vitamins such as folic acid Organosulfides/organo sulfur compounds 
Trace elements such as selenium Phytoestrogens/isoflavones 
Potassium Protease inhibitors 
Phytosterols 
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effects of fruit and vegetable consumption, due to contamination of food with 
heavy metals and pesticides. 
CAROTENOIDS AND HEALTH 
Carotenoids are widespread in nature. They are a group of fat-soluble pigments 
found in fruits and vegetables, insects, birds, and other plant-eating animal 
species, including humans. Carotenoids have light absorbing properties. Light 
absorption occurs in the low-energy, visible range of the spectrum, giving fruits 
and plants their brilliant yellow, orange, red and green colours. Carotenoids are 
also found in all green plant tissues, where they occur in the photosynthetic 
pigment-protein complexes of the chloroplasts (in leaves). In these tissues, the 
colour of carotenoids is masked by the green of the chlorophyll, but is revealed 
during the degradation of chlorophyll. This phenomenon can be seen for example 
during the ripening of fruits and in leaves with the onset of autumn. Also, many 
yellow or orange flowers owe their colour to carotenoids, which are located in 
chromoplasts (Britton et al. 1995b). Most carotenoids can be described by the 
general formula C4oH560n where n is 0-6. Only few carotenoids can be detected in 
human blood, including a-carotene, p-carotene, lutein, zeaxanthin, p-
cryptoxanthin, lycopene and canthaxanthin (see Figure 1). Carotenoids such as 
a-carotene, p-carotene and p-cryptoxanthin are precursors of retinol (vitamin A). 
a-Carotene 
Lutein 
'
ii
^-^!^^^^«!-^iV^V^1*' 
p-Cryptoxanthin 
OHJUk • • • • 1 • 1 • — 
P-Carotene 
Zeaxanthin 
Lycopene 
Canthaxanthin 
Figure 1. Structure of major carotenoids found in human blood 
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Those carotenoids containing oxygen are also referred to as oxycarotenoids or 
xanthophylls. 
Based on intake or biomarkers of intake, carotenoids have been postulated to 
play a protective role in angina pectoris (Riemersma et al. 1991), heart disease 
(Kardinaal et al. 1993, van Poppel 1994) and cancer (Stahelin et al. 1991), 
particularly cancer of epithelial tissues (van Poppel 1996), lung (Dartigues et al. 
1990, Knekt et al. 1990, Smith & Waller 1991) and stomach cancer (Chen et al. 
1992, Cipriani et al. 1991). The hypothesis that p-carotene plays a role in cancer 
prevention is based on studies suggesting that carotenoids function as 
antioxidants, as enhancers of immune function, as precursors of retinoids and/or 
by stimulation of cell-cell communication. Epidemiological studies reveal 
associations but not cause and effect. In order to determine whether p-carotene is 
the active phytochemical in cancer prevention, four major intervention trials in 
humans have been completed, all of which included p-carotene supplementation 
with or without other nutrients. Two studies, provided evidence suggesting that p-
carotene increased the risk of lung cancer in high-risk groups of male Finnish 
smokers (ATBC Cancer Prevention Study Group 1994) and of smokers or 
workers who had been occupationally exposed to asbestos (CARET study; 
Omenn et al. 1996). Another study showed neither negative nor positive effects 
on the incidence of cancer in a healthy population supplemented for 12 years with 
p-carotene (The Physicians Health Study; Hennekens et al. 1996). One study, 
which involved combined supplementation of p-carotene with tocopherol (vitamin 
E) and selenium to marginally malnourished people, showed lower mortality from 
gastric and total cancers in the supplemented group (Blot et al. 1993). Thus, with 
respect to the chemopreventive effect of fruits and vegetables, these intervention 
trials indicated that p-carotene alone is probably not the active phytochemical in 
the prevention of cancer. 
With respect to cardiovascular disease, the clinical trials in which p-carotene 
was given without other antioxidants found no evidence that supplementation had 
a protective effect. The trials included the ATBC study (Rapola et al. 1997); the 
Physicians Health Study (Hennekens et al. 1996); the trial involving those 
exposed to asbestos or heavy smoking (Omenn et al. 1996, Rimm et al. 1993); 
and a study involving patients at high risk for recurrent nonmelanoma skin cancer 
(Greenberg et al. 1996). Three of the four studies found increases in 
cardiovascular disease mortality in the supplemented groups ranging from 12 to 
26%. The Physicians Health Study found no difference (Kritchevsky 1999, Russell 
1998). 
There are a number of associations reported between carotenoid intake and 
12 
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disease. The inverse associations between lycopene intake and prostate cancer 
and between lutein intake and age-related macular degeneration (AMD) are each 
supported by one main study that has examined specifically these carotenoids but 
are not corroborated by other similar studies (Cooper et al. 1999). A number of 
possible confounding factors may explain the inconsistencies between the trials 
and observational epidemiological evidence. The intake and serum 
concentrations of other carotenoids, which are correlated with serum p-carotene 
concentrations, might be important factors, as might other phytochemicals or 
nutrients (Kritchevsky 1999). Dietary intakes of the carotenoids lutein and 
zeaxanthin, which are primarily obtained from dark-green, leafy vegetables, have 
been found to be most strongly associated with reduced risk for age-related 
macular degeneration (Seddon et al. 1994). 
With regard to the health effect of fruits and vegetables, with emphasis of the 
possible role of p-carotene and other carotenoids, smoking and alcohol intake 
may play a role and should be taken into account in future studies. Both the 
ATBC and CARET populations included persons who were in the initial stage of 
developing lung cancer prior to beginning p-carotene supplementation. The gas 
phase of cigarette smoke is a rich source of free radicals and is highly oxidative. 
Under conditions of high oxidative stress and phagocyte-mediated inflammatory 
responses, p-carotene and other carotenoids may be oxidised to epoxides and 
other reactive derivatives, which then act as pro-oxidants and as chemical 
messengers that stimulate cellular proliferation, especially in carcinogen-altered 
epithelial cells (Boosalis et al. 1996, Irribarren et al. 1997). In such a situation, p-
carotene or its metabolites could have promoted the latter stages of cancer. Thus, 
it could be hypothesised that p-carotene or its metabolites protect against cancer 
initiation (van Poppel et al. 1992) but act as promoters in the later stages of 
cancer development. 
Studies in humans have shown that for a given p-carotene intake, alcohol 
consumption and plasma p-carotene concentrations are correlated (Ahmed et al. 
1994). Whereas alcoholics generally have low plasma p-carotene concentrations, 
presumably reflecting a low intake, alcohol intake per se might in fact increase 
serum concentrations of p-carotene in humans even with as few as two drinks per 
day (Forman et al. 1995). The combination of an increase in serum p-carotene 
concentrations and a relative lack of a corresponding rise in retinol concentrations 
suggest a block in the conversion of p-carotene to retinol by ethanol. Because 
alcohol increases p-carotene concentrations, and because cardiovascular 
complications are apparently associated with elevated p-carotene concentrations, 
13 
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Leo & Lieber (1999) suggest that it is possible that p-carotene is cardiotoxic, a 
possibility that is still largely unexplored. Furthermore, the hepatotoxicity of the 
combination of alcohol and p-carotene was found to be exacerbated when the 
latter is given as beadlets (Leo et al. 1997). Beadlets resulted in a proliferation of 
the smooth endoplasmic reticulum and in leakage of mitochondrial glutamate 
dehydrogenase into plasma, reflecting mitochondrial injury (Leo et al. 1997). The 
reason for this toxicity is not clear. The composition of the beadlets is proprietary; 
of the known ingredients, none have been identified as toxic. Indeed 
subsequently, the data of the ATBC study and CARET showed that the increased 
incidence of pulmonary cancer was related to the amount of alcohol consumed by 
the participants (Albanes et al. 1996, Albanes et al. 1997, Omenn et al. 1996). 
FOLIC ACID AND HEALTH 
The term folate refers to a group of compounds that exhibit vitamin activity similar 
to that of pteroyl-L-glutamic acid (folic acid). Pteroic acid and hydrogenated and 
methylated derivatives can be conjugated to one glutamyl residue (monoglutamyl 
folates) or to more glutamyl residues (polyglutamyl folates). Folate is essential for 
haematopoiesis but is now receiving attention in other areas. Folates are 
abundant in many of the same fruits and vegetables that are rich in carotenoids. 
Folic acid is a leading candidate for being primarily responsible for reducing 
plasma homocysteine concentrations. A low intake of folate is associated with 
increased plasma homocysteine levels (Selhub et al. 1993), cardiovascular 
disease (Rimm et al. 1998) and colon cancer (Giovannucci et al. 1995). An 
elevated plasma homocysteine concentration is a risk factor for neural tube 
defects (Steegers-Theunissen et al. 1991) and cardiovascular disease (Graham 
et al. 1997, Kang et al. 1992, Nygard et al. 1995, Pancharuniti et al. 1994, 
Verhoef et al. 1996). Folic acid, vitamin B12, methionine, and choline are 
intimately interrelated in methyl group metabolism. Inadequate folate intake first 
leads to a decrease in plasma folate concentration, then to a decrease in 
erythrocyte folate concentration, a rise in homocysteine concentration, and 
ultimately to megaloblastic changes in the bone marrow and other rapidly dividing 
cells. Folate deficiency causes extensive incorporation of uracil instead of thymine 
into human DNA, leading to chromosomal breaks. This mechanism is the likely 
cause of the increased cancer risk, and perhaps the cognitive defects associated 
with low folate intake (Ames 1998). 
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BIOAVAILABILITY OF FOOD CONSTITUENTS 
Accurate information on the bioavailability of nutrients and nonnutrients is needed 
in order to devise food-based strategies for long-term alleviation of deficiency 
and/or to devise food or supplement-based interventions to reduce risk for chronic 
diseases, which appear linked to these food constituents. Thus, it is important to 
be able to estimate the uptake of the food constituents from the gastrointestinal 
tract; the extent of their metabolism in the intestinal wall and in other tissues of 
the body, including conversion to the active form of a nutrient; the concentrations 
reached and maintained in various organs and tissues of the body; and the rate 
and mode of excretion from the body. Vitamin toxicity is a growing problem and 
here, too, bioavailability and bioconversion is important. For example, the self-
limiting conversion of carotenoids to retinol apparently prevents retinol toxicity 
(Bates 1989), although very high intakes of some carotenoids can lead to 
hyperpigmentation of tissues (Dimitrov et al. 1988, Diplock 1995). 
The term bioavailability is used by a variety of investigators in various fields of 
research. The following series of definitions is used to clarify the situation, 
especially since the well-established toxicological/pharmacological definition of 
bioavailability is not compatible with the nutritional use of the term. Bioavailability 
can be defined as the proportion of a nutrient ingested which becomes available 
to the body for metabolic processes (Macrae et al. 1993) or the proportion of a 
nutrient being capable of being absorbed and available for use or storage or more 
briefly the proportion of a nutrient that can be used (Bender 1989). In order for a 
nutrient to be capable of being used - or available - it must either be present in the 
diet in a form that can be transported across the mucosa, or the ingested forms 
must be capable of being transformed into transportable forms and the nutrient 
must be absorbed in a form that can be utilised in normal metabolism. More 
recently bioavailability has been defined as the fraction of an ingested nutrient 
that is available for utilisation in normal physiological functions or for storage 
(Jackson 1997). The term bioconversion is used to refer to the conversion to the 
active form of a nutrient. The overall process from ingestion to the formation of an 
active form of a nutrient is termed bioefficacy although this is often referred to as 
bioconversion. 
Factors affecting bioavailability and bioconversion 
The factors that affect nutrient, and nonnutrient, bioavailability, and in some cases 
bioconversion, include: Species of carotenoid; molecular Linkage; Amount of 
carotenoid consumed in a meal; Matrix in which the nutrient is incorporated; 
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Effectors of absorption and bioconversion; Nutrient status of the host; Genetic 
factors; Host related factors; and Interactions. By using the capitalised letter, the 
mnemonic SLAMENGHI has been introduced to order these factors (Castenmiller 
& West 1998, de Pee & West 1996, West & Castenmiller 1998). The 
bioavailability of iron has been examined thoroughly (Benito & Miller 1998, Hurrell 
1997), whereas little information is available on the bioavailability and 
bioconversion of other food components, especially nonnutrients. Current 
knowledge of each of the SLAMENGHI factors for carotenoids is discussed in 
Chapter 2. Some of the factors can be manipulated, for example, the amount 
consumed, the food matrix or the amount of fat or dietary fibre in a meal. 
BIOAVAILABILITY OF CAROTENOIDS 
Absorption and transport of carotenoids 
Carotenoids are absorbed in a similar manner to other fat-soluble compounds. 
They are incorporated into mixed micelles, which are formed from triacylglycerols, 
phospholipids, other fat-soluble compounds and bile salts. The carotenoids are 
then absorbed intact in the small intestine by passive diffusion into the 
enterocytes or cleaved in the intestinal mucosa, forming retinyl esters, and 
subsequently incorporated in chylomicrons and transported in chylomicrons to the 
liver. Carotenoids, and tocopherols, can be resecreted from the liver with 
lipoproteins for transport by plasma to other tissues. In man, about 75-80% of the 
carotenoid hydrocarbons (p-carotene and lycopene) is transported in large, less 
dense low-density lipoproteins (LDL), 12% in very low-density lipoproteins (VLDL) 
and 8% in high-density lipoproteins (HDL) (Krinsky et al. 1958, Lowe et al. 1999, 
Mathews-Roth & Gulbrandsen 1974), whereas lutein and zeaxanthin are more 
evenly distributed between the smaller, more dense LDL particles and high 
density lipoproteins (Cornwell et al. 1962, Lowe et al. 1999). Among all 
lipoproteins, transfer of p-carotene may occur (Johnson & Russell 1992). 
Carotenoids may interact with each other during intestinal absorption, 
metabolism and serum clearance (Gaziano et al. 1995, Kostic et al. 1995). The 
concentration of various carotenoids in serum and other tissues depends not only 
on their absorption but also on differential uptake and subsequent metabolism, 
including the conversion of provitamin A carotenoids to retinol, by various tissues. 
For example, after ingestion of p-carotene, both p-carotene and retinol are found 
in serum, liver and adipose tissue (Krinsky et al. 1990). Lutein has been shown to 
accumulate in the eye (Nussbaum et al. 1981), while a-carotene, p-carotene, 
16 
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lycopene, zeaxanthin, and cryptoxanthin accumulate in a variety of tissues 
(Kaplan etal. 1990). 
Provitamin A carotenoids are converted to retinol by the action of 15-15'-
carotenoid dioxygenase. This process occurs primarily in the enterocytes 
although enzyme activity is found in other tissues such as the liver. It is not yet 
established beyond doubt whether just one enzyme exists and whether the 
cleavage of p-carotene is central or not (Wolf 1995). The formation of p-apo-13-
carotenone and beta-apo-14'-carotenal provides direct evidence for an enzymatic 
eccentric cleavage mechanism (Tang et al. 1991). Parker et al. (1993) used Re-
labelled p-carotene in humans and recovered most of the label in retinyl esters. 
This finding would suggest that p-carotene cleavage is central; central oxidation 
of p-carotene theoretically yields two molecules of retinol. Other provitamin A 
carotenoids apparently yield 1 mol retinol per mol carotenoid undergoing 
metabolism. 
Methods to determine bioavailability of carotenoids 
Various methods have been used up until now to measure carotenoid 
bioavailability and bioconversion. The balance method compares the amount of 
carotenoid recovered in the faeces with that fed. Studies from India indicated that 
between one quarter and a half of p-carotene in amaranth was recovered in 
faeces suggesting that the remainder was absorbed and converted to retinol (Lala 
& Reddy 1970). Three to five year old children absorbed 75% of a single dose of 
1200 ug p-carotene from an alga (Annapurna et al. 1991) and 45% of a 
supplement of 14 mg carotene with oil was absorbed in a placebo controlled 
experiment with 9-16 year old boys (Roels et al. 1958). Shiau et al. (1994) 
assessed the retention time of p-carotene during transit through the intestine by 
using the total gut washout method. For subjects receiving no meal, 83% of 
ingested p-carotene was recovered in rectal effluent collected within 24 hours 
post-p-carotene administration, whereas the quantity of p-carotene in faeces of 
individuals receiving meals was 49-71%. Goodman and colleagues (1966) 
administered 14C-labelled to subjects and recovered 9 and 17% of the 
radioactivity of p-carotene in lymph over a 20-h period. This result suggests that 
balance studies overestimate absorption. Probably, carotenes are broken down in 
the large intestine. Nowadays medical ethical committees are reluctant to approve 
studies using radioactive isotope-labelled compounds, such as 14C-labelled p-
carotene and retinol, in human subjects. More recently, uniformly labelled 13C-p-
carotene (Parker et al. 1993) and 2H-labelled d8-p-carotene (Dueker et al. 1994, 
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Novotny et al. 1995) have been used to measure relative p-carotene 
bioavailability and conversion to retinol. However, without the administration of 
labelled retinol it is not possible to quantify the contribution, which p-carotene 
makes to retinol synthesis. At the Division of Human Nutrition and Epidemiology 
(Wageningen University), a method has been developed using 13Cio-P-carotene 
and 13C10-retinyl palmitate to quantify the bioavailability and bioconversion of p-
carotene (van Lieshout et al. 1999). 
Most studies on bioavailability and bioconversion have measured p-carotene 
and retinol concentrations in serum or plasma. With the methods used, it was not 
possible to study the metabolism of p-carotene. Relative bioavailability can be 
measured by comparing the serum response of a carotenoid-rich food relative to 
a synthetic supplement of the carotenoid dissolved in oil (Brown et al. 1989, 
Jensen et al. 1986, Masaki et al. 1993, Micozzi et al. 1992). Another modification 
of the serum response is to measure the concentration of p-carotene and retinyl 
esters and other carotenoids in various lipoprotein fractions (van Vliet et al. 1995, 
van den Berg 1998). Results from several studies comparing weighed intakes of 
carotenoids and mean plasma concentrations suggest that plasma carotenoid 
concentrations are indicative of dietary intake, but the large intra-individual 
variation in plasma concentrations indicates that any assessment of longer-term 
status from data at any one time-point should be treated with caution (Scott et al. 
1996). 
BIOAVAILABILITY OF FOLATE 
Based on a review of the literature, Brouwer et al. (1999) concluded that the food 
matrix and the amount of folic acid consumed are the main factors influencing 
folate bioavailability. 
Absorption and transport of folate 
Natural folates are present primarily in the polyglutamate form. Before absorption, 
glutamate moieties distant to the proximal glutamate residue must be removed by 
the enzyme conjugase pteroylpolyglutamate hydrolase. After hydrolysis to 
monoglutamates, two different transport systems are present. Folates can be 
bound to membrane-associated folate binding proteins and transported across 
the brush border membrane by a carrier-mediated mechanism. Active mucosal 
transport is accelerated by glucose and galactose and impaired by unidentified 
factors present in many foods. At high intraluminal concentrations of folate (>10 
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|JM) a nonsaturable diffusion-mediated transport system plays a major role in 
folate absorption (Mason et al. 1990). Folic acid absorbed from the intestine at 
physiological concentrations is largely converted to reduced forms and then 
methylated or formylated, whereas at higher concentrations, it is transported 
through the enterocytes without such modifications (Herbert & Das 1994). Folate 
is delivered to bone marrow cells, reticulocytes, liver, cerebrospinal fluid, and 
renal tubular cells. Prior to tissue storage or use as a coenzyme, folate 
monoglutamate is converted to the polyglutamate form. 
Methods to determine bioavailability of folate 
Folate bioavailability can be determined by measuring urinary excretion of 
labelled folate (Gregory et al. 1991, Gregory et al. 1992) and area-under-the-
curve (AUC) of serum folate (Bailey et al. 1988, Pfeiffer et al. 1997, Tamura & 
Stokstad 1973). The primary indicator of folate adequacy selected is red cell 
folate, which reflects tissue folate stores and is an indicator of long-term status. 
Plasma homocysteine concentration increases when inadequate quantities of 
folate are available to donate the methyl group that is required to convert 
homocysteine to methionine. Serum or plasma folate concentration is considered 
a sensitive indicator of dietary folate intake (Jacques et al. 1993). High intakes of 
500 ug of folic acid or more have no additional effect on improving the functional 
parameter of folate status, plasma total homocysteine concentration. It is not clear 
whether high doses of folic acid pose health risks (Brouwer et al. 1999). 
ROLE AND MECHANISM OF ACTION OF ANTIOXIDANTS 
It is difficult to interpret whether the apparent benefits of fruit and vegetable intake 
are due to antioxidant vitamins, other nutrients, nonnutrients, dietary habits or 
other lifestyle characteristics. Foods and the human body are under constant 
oxidative stress from free radicals, reactive oxygen and nitrogen species and 
other prooxidants. Antioxidants are needed to prevent the formation and oppose 
the actions of reactive oxygen and nitrogen species, which are generated in vivo 
and cause damage to DNA, lipids, proteins, and other biomolecules. It is 
however, important to emphasise that not all reactions in living systems that 
involve free radicals are damaging; thus, several normal biological processes in 
vivo depend on free radicals (Diplock et al. 1994). Cells have intact 
prooxidant/antioxidant systems that function continuously to generate and to 
detoxify oxidants during normal aerobic metabolism. Oxidative stress is an 
19 
Chapter 1 
imbalance between prooxidants and antioxidants in favour of the prooxidants and 
has been demonstrated to play a role in many diseases, including cancer, 
cardiovascular and pulmonary diseases (Bast et al. 1998). Radicals of oxygen 
(superoxide anion and hydroxyl, alkyoxyl, and peroxyl radicals), reactive 
nonradical oxygen species (hydrogen peroxide and singlet oxygen) and radicals 
of carbon, nitrogen, and sulfur constitute the variety of reactive molecules that 
cause oxidative stress to cells. Radicals are defined as any atom or molecule that 
contain one or more orbital electrons with unpaired spin states; the radical may be 
a very small molecule such as oxygen or it may be a part of a large biomolecule 
such as a protein, carbohydrate, lipid, or nucleic acid (Diplock 1994, Thomas 
1994). They are in many instances highly reactive because the unpaired state is 
thermodynamically unstable. The effectiveness of an antioxidant against oxidative 
stress depends on its ability to counteract the specific molecules causing the 
stress and the cellular or extracellular location of the source of these molecules. 
In response to oxidative stress, biological tissues have developed 
multicomponent, multiphasic antioxidants (Decker 1998). Antioxidants might act 
through donation of electrons or hydrogen atoms (Bast et al. 1998). However, the 
first line of defence, which is largely enzymatic, is to prevent the generation of 
radical species derived from molecular oxygen. The enzymes superoxide 
dismutase, catalase and glutathione peroxidase are ubiquitously distributed in all 
aerobic organisms (Madhavi et al. 1996). Superoxide dismutase prevents the 
accumulation of superoxide anion (02*), which is not membrane-permeable, by 
converting it to hydrogen peroxide (H202), which is metabolised by catalase or 
glutathione peroxidase to water. The second line of defence is to reverse damage 
or prevent further damage to cellular constituents such as lipids and nucleic acids. 
To support both the first and second line of defence, a pool of antioxidants is 
required. These include endogenous constituents, such as serum proteins and 
their thiol groups, bilirubin, urate and glutathione and dietary constituents, such as 
ascorbic acid, tocopherols, carotenoids and flavonoids. The second line of 
oxidative defence can most clearly be seen in the case of lipid peroxidation. The 
polyunsaturated fatty acids (PUFA:H) of cell membranes are susceptible to free 
radical attack. A free radical (OH') can extract a hydrogen atom from PUFA:H, 
forming a PUFA radical (PUFA*). In combination with oxygen, a peroxyl radical is 
produced (PUFAiOO*) which reacts with PUFA:H to form a hydroperoxide 
(PUFA:OOH) and another PUFA*. Moreover in the presence of iron or copper 
PUFA:OOH can undergo one electron reduction to form more free radicals 
(PUFA:0* and OH*) (Duthie 1993). Primary antioxidants can react with peroxyl 
radicals before they react further with unsaturated lipid molecules and convert 
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them to more stable products. The best-known primary antioxidants are phenolics 
and tocopherols. Secondary antioxidants are compounds that retard the rate of 
chain initiation by various mechanisms other than the pathway followed by the 
primary antioxidants. The secondary antioxidants reduce the rate of autoxidation 
of lipids by such processes as binding metal ions, scavenging oxygen, 
decomposing hydroperoxides to nonradical products, absorbing UV radiation, and 
deactivating singlet oxygen (Madhavi et al. 1996). Some of the major antioxidant 
defence mechanisms within the cell are depicted in Figure 2. 
There is no doubt that antioxidants are of great importance in the aetiology of a 
number of different human diseases. It is critical to provide evidence that a diet 
with a high antioxidant capacity and activity from fruits and vegetables can either 
increase the overall antioxidant capacity or change the relative balance between 
individual antioxidant components in the human body; otherwise, any antioxidant 
hypotheses related to the protection of fruits and vegetables against diseases 
would not be sustained. Antioxidants may act synergistically. Palozza & Krinsky 
(1992) showed that p-carotene can act synergistically with a-tocopherol in rat liver 
microsomes: p-carotene regenerated a-tocopherol from the a-tocopheroxy 
radical. Tocopherol functions synergistically with ascorbic acid, which can react 
with tocopherol radicals to regenerate tocopherol. Glutathione reduces the 
ascorbyl free radical and ascorbate can regenerate a-tocopherol from the a-
tocopherol free radical (Haenen & Bast 1983) or repair the p-carotene radical 
(Bohm et al. 1998). Tocopherol, especially together with ascorbic acid, destroys 
nitrite, an essential component in the food chain associated with cancer of the 
stomach, oesophagus and liver (Weisburger 1991). 
Carotenoids as antioxidants 
Carotenoids have been shown to possess antioxidant activity in vitro. 
Nevertheless, there is no convincing evidence that carotenoids possess 
antioxidant activity in humans. Carotenoids such as a-carotene, p-carotene, 
lycopene, and some oxycarotenoids, such as zeaxanthin and lutein, exert 
antioxidant functions in lipid phases by physical or chemical quenching of singlet 
oxygen (102) or by reacting with a variety of free radicals (Burton & Ingold 1984, 
Sies & Stahl 1995). The antioxidant action is limited to low oxygen partial 
pressures, less than 150 torr, and at higher oxygen pressures p-carotene may 
become prooxidant (Krinsky 1993). 
In plant chloroplasts, carotenoids are important scavengers of singlet oxygen 
generated by an excited state of chlorophyll. The ability to quench singlet oxygen 
is related to the number of double bonds in the molecule. Carotenoids with 9 to 11 
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Figure 2. Major antioxidant defence mechanisms within the cell. 
R*, free radical; PUFA:H, polyunsaturated fatty acid; PUFA:OOH, fatty 
acid hydroperoxide; PA2, phospholipase A2; X, can be either ascorbic 
acid or a carotenoid while X* is the corresponding radical; GSH, 
reduced glutathione; GSSG, oxidised glutathione; GPx, glutathione 
peroxidase; GR, glutathione reductase; Cat, catalase; SOD, 
superoxide dismutase 
conjugated double bonds, which includes all the carotenoids in Figure 1, are 
electron-rich and can absorb the energy from the singlet oxygen and distribute it 
over all the single and double bonds in the molecule. These carotenoids are 
reported to be better quenchers than those with eight or fewer conjugated double 
bonds are (Hirayama et al. 1994). Thus, carotenoids are able to take over and 
absorb the energy from molecules in high-energy states. In this way carotenoids 
can quench the higher-energy form of oxygen, singlet oxygen (102). After this 
reaction, the oxygen returns to its basic triplet state (302): 
102 + 1 carotenoid -> 302 + 3carotenoid 
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The 'energised' carotenoid (3carotenoid) then releases the absorbed energy in the 
form of heat, thereby restoring it to its normal energy level. 
3carotenoid -> carotenoid + heat 
Carotenoids are therefore not destroyed during the process and can repeat the 
process with additional singlet oxygen molecules (Bast et al. 1998, Britton 1995a, 
Krinsky 1994, Madhavi et al. 1996). 
The proposed antioxidant mechanisms of carotenoids against free radicals, as 
in lipid oxidation, includes electron transfer, which results in the formation of 
carotenoid radical cations, addition reactions forming carotenoid-adduct radicals 
and further radical reactions, in which carotenoids act as hydrogen atom donors 
forming neutral carotenoid radicals (Bast et al. 1998, Haila 1999). Electron 
transfer results in the formation of a carotenoid radical cation, as follows: 
carotenoid -> carotenoid** + e' 
The resulting electron might be used to neutralise free radicals (R*): 
R* + e" -» R 
The carotenoid radical cation might also undergo a dismutation reaction, whereby 
a radical termination occurs: 
2 carotenoid** -> carotenoid + carotenoid2* 
Different carotenoid structures will differ in their ability to participate in electron 
transfer reactions. Addition reactions form carotenoid-adduct radicals, which can 
react further to form a non-radical product: 
ROO* + carotenoid -> ROO-carotenoid* 
ROO-carotenoid* + ROO* -> ROO-carotenoid-ROO 
Hydrogen abstraction leads to formation of the neutral carotenoid radical: 
R* + carotenoid -> RH + carotenoid* 
At higher oxygen pressure, carotenoid-adduct radicals can react with oxygen to 
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generate a carotenoid-adduct peroxyl radical: 
ROO-carotenoid* + 0 2 -> ROO-carotenoid-OO* 
This latter compound might have a prooxidant activity. 
From this short description it can be concluded that the possible antioxidative role 
of carotenoids in nutrition is complex. 
OUTLINE OF THE THESIS 
The objective of this thesis is to study the bioavailability of carotenoids and folate, 
with special emphasis on the effect of the food matrix on carotenoid bioavailability 
and to obtain insight in the antioxidant or prooxidant activity of various spinach 
products in man and in spinach products. 
In Chapter 2, an overview of the literature is given on the state of our 
knowledge with regard to factors affecting the bioavailability and bioconversion of 
carotenoids. As indicated by the mnemonic (SLAMENGHI) the bioavailability of 
carotenoids is influenced by extrinsic and intrinsic factors while dietary and 
nutrient interactions may also play a role. The effect of the food matrix and dietary 
fibre on the bioavailability of carotenoids and folate was examined in a controlled 
dietary intervention study described in Chapters 3 and 4, respectively. Whether 
the bioavailability or intake of carotenoids ((3-carotene and lutein) has an effect on 
markers of enzymatic and non-enzymatic antioxidant activities in human blood is 
examined in Chapter 5. And in Chapter 6 the antioxidant activity of differently 
processed spinach products was tested in different models. 
Spinach was selected as the experimental vegetable because in Europe, 
spinach is the most popular frozen vegetable. The mean intake of carotenoids in 
the Netherlands is estimated to be for a-carotene, (3-carotene and lutein plus 
zeaxanthin, 0.7, 3.0, and 2.5 mg/d, respectively. The most important foods 
contributing to the intake of p-carotene were carrots, while spinach, endive and 
kale contributed to the intake of p-carotene and lutein plus zeaxanthin (Goldbohm 
et al. 1998). The results are discussed and the conclusions are presented in 
Chapter 7. 
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ABSTRACT 
Factors that influence the bioavailability of carotenoids and their bioconversion to 
retinol are species of carotenoids, molecular linkage, amount of carotenoids 
consumed in a meal, matrix in which the carotenoid is incorporated, effectors of 
absorption and bioconversion, nutrient status of the host, genetic factors, host-
related factors, and mathematical interactions. In this paper, current knowledge of 
these factors is examined. Although data are not sufficiently comparable to allow an 
extensive systematic comparison of results, a number of conclusions can be drawn 
from the information now available. 
INTRODUCTION 
Carotenoids are important to man and other animals as precursors of vitamin A and 
retinoids. In addition, they act as antioxidants, immunoenhancers, inhibitors of 
mutagenesis and transformation, inhibitors of premalignant lesions, screening 
pigments in primate fovea, and nonphotochemical fluorescence quenchers. 
Increased dietary intake of carotenoids is associated with decreased risk of (a) 
macular degeneration and cataracts, (b) some cancers, and (c) some 
cardiovascular events (Krinsky 1993). Carotenoids also have a widespread function 
or use in coloration. 
Naming 
Most carotenoids can be described by the general formula C4oH56On where n is 0-6. 
Hydrocarbons {n = 0) are termed carotenes and oxygenated carotenoids are called 
xanthophylls. According to the International Union of Pure and Applied Chemistry 
(IUPAC 1959) recommendation for semi-systematic names, the trivial names for 
carotenes, such as a-carotene and (3-carotene, should be replaced by p,e-carotene 
and p,p-carotene respectively. However, the trivial names are well-established and 
more convenient to use, so the trivial names rather than the IUPAC semi-systematic 
names are used in this paper. 
Bioavailability 
Bioavailability is the fraction of an ingested nutrient that is available for utilisation in 
normal physiological functions or for storage (Jackson 1997). Published information 
on carotenoid bioavailability is based mainly on measurement of carotenoids in 
serum or plasma after ingestion. It should be noted that at steady state, plasma 
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carotenoids amount to approximately one percent of the total body content of 
carotenoids, whereas the highest concentration can be found in the liver (Schmitz et 
al. 1991). 
There are various methods for determining bioavailability of carotenoids: the 
balance method (Lala & Reddy 1970, Roels et al. 1958, Shiau et al. 1994), 
measurement of recovery of radioactive p-carotene in lymph (Blomstrand & Werner 
1967, Goodman et al. 1966), use of uniformly labelled p-carotene (Dueker et al. 
1994, Novotny et al. 1995), or comparison of the response in serum or lipoprotein 
fractions of carotenoids with standard doses of carotenoids. Most research has 
concentrated until now on determining serum or plasma concentrations of 
provitamin A carotenoids, especially p-carotene. Comparatively little is known about 
the occurrence, function, and bioavailability of non-provitamin A carotenoids. The 
concentration in serum may not be the best indicator of carotenoid status (Fotouhi et 
al. 1996, Kardinaal et al. 1995) because these concentrations are a result of 
absorption and removal from serum for storage, bioconversion, or excretion. 
Furthermore, fasting serum carotenoid concentrations can be affected, sometimes 
quite rapidly, by a number of factors, such as smoking. 
Bioconversion 
Carotene bioconversion, strictly speaking, is the proportion of bioavailable carotene 
converted to retinol. Often however, the term covers both the bioavailability and 
bioconversion process. Provitamin A carotenoids are converted to retinol by the 
action of 15-15'-carotenoid dioxygenase. This process occurs primarily in the 
enterocytes although enzyme activity is found in other tissues, such as the liver. 
There is still controversy about whether the cleavage is central or eccentric. Per 
molecule of p-carotene, central cleavage would result in the formation of two 
molecules of retinal, which could be reduced to retinol and then esterified, whereas 
eccentric cleavage would produce one molecule of a p-apo-carotenal that could be 
converted not only to retinal but also to p-apo-carotenoic acids and subsequently to 
retinoic acid. Van Vliet and co-workers (1995) suggested that the ratio of the 
response of retinyl esters to p-carotene may be a good indicator of intestinal p-
carotene conversion. Of absorbed p-carotene, 60-70% was converted, mainly into 
retinyl esters, but several details with respect to the cleavage reaction remain to be 
elucidated (van Vliet et al. 1996a). 
There is no information about the conversion of carotenoids that escape 
bioconversion in intestinal enterocytes. In vivo carotenoid conversion always refers 
to bioavailability plus bioconversion of carotenoids. In the future, it would be 
worthwhile to obtain information about bioavailability, bioconversion, and the 
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composite of both. 
FACTORS AFFECTING THE CAROTENOID BIOAVAILABILITY AND 
BYCONVERSION 
De Pee & West (1996) reviewed the evidence that carotene-rich fruits and 
vegetables can overcome vitamin A deficiency and concluded that the positive 
effects that get reported often come from studies with poor experimental designs. 
They noted that a number of factors influence the bioavailability of carotenoids, 
which they grouped in the mnemonic SLAMENGHI (Castenmiller & West 1997, de 
Pee & West 1996): Species of carotenoids, molecular Linkage, Amount of 
carotenoids consumed in a meal, Matrix in which the carotenoid is incorporated, 
Effectors of absorption and bioconversion, Nutrient status of the host, Genetic 
factors, Host-related factors, and mathematical interactions. The purpose of this 
paper is to discuss current knowledge of the factors affecting bioavailability and 
bioconversion of carotenoids. Prediction of carotenoid bioavailability from different 
foods and under specified circumstances would be possible if each of these factors 
could be quantified and if observed additive effects can be split into their 
SLAMENGHI components. This review is restricted mainly to studies of humans but 
will refer to animal studies where relevant. 
SPECIES OF CAROTENOIDS 
Bioavailability 
The naturally occurring configuration of carotenoids in plant foods is usually the all-
trans isomer. In general, cis isomers are more polar, less prone to crystallisation, 
and more soluble in oils and hydrocarbon solvents. The cis isomeric composition 
increases with food processing, particularly heating, and the quantity formed 
appears related to the severity and extent of heat treatment. Rushin and co-workers 
(1990) demonstrated that cis isomers (mainly 13-c/s) had not formed after blood 
was drawn and that cis isomers of p-carotene were present at significant 
concentrations in the human circulation. The all-frans form is absorbed more readily 
in humans than the 9-c/s form. When multiple doses of mixtures of the two were 
ingested, the proportion of the 9-c/s form found in serum was less than one sixth of 
the amount found in the carotenoid mixture (Ben-Amotz & Levy 1996, Gaziano et al. 
1995, Jensen et al. 1987, Tamai et al. 1995). Also, after a single dose, the increase 
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of all-frans-p-carotene in serum or in the chylomicron fraction of serum was much 
higher than for the 9-c/s isomer (Stahl et al. 1993, Stahl et al. 1995), which indicates 
a strong preferential absorption or transport of the all-frans isomer in comparison 
with the 9-c/s isomer. After a single oral dose, more than 95% of plasma 13C-labeled 
frans-p-carotene and labelled retinol was derived from labelled 9-c/s-p-carotene. 
This indicates that a significant portion of the labelled 9-c/s-p-carotene dose was 
isomerised to labelled frans-p-carotene before entering the blood stream (You et al. 
1996). When lycopene uptake from processed and unprocessed tomato juice was 
studied in humans, the cis isomer was somewhat better absorbed than the a\\-trans 
form (Stahl 8s Sies 1992). This would be related to the better solubility of the cis 
form. 
Larger amounts of p-carotene were incorporated into the micelles when the 
carotene mixtures contained 86% rather than 5% 9-c/s-p-carotene, and an increase 
in the level of total carotene in the solution was accompanied by a constant or even 
enhanced carotene incorporation (Levin & Mokady 1995). 
In all studies on isomeric forms (see Table 1), the effect of algae supplements 
(containing similar amounts of 9-c/s- and all-frans-p-carotene) was smaller than the 
response to similar concentrations of synthetic p-carotene (mainly a\\-trans). Based 
on studies with multiple doses, a daily intake of c/s-p-carotene from algae or 
synthetic p-carotene would results in a 0.018- and 0.003- nmol p-carotene increase 
per mg, respectively, in serum. For all-frans-p-carotene, these values are 0.027 
nmol for algae and 0.032 (j.mol for synthetic p-carotene. 
Bioconversion 
All carotenoids containing at least one unsubstituted p-ionone ring and a polyene 
side-chain attached containing at least 11 carbon atoms are potential precursors of 
vitamin A, with p-carotene showing the highest vitamin A activity on a molar basis. 
Data on the relative bioconversion of various carotenoids to retinol is presented in 
Table 2. These data are based on the storage of retinol in the liver when its 
carotenoids are fed and therefore comprise not only bioconversion but also 
bioavailability. The FAO/WHO Expert Consultation on vitamin A requirements has 
assumed that the vitamin A activity of other provitamin A carotenoids, including cis 
isomers of p-carotene, is 50% that of p-carotene (FAO/WHO Joint Expert 
Consultation 1988). Studies using intestinal preparations have generally supported 
these data: a-carotene, 29% (van Vliet et al. 1996c); p-cryptoxanthin, 55% (van Vliet 
et al. 1996c); and c/s-p-carotene, 7% (Nagao & Olson 1994). Intestinal perfusion 
studies with ferrets have shown that absorption, clearance and metabolism ofall-
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Table 1. SLAMENGHI factor S (Species): cis-trans isomers 
SLAMENGHI factor 
Study Details8 Bioavailability" Biocon-
versionc 
Ben- 2 x 15 M, 20-30 y; 40 mg p-carotene daily 
Amotz & for 14 days from alga Dunaliella bardawil 
Levy (42% all-frans, 43% 9-c/s) or synthetic B-
(1996) carotene (97% all-frans), or placebo 
Gaziano 7 M and 17 F; 100 mg p-carotene daily for 
et al. 6 days from Dunaliella salina (50% all-
(1995) irans) or synthetic all-frans-p-carotene 
Jensen et 6 M and 10 F, 18-60 y; 24 mg p-carotene 
al. (1987) daily for 7 days from Dunaliella salina (all-
frans:9-c/s = 40:60) or carrots (98% all-
frans) or placebo 
Stahl et 3 M and 2 F, 23-37 y; single dose of 5.6 
al. (1993) nmol p-carotene/kg body weight and 0.17 
nmol/kg body weight of a-carotene from 
Dunaliella salina (54% all-frans, 37% 9-
cis, 9% other cis isomers, 1 % a-carotene) 
Stahl & 5 M and 1 F, 22-36 y; single dose of 2.5 
Sies nmol lycopene per kg body weight as 
(1992) heated tomato juice (20-30% cis isomers) 
Tamai et 30 M, 20-25 y; 60 mg p-carotene daily for 
al. (1995) 44 weeks from Dunaliella bardawil (all-
frans:9-c/s = 50:50) or synthetic all-frans-
p-carotene or placebo 
Tang et 7 M and 5 F, 23-68 y; single dose of 120 
al. (1996) mg p-carotene 
You et al. 2 M and 1 F, 23-38 y; single dose of 1 mg 
(1996) 99.4% 9-c/s-p-carotene 
All-frans-p-carotene: 0.037, 0.037, 
0.522° 
0.006, 
; c/s-p-carotene: 
0.016d 
1.60° 
All-frans-p-carotene: 0.808, 
1.523d; c/s-p-carotene: 
0.059, 0.095d 
All-frans-p-carotene: 0.687, 
0.492e; c/s-p-carotene: 
0.047,0.017* 
Serum increase of a-
carotene was 5.6% of 
increase of all-frans-p-
carotene, reflecting ration 
in Betatene; no 9-c/s was 
found in serum 
c/s-Lycopene better 
absorbed than all-frans 
form 
All-frans-p-carotene: 0.559, 
1.21'; 
c/s-p-carotene: 0.084, 
0.149' 
frans-p-Carotene: 0.780; 
c/s-p-carotene: 0.020 
Labelling all-frans: >95% of No 9-c/s 
plasma frans-p-carotene retinol 
and retinol was derived detected 
from 9-c/s-p-carotene 
No 
change 
in serum or plasma carotenoid concentration shown as 
in serum or plasma retinol concentration shown in 
M, male; F, female; y, years. 
1
 Unless otherwise stated, increase 
micromoles per liter. 
Unless otherwise stated, increase 
micromoles per liter. 
1
 Results from alga and synthetic p-carotene, respectively. 
1
 Results from alga and carrot, respectively. 
Results estimated from alga and synthetic p-carotene, respectively 
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Table 2. SLAMENGHI factor S(pecies): relative bioconversion of carotenoids3 
Carotenoid Relative bioconversion 
(% on a weight basis) 
(3-Carotene 
9-c/s-p-Carotene 
13-c/s-p-Carotene 
a-Carotene 
y-Carotene 
p-Zeacarotene 
p-Cryptoxanthin 
3,4-Dehydro-p-carotene 
2,2'-Dimethyl-p-carotene 
p-Carotene-5',6'-monoepoxide 
a-Carotene-5,6-monoepoxide 
4-Keto-p-carotene 
3-Keto-p-carotene 
4-Hydroxy-p-carotene 
p-apo-8'-Carotenal 
p-apo-12'-Carotenal 
Non-provitamin A carotenoids6 
100" 
38c 
53c 
50-54"; 29d 
42-50" 
20-40" 
50-60"; 55d 
75" 
50" 
21b 
25" 
44-50" 
52" 
48" 
72" 
120" 
a
 Unless otherwise stated, the carotenoids are in trans form. 
bBauernfeind(1972). 
c
 Zechmeister(1949). 
d
 van Vlietetal. (1996c). 
e
 Non-provitamin A carotenoids such as lutein, lycopene, zeaxanthin, and canthaxanthin do not 
have at least one unsubstituted p-ionone ring and a polyene side-chain attached containing at 
least 11 carbon atoms. 
trans- and 9-c/s-p-carotene produced similar amounts of retinoic acid, with 9-c/s-p-
carotene giving rise to equal amounts of a\\-trans- and 9-c/s-retinoic acid (Hebuterne 
etal. 1995). 
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MOLECULAR LINKAGE 
There are few data on the effect of carotenoid esters, which are common in fruits 
and vegetables, on bioavailability. Herbst et al. (1997) found that lutein diesters 
showed a trend toward greater bioavailability than free lutein suggesting that the 
human gut is very efficient in cleaving esters of lutein, and therefore, esterified lutein 
in food may be equally or better bioavailable than free lutein. No p-cryptoxanthin or 
esters from other carotenoids were detected in chylomicrons or serum after 
consumption of tangerine juice (Wingerath et al. 1995). Since esters are not 
absorbed by the enterocyte, we would not expect molecular linkage to have an 
effect on bioconversion. 
AMOUNT OF CAROTENOIDS CONSUMED IN A MEAL 
Bioavailability of p-carotene 
Serum p-carotene concentrations vary depending on the amount of p-carotene in a 
meal. Shiau et al. (1994) reported that with a meal, only 35-71% of p-carotene was 
recovered in rectal effluent as compared with 83% without a meal. The kinetics of 
serum response to orally ingested p-carotene seems independent of dose (Canfield 
et al. 1997, Henderson et al. 1989), but other factors play a role because the 
responses observed in different studies vary considerably. 
A large number of studies have measured serum or plasma response to 
supplementation with carotenoids, mainly p-carotene. Other studies have examined 
the effect of supplementing a meal with a mixture of carotenoids has on such 
responses. Sometimes these studies have used large, pharmacological doses of p-
carotene, and often they have not been well controlled. The between-individuals 
response to repeated doses of p-carotene, which lead to plateau concentrations 
(Costantino et al. 1988), appears to be generally less variable than the response to 
single doses. An overview of studies is given in the Annex (and posted on a 
website: Supplementary Materials section at http://www.AnnualReviews.org). Prince 
& Frisoli (1993) found that administering p-carotene daily in three divided doses with 
meals increased the serum p-carotene concentration three times more than when 
the same total dose was administered once daily. The studies listed in the Annex 
are not strictly comparable, often because the matrix in which the carotene was 
supplied is different (see below), and, for example, the p-carotene preparations 
used were different. Some supplements contained carotenoids in water-soluble 
beadlets whereas others contained crystalline carotenoids dissolved or 
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resuspended in oil. Calves receiving the commercial beadlet sources had higher 
serum carotenoid levels than calves receiving carotenoids in oil. When fed water-
soluble p-carotene beadlets, calves had peak p-carotene levels 28 times higher 
than when fed crystalline p-carotene (Bierer et al. 1995). 
Data from single-dose studies indicate that in normal subjects the efficiency of 
carotenoid absorption varies widely. Serum p-carotene concentrations rise quickly 
after a single oral dose and usually peak at 5 h and remain elevated for more than 
24 h. Omission of a meal delays the time to reach peak concentrations. A delayed 
and less-efficient absorption was reported with higher doses (Nierenberg et al. 
1991). Some subjects do not show a plasma response after supplementation 
(Gartner et al. 1997, Johnson & Russell 1992). After a meal, there may be large 
intra-individual variability in triglyceride response. Thus, it may be advisable to 
adjust carotenoid values in serum for triglyceride response after a single dose of p-
carotene (van Vliet et al. 1995). Most studies on carotenoid bioavailability do not 
report triglyceride responses. 
To study the linear and dose-response relationship between p-carotene 
supplementation and increases in serum p-carotene concentrations, a meta-
analysis was carried out that included all studies with a daily p-carotene supplement 
of <50 mg that lasted <1 year. The analysis included 31 studies, and the 
heterogeneity between the study results was apparent. The 95% between-study 
interval in serum response per mg of supplemented p-carotehe ranged from 0.0317 
umol to 0.0388 umol/liter. The duration of p-carotene supplementation was a 
significant predictor of p-carotene response. 
Bioavailability of other carotenoids 
Carotenoids may interact with each other during intestinal absorption, metabolism, 
and serum clearance. Data suggest that the concentration of a-carotene in plasma 
(Carughi & Hooper 1994) and chylomicrons (Gartner et al. 1996) and the 
concentration of lycopene in plasma (Carughi & Hooper 1994) reflect the content of 
these carotenoids in the meal or supplement. 
Some studies showed no effect of p-carotene on serum levels of a-carotene, 
cryptoxanthin, lycopene, and lutein (Fotouhi et al. 1996, Henderson et al. 1989), 
whereas others found significantly different carotenoid concentrations after 
supplementation with p-carotene. The plasma lutein concentration was significantly 
reduced after multiple (Micozzi et al. 1992) and single doses (Kostic et al. 1995) of 
P-carotene. In the presence of high amounts of p-carotene, the uptake from the 
intestinal lumen into chylomicrons of lutein and zeaxanthin as compared to a\\-trans-
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p-carotene was preferred (Gartner et al. 1996). p-Carotene supplementation 
reduced the lycopene concentrations in low-density lipoproteins (Gaziano et al. 
1995) and serum significantly (Prince & Frisoli 1993). In contrast, Wahlqvist et al. 
(1994) found an increase in lycopene concentration after p-carotene 
supplementation, but only in men. a-Carotene concentrations were increased after 
P-carotene supplementation (de Pee et al. 1995, Micozzi et al. 1992, Wahlqvist et al. 
1994). The ingestion of concurrent doses of p-carotene and canthaxanthin reduced 
the peak serum canthaxanthin concentration, but canthaxanthin did not inhibit the 
appearance of p-carotene in serum (White et al. 1994). 
In summary, p-carotene supplementation increases concentrations of a-carotene 
in a dose-dependent but non-linear way and would appear to decrease serum 
concentrations of lutein, lycopene, and canthaxanthin. Related to dietary intake in 
milligrams per day, the increases in serum carotenoid concentration for other 
carotenoids are 0.06-0.15 |amol of lutein/liter, 0-0.09 (imol of lycopene/liter, and 
0.11-0.27 (imol of a-carotene/liter. 
Bioconversion 
In 1967, the FAC7WHO (1967) concluded that when consumed in a mixed meal, 6 
ng of p-carotene - or 12 |og of other provitamin A carotenoids - is absorbed and 
converted to 1 ^g of retinol. However, the FAG7WHO Joint Expert Consultation 
recognised in 1988 that retinol equivalence is related to dose level. When the p-
carotene intake per meal is <1000 or >4000 \xg, the amount of p-carotene 
equivalent to 1 |ig of retinol was considered to be 4 and 10 ^g, respectively 
(FAO/WHO Joint Expert Consultation 1988). 
In rats, low intake of vitamin A increases cleavage activity as measured in vitro 
(van Vliet et al. 1996b, Villard & Bates 1986), and a high intake of p-carotene 
increases cleavage activity in the liver of rats (van Vliet et al. 1996b). Based on the 
difference in liver vitamin A contents between p-carotene-supplemented and 
unsupplemented rats, p-carotene conversion factors were estimated at 9:1 for rats 
fed high amounts of vitamin A and 4:1 for rats fed normal and low amounts of 
vitamin A (van Vliet et al. 1996b). Intestinal p-carotene cleavage activity was higher 
in vitamin A-deficient rats than in rats with a high intake of vitamin A or p-carotene. 
The addition of lutein to an incubation of p-carotene reduced retinal formation, 
whereas lycopene had no effect (van Vliet et al. 1996c). 
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MATRIX IN WHICH THE CAROTENOID IS INCORPORATED 
Bioavailability 
p-Carotene dissolved in oil is absorbed far more readily than p-carotene from foods. 
It is possible to calculate relative bioavailability by comparing the effect a food has 
on serum p-carotene values with the effect pure p-carotene has. It should be noted 
that "pure" p-carotene can be water-soluble p-carotene beadlets or p-carotene in a 
suspension with oil. Bioavailability of p-carotene from these preparations may be 
different. Compared with the serum response from p-carotene supplements, the 
bioavailability of p-carotene from various foods is as follows: stir-fried vegetables, 
7% (de Pee et al. 1995); carrots, 18-26% (Brown et al. 1989, Micozzi et al. 1992, 
Torronen et al. 1996); and spinach, 7% (JJM Castenmiller, CE West et al. 
unpublished information). A subsequent study in Indonesia (de Pee et al. 1998) 
found the serum response of p-carotene from fruits to be four times that from 
vegetables. The low bioavailability of carotenoids from dark-green leafy vegetables 
may be attributed to their entrapment and complexing to proteins in chloroplasts and 
within cell structures. Such entrapment may not only be physical (matrix effect) but 
also molecular (effector effect, see below). The a- and p-carotene in carrots exist as 
crystals up to 1000 ^m in length. Although soluble in the intestinal contents, the 
transit time is probably insufficient for extensive solubilisation to take place during 
this passage through the intestinal tract. Similarly, lycopene also exists in tomatoes 
in the crystalline form. In orange and yellow fruits (mango, papaya, etc) and in 
pumpkin and sweet potato, carotenoids are dissolved in oil droplets in chromoplasts 
and can be readily extracted during digestion. Cooking increases the bioavailability 
of carotenoids, possibly because of the softening or disruption of plant cell walls and 
the disruption of carotenoid-protein complexes (Erdman et al. 1988). Stahl & Sies 
(1992) reported that lycopene concentrations in human serum increased from 
processed but not unprocessed tomato juice. Bioavailability of lycopene was greater 
from tomato paste than from fresh tomatoes (Gartner et al. 1997). 
Bioconversion 
The FAO/WHO Joint Expert Consultation (1988) concluded that 6 ^g of p-carotene 
from a mixed meal provided 1 ^g of retinol. For p-carotene dissolved in oil, the 
International Union of Pure and Applied Chemistry concluded from two studies 
(Hume & Krebs 1949, Wagner 1940) that 3.33 ^g provided 1 ng of retinol (IUPAC 
1959). The effect of the matrix, however, is almost certainly limited to phenomena 
that take place in the lumen of the small intestine. Thus, reported effects of the 
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matrix on the overall yield of retinol from carotenoids can be attributed to matrix 
effects on bioavailability. The earlier studies on the yield of retinol from carotenoids 
have been reviewed by de Pee & West (1996). From a carefully carried study of 
schoolchildren in Indonesia, it has been calculated that 1 ng of retinol was provided 
by 26 |ag (95% confidence interval, 13-76) of p-carotene from dark-green leafy 
vegetables and carrots and by 12 |a.g (95% confidence interval, 6-29) from yellow 
and orange fruits. Almost identical data have been found in a study of lactating 
women in Vietnam (NG Khan, CE West, S De Pee, D Bosch, HH Khoi, JGAJ 
Hautvast, unpublished data). 
EFFECTORS OF ABSORPTION AND BYCONVERSION 
Absorption of carotenoids is similar to that of other lipids. A variety of nutrients 
consumed together with carotenoids may affect carotenoid absorption, metabolism, 
and/or bioconversion. The presence of protein in the small intestine helps stabilise 
fat emulsions and enhances micelle formation and carotenoid uptake. Lecithin may 
enhance triglyceride absorption through facilitating micelle formation, and long-chain 
fatty acids increase cholesterol absorption and, thus, the absorption of fat-soluble 
vitamins. A decrease in carotenoid bioavailability may be caused by interaction in 
the gastrointestinal tract with drugs or constituents of foods, such as sulfides and 
acids, in the gastrointestinal tract (Peiser & Yang 1979, Wedzicha & Lamikanra 
1983). Gastric pH also plays a role: a single 120-mg dose of p-carotene increased 
plasma concentrations of p-carotene at normal gastric pH to a level twice as high as 
that at a gastric pH of 6.4 (Tang et al. 1996). 
Intake of dietary fat 
The absorption and bioconversion of p-carotene is markedly reduced when the 
intake of fat is very low (Jialal et al. 1991, Prince & Frisoli 1993). Addition of a small 
quantity of fat to the diet greatly improves the absorption of vegetable carotenoids 
(Roels et al. 1958), with optimal absorption requiring an intake of at least 5 g of fat 
per day (Jayarajan et al. 1980). We conclude that a minimum amount of fat is 
necessary for uptake of carotenoids. There is no dose-response relationship above 
the threshold value, but there is some increase in the serum p-carotene response to 
a high-fat diet (Dimitrov et al. 1988, Nierenberg et al. 1991, Shiau et al. 1994). Some 
data suggest that polyunsaturated fatty acid-rich dietary fat increases the serum 
response to p-carotene more than does mono-unsaturated fatty acid-rich dietary fat 
(Kasper & Ernst 1969). The serum response to dietary p-carotene is related to the 
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serum response to dietary triglyceride (Henderson et al. 1989). The solubility of P-
carotene (apolar) and zeaxanthin (polar) decreases with increased chain length in 
triglyceride fatty acids (Borel et al. 1996), which may explain why, after a single 120-
mg dose of p-carotene, the p-carotene response in chylomicrons was lower after 
ingestion of a meal comprised of triglycerides from C8 and C10 rather than Ci6 and 
Cis fatty acids. Also, the concentration of retinyl palmitate in chylomicrons was 
lower, although the conversion to retinol was not significantly different between the 
two meals (Borel et al. 1997). Sucrose polyester, a nonabsorbable fat analogue, 
reduces plasma carotenoid concentrations markedly (Weststrate & van het Hof 
1995). 
Intake of dietary fibre 
In a study to examine the effect of dietary fibre on serum carotene values in 
humans, the plasma p-carotene was reduced by 42% when pectin was given (Rock 
& Swendseid 1992). Results from studies with chickens suggest that the extent of 
methyl esterification of the pectin is important in determining the extent of inhibition 
of absorption (Erdman et al. 1986). One of the effects of dietary fibre on lipid 
metabolism centres on its interaction with bile acids, resulting in increased faecal 
excretion of bile acids and, thus, decreased absorption of fats and fat-soluble 
substances, such as carotenoids and cholesterol. 
Intake of alcohol 
Several investigators (Albanes et al. 1997, Lecomte et al. 1994, Stryker et al. 1988) 
have reported that drinkers, compared with subjects with low or no alcohol intake, 
had lower p-carotene levels, whereas plasma retinol levels were similar (Lecomte et 
al. 1994) or higher (Albanes et al. 1997, Simonetti et al. 1995). The response was 
not related to the level of alcohol consumption (Albanes et al. 1997). Conversely, 
after withdrawal, plasma carotenoid levels increased, whereas retinol concentration 
diminished (Lecomte et al. 1994). In a 6-month controlled dietary study involving 
women who were non-smokers, plasma a- and p-carotene concentrations were 
significantly higher, 19% and 13%, respectively, and the lutein/zeaxanthin 
concentration was significantly lower during the alcohol-intake phase of the study 
(Forman et al. 1995). The combination of an increase in plasma and liver p-carotene 
after ingesting ethanol and a relative lack of a corresponding rise in retinol suggests 
that alcohol interferes with the conversion of p-carotene to vitamin A (Leo et al. 
1992). When ethanol was used in intestinal rat and hamster preparations as a 
solvent for p-carotene, retinal formation was reduced to 55% (van Vliet et al. 1996c). 
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Intake of other food constituents 
Supplementation with vitamin E plus ascorbic acid did not alter serum p-carotene 
levels (Nierenberg et al. 1994). 
NUTRIENT STATUS OF THE HOST 
Bioavailability 
The absorption of carotenoids is likely to be dependent on vitamin A status. Mattson 
& Deuel (1943) showed that high vitamin A intake reduces carotenoid pigmentation 
in chickens, an effect confirmed by others (Thompson 1975). Supplementation with 
vitamin A decreases the absorption of p-carotene but of canthaxanthin as well 
(Sklan et al. 1989). It has been common practice to feed chickens high levels of 
vitamin A to produce pale poultry meat. It could be argued, although it is unlikely, 
that part of this effect is due not to an increased vitamin A status but to the 
concurrent ingestion of retinol with other carotenoids. 
Bioconversion 
Feeding p-carotene-rich foods to humans leads to an increase in serum retinol 
levels only when these are initially low (Charoenkiatkul et al. 1985, Lala & Reddy 
1970). Treatment with p-carotene does not significantly modify the vitamin A levels 
in vitamin A-replete subjects. It is assumed that a plasma level of p-carotene equal 
or higher than 1.1 (imol/liter reflects a nutritional intake of provitamins sufficient to 
support homeostasis of retinol. Novotny et al. (1995) estimated from a study of one 
vitamin A-replete person that 22% of a single 40-mg dose of p-carotene was 
absorbed and that 18.5 p.g of dietary p-carotene is equivalent to 1 |ag of retinol. 
Since ingestion of p-carotene does not lead to vitamin A toxicity, it is tempting to 
suggest that not only current p-carotene intake but also circulating p-carotene levels 
(carotene status) inhibits carotenoid bioconversion. At lower levels of p-carotene 
intake, retinol levels in serum and liver are increased by ingestion of p-carotene, 
whereas ingestion of canthaxanthin reduces retinol levels in serum and liver (Sklan 
et al. 1989). This could be interpreted as inhibition of bioconversion but could be 
readily explained by the lack of provitamin A precursor. No studies on the effect of 
vitamin A status on dioxygenase activity have been carried out with humans, though 
studies of rats (van Vliet et al. 1996b, Villard & Bates 1986) have shown that diets 
low in vitamin A do increase dioxygenase activity (Brubacher & Weiser 1985). 
Retinol deficiency can arise despite a plentiful supply of retinol or carotene. Low-
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protein diets reduce dioxygenase activity in rats (Gronowska-Senger & Wolf 1970) 
or limit the production of retinol-binding protein. Zinc also affects the synthesis of 
retinol-binding protein and may also influence the conversion of p-carotene to 
vitamin A through retinal reductase, which is zinc dependent. Zinc-deficient rats had 
serum retinol levels not significantly different from controls. However, their retinol 
liver reserves were much lower. The results suggest that zinc deficiency impairs the 
efficiency of p-carotene utilisation in the rat (Takruri & Thurnham 1981). 
GENETIC FACTORS 
Data from the Cardia study (Slatterly et al. 1995) showed that, in the United States, 
Caucasian men and women take supplements containing vitamins A and p-
carotene twice as frequently as do African American men and women. They also 
have lower mean plasma lutein concentrations and higher mean plasma retinol 
concentrations than their African American counterparts have. When adjusted for 
influencing factors, the plasma p-carotene concentration was also higher in African 
Americans than in white haemodialysis patients in the United States (Rock et al. 
1997). In Nigerian women (Adams-Campbell et al. 1992), p-carotene levels were 
1.2-13 times higher than was found in the US population. However, many of these 
effects could be attributed to diet. Failure to split p-carotene in humans is rare but 
can lead (a) to metabolic carotenemia with normal or even low intakes of 
carotenoids (Monk 1982) or (b) to vitamin A deficiency if retinol intake is low 
(McLaren & Zekian 1971). 
HOST-RELATED FACTORS 
Host-related factors may explain many of the differences observed in the serum 
response to ingestion of dietary carotenoids. One of the best predictors of the 
response to an oral dose of p-carotene is the initial serum p-carotene concentration 
(Albanes et al. 1992, Nierenberg et al. 1991). Such initial serum carotenoid levels 
could be attributed to factors already discussed, such as long-term intake (status) 
and genetic factors. In addition, postabsorption metabolism and not bioavailability 
may be responsible for the differences observed. This could explain many of the 
effects of body weight (Nierenberg et al. 1991), use of alcohol, and smoking. Thus, 
in the discussion below, studies that indicate differences in bioavailability and not 
just serum concentrations of carotenoids are highlighted. 
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Effect of sex and age 
The serum response to p-carotene is higher in women than in men (Nierenberg et 
al. 1991); however, part of this effect could be attributed to differences in body 
weight and body composition. There is no evidence for a reduced serum response 
with ageing, which could be explained by the passive nature of the absorption 
process. In one study, the serum response was higher in older people (Maiani et al. 
1989), whereas in other studies the opposite was found (Sugarman et al. 1991, 
Yeumetal. 1996). 
Effect of illness and protein-energy malnutrition 
Absorption of fat-soluble substances including carotenoids is impaired in any 
disease in which there is fat maldigestion and malabsorption. Fat maldigestion 
arises when there is impaired production of lipase and bile acids and impaired 
neutralisation of chyme in the duodenum (Das et al. 1996, Lala & Reddy 1970). 
MATHEMATICAL INTERACTIONS 
Mathematical interactions refers to the difference in effect observed when two 
factors play a role together compared with the product of the effects observed 
separately. However, data are not yet available to allow any estimate of 
mathematical interactions. 
CONCLUSIONS 
Carotenoid bioavailability and bioconversion are influenced by a number of factors, 
the SLAMENGHI factors. Each carotenoid seems to show an individual pattern of 
absorption, plasma transport, and metabolism. We investigated the state of 
knowledge with regard to SLAMANGHI factors. 
We conclude that, at this stage, data are not sufficiently comparable to allow 
systematic comparison of results and often the effects studied with regard to 
bioavailability cannot be attributed to individual factors. However, a number of 
conclusions can be drawn. 
The bioavailability and provitamin A activity of the various carotenoids and 
geometrical isomers of carotenoids differ. The absorption of all-frans-p-carotene is 
higher than that of 9-c/s-p-carotene. Also, the bioconversion of p-carotene is higher 
for the a\\-trans isomer than for the cis isomers. The vitamin A activity of other 
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provitamin A carotenoids is lower than that of p-carotene. Carotenoid esters in foods 
are readily split in the gut, and thus, molecular linkage does not play a role in 
carotenoid bioavailability and bioconversion. A positive relationship between intake 
and response of p-carotene suggests that absorption is a nonsaturable passive 
process. p-Carotene supplementation was shown in a number of studies to increase 
serum concentrations of p-carotene and decrease serum concentrations of lutein, 
lycopene, and canthaxanthin. Recent studies of rats (van Vliet et al. 1996b) confirm 
the dose-related factors for the conversion of p-carotene from a mixed meal, as 
suggested by FAO/WHO (1988). In vitro studies would suggest that lutein interferes 
with the conversion of p-carotene to retinol (van Vliet et al. 1996c), and this may 
explain, in part, the low conversion to retinol of p-carotene from dark-green leafy 
vegetables (de Pee et al. 1995). Relatively few properly designed studies have been 
carried out to examine the effect of food matrix on carotenoid bioavailability (de Pee 
& West 1996). From these studies it can be concluded that bioavailability of p-
carotene from foods is low, particularly from dark-green leafy vegetables (7%). Due 
to the low bioavailability, it has been calculated that 1 u,g of retinol is provided by 26 
u.g of p-carotene from dark-green leafy vegetables and carrots and by 12 ng from 
yellow and orange fruits (de Pee et al. 1998). Intake of dietary fat has a positive 
effect on p-carotene bioavailability and dietary fibre has a negative effect, and 
alcohol intake seems to interfere with the bioconversion of p-carotene to retinol. 
Nutrient status and genetic factors related to the host may explain some of the 
differences observed. Effects of season, sex, age, and smoking are largely 
explained by differences in long- and short-term intakes of carotenoids. Few 
controlled supplementation studies have been carried out to study the effect of 
these variables on carotenoid response in serum. 
There is a need for more carefully designed studies to define the role of individual 
SLAMENGHI factors. The improvement in high-performance liquid chromatography 
methods for the quantification of carotenoids and the current development of 
isotopic methods should lead to the generation of much data in the coming years. 
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ABSTRACT 
Carotenoid bioavailability depends, amongst other factors, on the food matrix and 
on the type and extent of processing. To examine the effect of variously 
processed spinach products and of dietary fibre on serum carotenoid 
concentrations, subjects received, over a 3-week period, a control diet (n = 10) or 
a control diet supplemented with carotenoids or one of four spinach products (n = 
12 per group): whole-leaf spinach with an almost intact food matrix, minced 
spinach with the matrix partially disrupted, enzymatically liquefied spinach in 
which the matrix was further disrupted and the liquefied spinach to which dietary 
fibre (10 g/kg wet weight) was added. Consumption of spinach significantly 
increased serum concentrations of all-frans-p-carotene, c/'s-p-carotene, (and 
consequently total p-carotene), lutein, a-carotene and retinol and decreased the 
serum concentration of lycopene. Serum total p-carotene responses (changes in 
serum concentrations from the start to the end of the intervention period) differed 
significantly between the whole-leaf and liquefied spinach groups and between 
the minced and liquefied spinach groups. The lutein response did not differ 
among spinach groups. Addition of dietary fibre to the liquefied spinach had no 
effect on serum carotenoid responses. The relative bioavailability as compared to 
bioavailability of the carotenoid supplement for whole-leaf, minced, liquefied and 
liquefied spinach plus added dietary fibre for p-carotene was 5.1, 6.4, 9.5 and 
9.3%, respectively, and for lutein 45, 52, 55 and 54%, respectively. We conclude 
that the bioavailability of lutein from spinach was higher than that of p-carotene 
and that enzymatic disruption of the matrix (cell wall structure) enhanced the 
bioavailability of p-carotene from whole-leaf and minced spinach, but had no 
effect on lutein bioavailability. 
KEY WORDS: carotenoids, bioavailability, processing spinach, dietary fibre, 
humans 
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INTRODUCTION 
Carotenoids have many functions in the human body, including being precursors 
of retinol and retinoids, and acting as antioxidants (Krinsky 1993). They are found 
in dark-green, leafy vegetables; in yellow and orange coloured fruits and 
vegetables; and, to a lesser extent, in animal products. Carotenoids are found in 
the chloroplasts of all green plant tissues, where they occur in the photosynthetic 
pigment-protein complexes, and in the chromoplasts of fruits. Some carotenoids, 
including p-carotene, lycopene, and some oxycarotenoids such as lutein and 
zeaxanthin, exert antioxidant activity in lipid phases by quenching oxygen or free 
radicals (Sies & Stahl 1995). This may explain why a higher dietary intake of 
carotenoids has been found to be associated with a lower risk for age-related 
macular degeneration (Seddon et al. 1994) and some forms of cancer and 
cardiovascular disease (van Poppel 1996). 
Bioavailability is defined as the fraction of an ingested nutrient that is available 
to the body for utilisation in normal physiological functions or for storage (Jackson 
1997). We have developed the mnemonic SLAMENGHI, which includes all 
factors that could affect bioavailability, especially bioavailability of p-carotene and 
other carotenoids (Castenmiller & West 1998, de Pee & West 1996). The 
SLAMENGHI factors are as follows: Species of carotenoids, molecular Linkage, 
Amount of carotenoids consumed in a meal, Matrix in which the carotenoid is 
incorporated, Effectors of absorption and bioconversion, A/utrient status of the 
host, Genetic factors, Host-related factors, and /nteractions. Current information 
on carotenoid bioavailability is limited, fragmentary, and often conflicting. Apart 
from the many factors, which determine bioavailability, the lack of adequate 
indicators has made it difficult to establish the bioavailability of carotenoids in 
food. 
Carotenes dissolved in oil are more readily absorbed than when they are 
incorporated in foods such as fruits and vegetables. The plasma response to 
ingestion of p-carotene dissolved in oil was found to be about five times the 
response to a similar amount of p-carotene in carrots (Brown et al. 1989, Micozzi 
et al. 1992). Recent studies in Indonesia have shown that feeding p-carotene 
from dark-green, leafy vegetables produced a lower plasma response than similar 
quantities of p-carotene in a fat matrix (de Pee et al. 1995). The serum response 
to p-carotene from fruits was four times higher than that from vegetables (de Pee 
et al. 1998). Cooking or fine grinding of foods could increase the bioavailability of 
carotenes by disrupting or softening plant cell walls and disrupting carotenoid-
protein complexes (Hussein & El-Tohamy 1990, van Zeben & Hendriks 1948). 
75 
Chapter 3 
The greater ease with which carotenoids in thermally treated foods can be 
extracted during analysis may imply that they are also biologically more available. 
We describe a controlled dietary intervention study with differently processed 
spinach products to examine the effect of the food matrix on carotenoid 
concentrations in human serum. Different processing techniques were used as a 
means of testing the role of cellular structure. One of the spinach products was 
treated with a mixture of enzymes, which causes disruption of the cell wall 
structure as well as depolymerisation of the cell wall components, reducing the 
dietary fibre content of the spinach product. Dietary pectin added to meals 
reduced plasma responses to p-carotene in humans (Rock & Swendseid 1992). 
Thus, by adding sugar beet fibre, we also examined the effect of restoring fibre to 
the enzyme-treated spinach on serum carotenoid concentrations. Although the 
fibre added replaces that lost during enzyme treatment, it did not restore cell wall 
structure or cellular integrity. 
MATERIALS AND METHODS 
Subjects 
The subjects were 72 healthy, non-smoking, normolipidemic volunteers: 42 
women and 30 men, aged 18-58 y. The subjects, students of Wageningen 
Agricultural University and other residents of the Wageningen area, were 
recruited through local advertisements and all gave their written informed 
consent. None of the subjects were taking oral medication, apart from oral 
contraceptives, nor supplements of any kind during the last 3 mo before the study 
started and during the study period. Subjects were screened for fasting elevated 
glucose and protein levels in urine and for low haemoglobin and abnormal 
haematology. All subjects completed a medical and a general questionnaire and 
food frequency questionnaires to estimate their habitual intakes of energy, 
carotenoids and vitamin A. All subjects had normal body mass indices (18-28 
kg/m2), fasting serum cholesterol concentrations < 6.5 mmol/L and fasting 
triacylglycerol concentrations < 2.8 mmol/L. During the study, two male volunteers 
withdrew from the study for personal reasons. Characteristics of the subjects are 
presented in Table 1. The protocol for this study was approved by the Medical-
Ethical Committee of the Division of Human Nutrition and Epidemiology of 
Wageningen Agricultural University. 
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Table 1. Characteristics of subjects participating in a study to determine the 
bioavailability of (J-carotene and lutein from differently processed spinach 
products1 
Group 
Control Carotenoid Whole-leaf Minced Liquefied Liquefied 
supplement spinach spinach spinach spinach plus 
dietary fibre 
Men, women; 3, 7 5, 7 5, 7 5, 7 5, 7 5, 7 
n, n 
Age, y 21 (18,25)2 21(18,24) 20(18,58) 21(18,42) 21(18,38) 20(18,54) 
Energy 11.4 ±2.6 12.8 ±3.4 11.5 ±2.3 11.3 ±2.1 11.4 ±2.1 11.4 ±2.3 
(estimated), 
MJ/d 
Serum 4.14 ±0.65 4.07 ± 0.61 4.11 ±0.79 4.23 ±0.74 3.93 ± 0.47 4.17 ±0.87 
cholesterol, 
mmol/L 
Serum 0.88 ±0.41 0.87 ± 0.32 0.92 ± 0.32 1.00 ±0.39 0.89 ±0.27 1.00 ±0.34 
triacylglyce-
rol, mmolA. 
Body mass 21 ±2.1 22 ±2.3 22 ±2.0 22 ± 2.4 23 ±2.1 22 ±1.8 
index, kg/m2 
1
 Data collected at beginning of study except for energy intake which is the mean over the 
intervention period. Values are means ± SD. 
2
 Medians (ranges). 
Study design 
The study started with a 3-wk run-in period followed by a dietary intervention 
period of 3 wk. During the intervention period, subjects were allocated to one of 
six experimental groups. Blood was taken by venipuncture from fasting subjects 
between 7.15 and 10.00 h at the start of the run-in period and at days 0, 1, 8, 15, 
21 and 22 of the dietary intervention period. Blood samples, to which no 
anticoagulant was added, were left to clot and were centrifuged within 1 h after 
being drawn. The serum was separated and stored at -80°C until analysis. 
During the first 3 wk of the study (run-in period), subjects chose their own diets 
but were instructed to avoid foods rich in carotenoids and vitamin A. During the 
dietary intervention period, subjects were supplied with total diets, except for a 
limited choice of free products (approximately 10 energy%), which did not contain 
carotenoids or retinol. Subjects received a hot meal at the Division of Human 
Nutrition and Epidemiology and foods for their other meals and snacks were 
packed to be taken home. A maximum of two alcoholic consumptions per day 
was allowed but was not permitted to be consumed together with the hot meal. 
Duplicate portions of diets were collected for chemical analysis. The daily 
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selection of free choice foods was recorded in a diary, and the nutrient content 
was calculated (Stichting NEVO 1995). Individual body weights throughout the 
study were maintained at ± 2 kg. 
Diet 
All subjects in the six treatment groups were fed the same control diet throughout 
the study, and the menu was changed daily on a weekly cycle. The control diet 
consisted of foods, other than fruits and vegetables with moderate or high 
amounts of carotenoids, and met the requirements of Dutch Recommended Daily 
Allowances (Netherlands Food and Nutrition Council 1992). Four groups received 
a spinach product, one control group received no additional source of carotenoids 
and one group received a carotenoid supplement. The carotenoid supplement 
was a suspension in vegetable oil of microcrystalline p-carotene (40 g/kg; 
Hoffmann-La Roche, Basel, Switzerland) and crystalline lutein and zeaxanthin 
derived from marigold flowers (60 g/kg and 3 g/kg, respectively; FloraGLO, Kemin 
Industries, Des Moines, IA), added to salad dressing. The energy content of the 
diets of the control group and carotenoid supplement group was adjusted to that 
of the spinach groups by providing extra amounts of appropriate foods. The 
spinach groups received 20 g whole-leaf spinach, minced spinach, liquefied 
spinach or liquefied spinach to which dietary fibre was added/MJ. All spinach 
products originated from one batch and were prepared and provided by 
Langnese-lglo in Wunstorf (Germany) for Unilever Research Vlaardingen (The 
Netherlands). Four different spinach products were prepared: whole-leaf spinach 
with an almost intact food matrix; minced spinach in which the matrix is partially 
disrupted; enzymatically liquefied spinach in which the matrix is disrupted; and the 
enzymatically liquefied spinach to which dietary fibre was added. The whole-leaf 
spinach was washed and subsequently blanched for 90 s and cooled down 
quickly. The minced spinach was minced to 5 mm after blanching. The liquefied 
spinach was prepared by treating minced spinach with an enzymatic preparation 
with pectinase, hemicellulase and cellulase activities (Rapidase LIQ plus, Gist-
brocades, Seclin, France) during 2.5 h at 35°C. After the enzyme treatment, the 
spinach was boiled for 5-10 min to inactivate the enzymes. The spinach products 
were frozen immediately after processing. Liquefaction resulted in a breakdown of 
cell wall material. Therefore, the fourth group received the liquefied spinach plus 
fibre prepared from sugar beet (10 g/kg wet weight, Fibrex 600, TEFCO Food 
Ingredients b.v., Bodegraven, The Netherlands) to compensate for the loss of 
dietary fibre. This fibre product contains per 100 g of product, 73 g of dietary fibre 
of which one third is soluble and 22 g is pectin. All frozen spinach was thawed 
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and heated by microwave before consumption. The spinach products contained 
no measurable nitrite, and the content of nitrate was less than 1000 mg/kg, thus 
ensuring that the nitrate intake of the subjects was below the Acceptable Daily 
Intake for nitrate (FAO/WHO 1995). Microbiological counts showed normal values 
and confirmed that the spinach products were safe for human consumption. 
Serum measurements 
Serum carotenoids and retinol were measured by high-performance liquid 
chromatography (HPLC) (Craft et al. 1992). To avoid day-to-day analytic 
variations, all samples from an individual were analysed sequentially as a set. 
After precipitation with ethanol, extraction followed with hexane twice; samples 
were evaporated under nitrogen and injected into the HPLC system described 
below. Serum cholesterol and triacylglycerol concentrations were analysed with 
the Abbott Spectrum high performance diagnostic system following a standard 
procedure (Siedel et al. 1983, Sullivan et al. 1985). 
Food measurements 
The duplicate portions of the daily food intake of one subject collected throughout 
the study were mixed thoroughly as weekly portions, and subsequently pooled 
samples were stored at -20°C until analysis. The moisture level and the ash 
content in each weekly portion were determined (Osborne & Voogt 1978) using a 
vacuum oven at 85°C and a muffle furnace at 550°C. The protein concentration 
was determined by the Kjeldahl method using a conversion factor of 6.25. The 
Folch method (Folch et al. 1957) was used to extract fat. Digestible carbohydrate 
was calculated by difference. Dietary fibre was analysed according to the AOAC 
Official Method 992.16 for total dietary fibre (AOAC 1996). The dietary fibre 
content of the various spinach products was determined as methanol-ether 
insoluble solids (MEIS) and the amount of pectin (polygalacturonic acid) in the 
spinach products was measured by hydrolysing pectic substances to water-
soluble galacturonic acid using an enzyme preparation (Katan & van de 
Bovenkamp 1981). Carotenoids and retinol were determined in the pooled 
samples and in spinach products and salad dressings containing the carotenoid 
supplement. Carotenoids and retinol were extracted from wet material after 
homogenisation, using tetrahydrofuran (THF) and redissolved in THF/methanol 
(1:1 v/v) and injected into the HPLC system described below. 
Chemicals and instrumentation for carotenoid and retinol analysis 
Pure grades of all-frans-a-carotene, all-frans-p-carotene and lycopene were 
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obtained from Sigma Chemical Co. (St Louis, MO) and all-frans-lutein, all-frans-
zeaxanthin, and all-frans-p-cryptoxanthin from Hoffmann-La Roche Ltd (Basel, 
Switzerland). The carotenoid concentrations of the standards were measured in a 
Zeiss M4 QUI spectrophotometer (Carl Zeiss, Oberkochen/Wurttemberg, 
Germany). The HPLC system, manufactured by Thermo Separation Products 
(San Jose, CA), was equipped with a pump (P4000), a solvent degasser 
(SCM1000), a temperature controlled autosampler (AS3000), a UV-visible 
forward optical scanning detector (Spectra Focus UV3000), interface (SN4000), 
and control and integration software (PC1000, version 3.0). A reversed phase 
Vydac 218 TP 54 column containing silica polymerically modified with C18 from 
The Separations Group (Hesperia, CA) was used, and the metal frits in the 
column were replaced by PAT (Peek Alloyed with Teflon) frits from the same 
manufacturer to minimise carotenoid degradation on the column. The mobile 
phase consisted of a mixture of methanol and tetrahydrofuran (98:2 v/v). For each 
series of analyses of serum samples, a control serum sample was analysed. The 
coefficients of variation (CV) within runs for serum analysis of a-carotene, p-
carotene, lutein, zeaxanthin, p-cryptoxanthin, lycopene and retinol in control pools 
averaged 7.4, 3.9, 3.6, 8.7, 4.5, 10.4 and 1.6%, respectively. For each series of 
analyses of food samples, a control sample (homogenised baby food) was 
extracted in duplicate and injected into the HPLC system for monitoring the 
stability of the analytical procedure over time. The CV within runs for food 
analysis of a-carotene, p-carotene and lutein in control pools averaged 5.7, 6.8 
and 8.8%, respectively. All sample preparations and extractions were carried out 
in duplicate and under subdued yellow light with minimal exposure to oxygen 
(Hulshof et al. 1997). 
Statistical analysis 
Serum concentrations were averaged for d 0 and 1 and for d 21 and 22 for each 
subject. For each person the response to treatment was calculated as the change 
in serum concentrations from the start to the end of the intervention period. Two-
tailed f-tests for independent samples were performed to evaluate differences in 
serum responses between the control and treatment groups and between the 
carotenoid supplement and pooled spinach groups. To compare differences in 
responses among the groups receiving various spinach products, after significant 
F-tests (ANOVA) the Tukey method for multiple comparisons was used (Godfrey 
1985). Analyses were carried out using general linear models to compare 
differences in response among intervention groups, controlling for several factors 
and covariables, including sex, vegetarian diet, age, body mass index, change in 
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cholesterol and triacylglycerol concentrations. Spearman correlation coefficients 
for the entire study group were calculated when relevant. Differences associated 
with P < 0.05 were regarded as significant (SPSS/PC 7.5, 1997, SPSS Inc., 
Chicago, IL). 
The relative bioavailability of p-carotene and lutein was calculated by dividing 
the serum response (nmol/L) relative to the intake of the respective carotenoid in 
each spinach group (mg/MJ) by the serum response to the carotenoid in the 
supplement group relative to the intake of carotenoid in the carotenoid 
supplement (mg/MJ). The serum carotenoid responses were adjusted for serum 
responses in the control group, and the amount of carotenoid consumed (mg/MJ) 
by the control group was subtracted from the amount consumed by each spinach 
group. 
RESULTS 
Carotenoids 
The composition of the diets is given in Table 2. Consumption of spinach 
significantly increased the serum concentrations of all-frans-p-carotene, c/'s-p-
carotene (and consequently total p-carotene), lutein (Table 3, Fig. 1 and Fig. 2), 
a-carotene and retinol (P < 0.05); decreased the serum concentration of lycopene 
as compared to the control group (P < 0.05); and had no effect on serum 
concentrations of zeaxanthin and p-cryptoxanthin. The serum responses 
(changes in serum concentrations from the start to the end of the intervention 
period) of total p-carotene and lutein were significantly related (rs = 0.51; P < 
0.001). The a-carotene response was significantly correlated to the total p-
carotene response (rs = 0.69; P < 0.001) and the all-frans-p-carotene and c/'s-p-
carotene responses were significantly correlated (rs = 0.79; P < 0.001). 
There were significant differences only among the spinach groups for serum 
responses of p-carotene: total p-carotene responses were significantly different 
between the whole-leaf and liquefied spinach group (P = 0.03) and between the 
minced and liquefied spinach groups (P = 0.05), and all-frans-p-carotene 
responses were significantly different between the whole-leaf and liquefied 
spinach groups (P = 0.03). The serum c/s-p-carotene and lutein responses were 
similar among spinach groups. In a multiple linear regression model with all 
spinach groups and with serum total p-carotene response as dependent variable, 
treatment (group) and body mass index were significant in the model, whereas for 
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Table 2. Total daily intake of carotenoids, dietary fibre and energy of 
subjects participating in a study to examine the bioavailability of p-carotene 
and lutein from various spinach products1 
Total p-carotene, mg/d 
All-frans-p-carotene, mg/d 
C/s-p-carotene, mg/d 
Lutein, mg/d 
Dietary fibre, g/d 
Energy, MJ 
Control 
0.5 
0.4 
0.1 
0.5 
27.4 
10.6 
Carotenoid 
supplement 
9.8 
8.9 
0.9 
6.6 
25.2 
10.7 
Group 
Whole-
leaf 
spinach 
10.4 
8.8 
1.7 
12.6 
32.4 
10.8 
Minced 
spinach 
8.8 
7.4 
1.4 
11.2 
32.3 
10.8 
Liquefied 
spinach 
9.0 
7.6 
1.4 
11.3 
28.2 
10.8 
Liquefied 
spinach 
plus 
dietary 
fibre 
8.8 
7.4 
1.4 
10.9 
31.3 
10.8 
Results are based on the analysis of duplicate portions for one subject per group consuming 
approximately 11 MJ together with an estimate calculated from the composition of the free 
items consumed. The free items did not contain carotenoids or retinol. There were no 
significant differences in nutrient intakes among the 3 wk of dietary intervention. The mean 
daily intake of macronutrients and alcohol was as follows (energy%): protein, 13.9; fat, 34.1; 
carbohydrate, 51.0; alcohol, 1.0. 
the serum lutein response, only the serum cholesterol response was significant 
(data not shown). 
The carotenoid supplement group had significantly higher responses of serum 
concentrations of all-frans-p-carotene, c/s-p-carotene, (and consequently total p-
carotene), lutein (Table 3), zeaxanthin and a-carotene than the control group, and 
significantly higher responses of all-frans-p-carotene, c/s-p-carotene, (and 
consequently total p-carotene) (Table 3), zeaxanthin, a-carotene, lycopene and p-
cryptoxanthin than the pooled spinach groups. Thus, the food matrix (cellular 
structure) played an important role in the uptake of p-carotene from spinach. 
Processing spinach in various ways did not affect lutein bioavailability. 
Dietary fibre 
The all-frans-p-carotene, c/s-p-carotene, total p-carotene and lutein serum 
responses in the liquefied spinach group were not different from the responses in 
the liquefied spinach plus added dietary fibre group. Adding 10 g of sugar beet 
fibre per kg wet weight of spinach had no effect on serum carotenoid response. 
The enzyme-treated spinach contained 13% less MEIS (methanol-ether insoluble 
solids) and 17% less polygalacturonic acid than the whole-leaf spinach, which 
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contained per 100 g dry matter 71 g MEIS and 11 g polygalacturonic acid, 
respectively. The composition of the sugar beet fibre added to spinach is 
comparable to the fibre present in the whole-leaf spinach, but had a higher 
amount of pectin. 
4.50 -
4.00 -
_i 
=§ 3-50 
E 
* 3.00 
c | 2.50-
CO 
V 2.00 -
O) 
f 1.50 
a 
2 1.00 
E 
| 0.50 1 
o.oo 4 
—•— control 
-•-carotenoid supplement 
-A-whole leaf spinach 
- K - minced spinach 
- © - liquefied spinach 
- •— liquefied spinach plus fib re 
• • 
// T 
/ / 
-21 0 8 15 
Time, days 
• • 
•-
= f 
1 
21 
Figure 1. Serum (3-carotene concentrations in groups of healthy 
subjects fed a control diet or a control diet with a carotenoid 
supplement or with various spinach products. Values are expressed 
as means and as means ± SD for the carotenoid supplement group; n 
= 12, for control group: n = 10. Serum concentrations were averaged 
for d 0 and 1 (d 0) and for d 21 and 22 (d 21) for each subject. For 
significant differences among the study groups, see Table 3. 
Retinol 
The decrease in serum concentration of retinol was significantly less (P = 0.04) in 
the pooled spinach groups than in the control group. Serum retinol concentrations 
decreased in the control group (7.6%), in the minced spinach group (5.1%) and 
liquefied spinach plus dietary fibre group (2.9%), but increased in the carotenoid 
supplement group (2.9%), whole-leaf spinach group (1.4%) and liquefied spinach 
group (0.4%). 
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Figure 2. Serum lutein concentrations in groups of healthy subjects 
fed a control diet or a control diet with a carotenoid supplement or 
with various spinach products. Values are expressed as means and 
as means ± SD for the control group; n = 12, for control group: n - 10. 
Serum concentrations were averaged for d 0 and 1 (d 0) and for d 21 
and 22 (d 21) for each subject. For significant differences among the 
study groups, see Table 3. 
Cholesterol and triacylglycerol 
The changes in serum cholesterol and triacylglycerol concentrations after 3 wk of 
dietary intervention (serum cholesterol and triacylglycerol responses) of the 
carotenoid supplement group and pooled spinach groups were not significantly 
different from the response in the control group. Normalised serum concentrations 
of total p-carotene and lutein were calculated as follows: carotenoid 
concentration/(cholesterol + triacylglycerol concentration). Adjustment of serum 
carotenoid concentrations for concentrations of cholesterol and other lipids may 
provide a better reflection of dietary intake of carotenoids (Willett et al. 1983). 
Analysis of the normalised serum carotenoid concentrations of total p-carotene 
and lutein showed significant differences of the normalised p-carotene responses 
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between the whole-leaf spinach and liquefied spinach group (P = 0.05) and 
between the whole-leaf spinach group and liquefied spinach plus added dietary 
fibre group (P < 0.02). 
Diets 
The chemical analysis of the diets supplied showed consistent data for the 3 wk 
and among the treatment groups. Surprisingly, the enzyme-treated spinach 
products, which were treated for 2.5 h at 35°C, did not have a higher 
concentration of c/s-P-carotene than the whole-leaf spinach. Chemical analysis of 
the salad dressings showed that the carotenoid supplement should provide daily 
per 11 MJ energy intake: p-carotene, 10.9 mg (all-frans-p-carotene, 10.5 mg; cis-
p-carotene, 0.4 mg); lutein, 12.2 mg; and zeaxanthin, 1.0 mg. However, from the 
analysis of the duplicate portions of ~ 11 MJ of the carotenoid supplement group, 
the daily intake of lutein was 46% lower (6.6 ± 0.2 mg) than was to be expected 
from the lutein concentrations in the salad dressings, whereas the daily intake of 
p-carotene in the duplicate food portions was 10% lower than expected based on 
the amounts analysed in the salad dressing (Table 2). Prepared spinach 
products, as consumed during the dietary intervention period, contained 15-18% 
of the p-carotene as cis isomers. The amounts of total p-carotene and lutein in the 
duplicate food portions were 0-9% and 31-43%, respectively, lower than those 
expected to be present in the daily food from analysis of the spinach products. 
The amount of carotenoids measured in the duplicate portions was used to 
calculate relative bioavailability. 
Estimate of relative bioavailability 
Based on the analysis of the duplicate portions, the bioavailability of p-carotene 
from spinach as compared to the carotenoid supplement was 5.1, 6.4, 9.5 and 
9.3% for whole-leaf, minced, liquefied and liquefied spinach plus added dietary 
fibre, respectively. The bioavailability of p-carotene from whole-leaf spinach was 
calculated as follows: 
[(0.121 - -0.021 )/(2.61- -0.021)] x [(9.8/10.7 - 0.5/10.6)/(10.4/10.8 - 0.5/10.6)] x 
100%. 
The relative bioavailability of lutein from spinach was 45, 52, 55 and 54% for 
whole-leaf, minced, liquefied and liquefied spinach plus added dietary fibre, 
respectively. Thus, enzymatic treatment increased the relative bioavailability of p-
carotene in spinach by about half. The relative bioavailability of lutein in spinach 
was more than five times higher than that of p-carotene and was not affected by 
the enzymatic treatment. 
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DISCUSSION 
Consumption of processed spinach products significantly increased serum 
concentrations of all-frans-p-carotene, c/s-p-carotene, (and consequently total p-
carotene), lutein, p-carotene and retinol and decreased serum concentrations of 
lycopene. For p-carotene, but not for lutein, there was a significant effect of 
processing: liquefied spinach, in which the vegetable food matrix is disrupted, 
produced a higher serum response than whole-leaf spinach, where the food 
matrix is still intact, and minced spinach. Addition of dietary fibre to liquefied 
spinach does not restore the cellular structure but did compensate for the fibre 
that was broken down and had no effect on serum responses of carotenoids as 
compared to serum responses after consumption of liquefied spinach. 
There are three possible explanations for the low bioavailability of p-carotene 
(5.1-9.5%) from spinach as compared to the carotenoid supplement. First is the 
food matrix in which the carotenoids are embedded. Other investigators also 
found a low bioavailability of p-carotene from vegetables as compared to pure p-
carotene: stir-fried vegetables, 7% (de Pee et al. 1995); carrots, 18-26% (Brown 
et al. 1989, Micozzi et al. 1992, Torronen et al. 1996). Rock et al. (1998) found a 
trend for a greater percentage increase in plasma concentrations of total p-
carotene in the period when thermally processed and pureed carrots and spinach 
were fed to healthy women as compared to the period when these women were 
fed raw carrots and spinach. 
Second is the isomeric form of p-carotene in spinach. The carotenoid 
supplement dissolved in oil contained mainly all-frans-p-carotene (approximately 
96%), whereas in the spinach products 15-18% of the p-carotene was present as 
cis isomers. Several investigators have shown that all-frans-p-carotene is more 
readily absorbed than its cis isomers (Ben-Amotz & Levy 1996, Gaziano et al. 
1995, Jensen et al. 1987, Tamai et al. 1995). Rock et al. (1998) recently found 
that feeding subjects thermally processed and pureed spinach that provided an 
increased proportion of c/s-p-carotene was not associated with a significant 
increase in the plasma c/s-p-carotene concentration after 4 wk. They concluded 
that isomerisation of p-carotene in foods by heat treatment does not negate the 
enhanced p-carotene uptake associated with consuming processed vegetables 
compared with raw vegetables. In our study, a significant increase in the serum 
concentrations of the c/s-p-carotene was observed in the treatment groups at the 
end of the dietary intervention period. The relative bioavailability of all-frans-p-
carotene for whole-leaf, minced, liquefied, and liquefied spinach plus added 
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dietary fibre was 6.2, 6.8, 10.1, and 9.9% and of c/s-p-carotene was 4.1, 4.2, 6.6, 
and 6.2%, respectively. These results provide some support for more ready 
absorption of all-frans-p-carotene than c/s-p-carotene. However, the issue needs 
further research. The ratio of serum a\\-trans- to c/s-p-carotene was strongly 
correlated in our study. It is not known whether this is due to an artefact produced 
by the chemical analysis because measuring c/s-p-carotene isomers in 
chlorophyll-containing foods is extremely difficult or whether p-carotene isomers 
are in some sort of equilibrium in human serum. 
Third, there may be an effect of other carotenoids on the bioavailability of p-
carotene. Kostic et al. (1995) found that when p-carotene and lutein were given to 
subjects in the same dose, p-carotene significantly reduced the serum area-
under-the-curve values for lutein. Also Micozzi et al. (1992) found that oral doses 
of p-carotene (12 or 30 mg daily for 6 wk) lowered serum lutein concentrations in 
men. In contrast, a preferential increase in chylomicron concentrations of lutein 
compared to p-carotene in the presence of high amounts of p-carotene and small 
amounts of lutein was described by Gartner et al. (1996). Although our study was 
not designed to examine the interaction between carotenoids, we found no 
evidence to conclude that p-carotene and lutein interact with each other. 
The relative bioavailability of lutein from spinach products ranged from 45 to 
55%. Thus, we conclude that the relative bioavailability of lutein from spinach is 
greater than that of p-carotene and less affected by the food matrix. Lutein, which 
is a dihydroxycarotenoid, is about 0.1% as lipophylic as p-carotene. This may 
explain why the matrix in which lutein is embedded in spinach does not reduce 
lutein absorption as it does the absorption of p-carotene. The amount of lutein 
found in the duplicate portions was much lower than was to be expected from 
addition of the results of the separate analyses of the control diet and either the 
carotenoid supplement or the spinach products. Lutein from spinach products and 
from the carotenoid supplement was apparently lost when added to a complete, 
daily diet. The composition of the carotenoid supplement was based on analysis 
of the various spinach products and experiments to examine the preferred 
preparation of the spinach for this study. Unexpectedly, at the time of the 
intervention study, the lutein content of the spinach products was found to be 
higher than those analysed several months before the study, which partly 
explains why the carotenoid supplement group received less lutein than the 
spinach groups. 
One of the effects of dietary fibre on lipid metabolism centres upon its 
interactions with bile acids, resulting in their increased loss by faecal excretion, 
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disturbance of micelle formation and thus a decreased absorption of fats and fat-
soluble substances (Olson 1994). Addition of dietary fibre to liquefied spinach had 
no effect on the serum p-carotene responses. Rock and Swendseid (1992) 
reported earlier that adding 12 g dietary citrus pectin to controlled meals with 25 
mg synthetic p-carotene (0.48 g pectin/mg p-carotene) reduced the increase in 
plasma p-carotene. In our study, where the proportion of dietary fibre added (0.23 
g fibre/mg p-carotene) was half that used earlier (Rock & Swendseid 1992), we 
were not able to demonstrate an effect of dietary fibre. 
In all groups, intake of carotenoids other than p-carotene and lutein was rather 
low. We found that the p-carotene response was significantly correlated to the p-
carotene response, which is in line with the finding of others that p-carotene 
supplementation increases concentrations of a-carotene (Castenmiller & West 
1998). 
In conclusion, this study confirmed that the bioavailability of p-carotene, and to 
a lesser extent of lutein, was affected by the food matrix and that processing 
spinach had an effect on the matrix (disruption of cell wall structure and loss of 
cellular integrity), and thus on the bioavailability of p-carotene from spinach. The 
bioavailability of p-carotene from liquefied spinach was higher than from whole-
leaf or minced spinach. We could not demonstrate an effect on serum p-carotene 
or lutein responses from the addition of dietary fibre to liquefied spinach. This 
suggests that once the cell wall components are broken down, addition of dietary 
fibre in amounts previously present in the food, has no effect on bioavailability of 
carotenoids. A limitation of the present study may be that subjects in the control 
group were fed low-carotenoid diets. The effects of feeding carotenoids in this 
type of study may result in greater apparent increases and differences in serum 
carotenoid responses. To obtain estimates of absolute bioavailability and to 
understand the mechanisms involved, it will be necessary to carry out studies 
using other experimental approaches including those involving isotopically 
labelled carotenoids. 
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ABSTRACT 
Objective: To examine the effect of the food matrix and dietary fibre on the 
bioavailability of folate as measured by plasma folate response. 
Design and subjects: In a controlled, three-week dietary intervention study, 28 
men and 42 women were divided into six groups to receive either a control diet (n 
= 10), or the control diet plus 20 g/MJ per day (n = 12 per group) of whole-leaf 
spinach, minced spinach, liquefied spinach, or liquefied spinach to which dietary 
fibre (10 g/kg wet weight) was added. The sixth group received the control diet 
plus a synthetic carotenoid supplement with similar amounts of p-carotene and 
lutein as found in spinach. 
Results: A significantly higher plasma folate response was found for the pooled 
spinach groups than for the control group. Among the spinach groups no 
significant differences were detected. However, the plasma folate response of the 
pooled minced and liquefied spinach groups was greater than that of the whole-
leaf spinach group (P = 0.03). Re-addition of dietary fibre to the liquefied spinach 
to compensate for the fibre broken down during liquefaction did not reduce the 
plasma folate response. The consumption of the carotenoid supplement did not 
have an effect on plasma folate concentrations compared with the control group. 
Conclusions: Consumption of spinach in a mixed diet increased folate status and 
the food matrix in which the folate is entrapped plays a role in folate 
bioavailability. There is no interaction between carotenoid and folate responses 
after consumption of spinach. 
Sponsorship: Unilever Research Vlaardingen, The Netherlands, and the 
Commission of the European Communities, Agriculture and Fisheries (FAIR) 
specific RTD programme CT95-0158, "Improving the quality and nutritional value 
of processed foods by optimal use of food antioxidants". 
KEY WORDS: dietary fibre, plasma folate concentration, food processing, dietary 
carotenoids 
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INTRODUCTION 
The term folate refers to a group of compounds that exhibit vitamin activity similar 
to that of pteroyl-L-glutamic acid (folic acid) and which are conjugated to one 
glutamyl residue (monoglutamyl folates) or more (polyglutamyl folates). A low 
intake of folate is associated with increased plasma homocysteine levels (Selhub 
et al. 1993), cardiovascular disease (Rimm et al. 1998) and colon cancer 
(Giovannucci et al. 1995). An elevated plasma homocysteine concentration is a 
risk factor for neural tube defects (Steegers-Theunissen et al. 1991) and 
cardiovascular disease (Graham et al. 1997, Kang et al. 1992, Nygard et al. 1995, 
Pancharuniti et al. 1994, Verhoef et al. 1996). The relationship between low folate 
intake and elevated homocysteine levels can be attributed to impaired one-carbon 
metabolism (Allen et al. 1993). Analysis of data from the Framingham study 
showed that an increased frequency of consumption of fruits and vegetables, the 
dominant source of total folate in the human diet, was associated with both higher 
levels of plasma folate and lower levels of plasma homocysteine (Tucker et al. 
1996). Many studies have been directed toward determining folate bioavailability 
in individual foods but data on the bioavailability of folate from foods in a mixed 
diet is scarce. Based on plasma folate response, Sauberlich et al. (1987) found 
that bioavailability of endogenous food folate from such a diet was no more than 
50% of that of folic acid added to the diet. Recently, this finding was confirmed by 
Cuskelly et al. (1996) who also demonstrated that the bioavailability of folic acid in 
fortified cereal-grain foods was similar to that of folic acid supplements. 
Factors that are considered to influence bioavailability of nutrients, such as 
folate in plants are: chemical species; molecular linkage; amount of folate in a 
meal; food matrix, effectors and inhibitors of absorption; nutritional status; genetic 
factors; and host-related factors (Castenmiller & West 1998, Gregory 1995, 
Gregory 1997). The complex food matrix of leafy vegetables may inhibit folate 
absorption, as was observed in the case of carotenoid bioavailability (de Pee et 
al. 1995). If so, chopping or otherwise destroying the matrix of vegetables during 
food processing, might increase the bioavailability of folate. Folate absorption 
may also be affected by the presence of dietary fibre. Data on the effect of dietary 
fibre in humans are limited to the effect of wheat bran on folate bioavailability 
(Bailey et al. 1988, Brodribb & Humphreys 1976, Keagy et al. 1988, Russell et al. 
1976), and little is known about the effect of dietary fibre, other than from wheat 
bran, on folate absorption in humans. 
In this controlled dietary human intervention study we examined whether the 
consumption of spinach as part of a meal increased plasma folate concentrations 
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and whether the partial or complete destruction of the spinach food matrix had an 
effect on the bioavailability of folate. One of the spinach products was treated with 
a mixture of enzymes, which changed the spinach food matrix by causing 
disruption of the cell wall and loss of dietary fibre. We examined the effect of 
adding dietary fibre back to spinach in which some of the fibre had been broken 
down by enzymatic means. This fibre replaced the fibre that was lost but did not 
restore the cell wall structure. We also evaluated the effect of carotenoids per se 
on the plasma folate concentration. 
METHODS 
Subjects 
We recruited subjects through advertisements in local newspapers and posters in 
university and public buildings in Wageningen. Initially 72 subjects were included 
in the study. They were apparently healthy, non-smoking men and women, aged 
18-58 y, who did not use vitamin or yeast tablets or anti-malaria medication during 
the 3 mo preceding the study. Women who were planning to become pregnant 
were not allowed to participate in the study. The experiment was originally 
designed to study the bioavailability of carotenoids, for which reason a control 
group receiving a carotenoid supplement was included. Because no data are 
available on possible interactions of carotenoids and folic acid, it was decided that 
the carotenoid supplement group should not receive folic acid in addition to the 
carotenoid supplement. The results on the bioavailability of carotenoids are 
reported separately (Castenmiller et al. 1999). During the experimental period two 
men withdrew for personal reasons. Therefore, 70 persons (28 men and 42 
women) participated in this study. 
Design 
The study had a parallel design and consisted of a 3-wk run-in period, in which 
participants chose their own diets but were instructed to avoid foods rich in 
carotenoids and folates. The run-in period was followed by a 3-wk intervention 
period in February - March 1997. All subjects were free-living. At the end of the 
run-in period subjects were stratified according to age and sex, and subsequently 
randomised over six treatment groups. All subjects received a control diet and 
four groups received 20 g/MJ of one of the following frozen spinach products: 
whole-leaf spinach, with an almost intact food matrix; minced spinach, in which 
the food matrix was disrupted; liquefied spinach, in which the matrix was further 
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disrupted; and the liquefied spinach above to which dietary fibre was added. The 
control group received the control diet, which was adjusted for energy and 
macronutrients to compensate for the energy and macronutrients provided by the 
spinach products. The carotenoid supplement group received the control diet and 
a synthetic carotenoid supplement, containing 0.8 mg p-carotene/MJ and 1.2 mg 
lutein/MJ (see Castenmiller et al. 1999). 
To estimate energy intake, participants had recorded their habitual diet of the 
past four weeks, using a validated food frequency questionnaire (Feunekes et al. 
1993). During the intervention period, almost all foods were supplied according to 
each person's energy requirement. In addition to the food supplied, each subject 
had a limited free choice of products. A maximum of two alcoholic consumptions 
per day was allowed, provided they were not consumed with the hot meal. On 
weekdays at noon hot meals were served at the Division of Human Nutrition and 
Epidemiology in Wageningen. All other foods were provided and packed for 
consumption elsewhere. On Fridays, food for the weekend and instructions for its 
preparation were given. The portion of spinach was consumed entirely as part of 
the hot meal. Menus were changed daily with a one-week cycle. Body weight was 
recorded twice weekly and energy intake was adjusted, when necessary, to limit 
changes in weight to less than 2 kg. Subjects recorded in diaries illness, 
medication used, the free choice items selected, and any deviations from their 
diets. Inspection of the diaries did not reveal any deviations from the protocol, 
which were thought to affect the results. 
The frozen spinach used for the study was provided by Unilever Research 
Vlaardingen (The Netherlands). The whole-leaf spinach was washed and 
subsequently blanched for 90 s and cooled down quickly. The minced spinach 
was minced to 5 mm after blanching. To prepare liquefied spinach, chopped 
spinach was warmed to 35°C and an enzyme mixture containing pectinase, 
hemicellulase and cellulase activities (10 g/kg wet weight of spinach; Rapidase® 
LIQ plus, kindly supplied by Gist-brocades, Delft, The Netherlands) was added. 
The spinach was then maintained at 35-40°C and stirred for 2.5 h. After this, the 
spinach was boiled for 5 - 10 min to destroy all enzyme activity. The cooking 
water was not discarded after boiling the spinach, so that the loss of folate due to 
leaching of folate into the cooking water was minimal. To study the effect of fibre, 
a mixture of dietary fibre derived from sugar beet (10 g/kg; Fibrex 600®, kindly 
supplied by TEFCO Food Ingredients Inc., Bodegraven, The Netherlands) was 
added to the liquefied spinach to compensate for the fibre that was digested by 
the enzymes. This sugar beet fibre product was selected because it is 
comparable to the fibre present in the whole-leaf spinach and contained per 100 g 
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product, 73 g dietary fibre of which one third is soluble and 22 g pectin. 
During the intervention period, complete duplicate portions of the control diet 
for an imaginary subject with a daily energy intake of 11 MJ were collected. 
Duplicate portions for analysis of macronutrients and fibre were pooled as weekly 
portions, mixed thoroughly and stored at -20CC until analysis. Duplicate portions 
for the analysis of folate were blended daily and stored at -80°C until analysis. 
The different spinach products were sampled during the study and frozen at -80°C 
to determine the content of folate. The total daily intake of energy, macronutrients 
and fibre was based on analysis of the pooled weekly duplicate portions and an 
estimate of the energy and nutrient content of the free choice items, which was 
calculated using data from the Dutch food composition database (NEVO 
Foundation 1995). To estimate the total folate intake of subjects, values for the 
chemically analysed mean folate content of the control diet on week days were 
added to those of the spinach products consumed and the estimated folate intake 
from the free choice foods in each group (Brants & Hulshof 1995). 
Blood collection 
Fasting blood samples were drawn at days 0, 1, 8, 15, 21 and 22 of the 
intervention period, in EDTA vacutainer tubes (Venoject II, Terumo, Madrid, 
Spain). Samples were immediately placed on ice and centrifuged within 30 min at 
3000 x g for 10 min. Plasma was separated and stored at -35°C until analysis. 
Measurements 
Plasma folate concentration was assessed in all blood samples. Plasma vitamin 
B12 concentration was determined only at day 0 to check for deviations from the 
normal level. Folate and vitamin B12 concentrations in plasma were determined 
with the Abbott IMx folic acid and vitamin B12 assays (IMx automated 
microparticle enzyme immunoassay system, Abbott Laboratories, North Chicago, 
IL, USA). The intra-assay coefficient of variation (CV) of the folate assay varied 
between 3 and 6% and the inter-assay CV between 6 and 10%, depending on the 
folate concentration. For vitamin Bi2, both the intra- and inter-assay CV were 
lower than 5%. All samples from each subject were analysed in the same assay. 
The moisture level and the ash content in each weekly food portion were 
determined using a vacuum oven at 85°C and a muffle furnace at 550°C. The 
protein concentration was assessed by the Kjeldahl method using a conversion 
factor of 6.25; fat was measured by the method of Folch et al. (1957) and 
digestible carbohydrate was calculated by difference. Dietary fibre was analysed 
according to the AOAC Official Method for total dietary fibre (AOAC 1996). The 
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dietary fibre content of the various spinach products was determined as 
methanol-ether insoluble solids (MEIS) and the amount of pectin 
(polygalacturonic acid) in the spinach products was measured by hydrolysing 
pectic substances to water-soluble galacturonic acid using an enzyme 
preparation (Katan & van de Bovenkamp 1981). Total folate in food samples of 
the control group and the various spinach products was measured by a 
Lactobacillus casei microbiological assay as described by Home & Patterson 
(1988) and modified by Tamura et al. (1990). Before extraction, 2% sodium 
ascorbate was added to the sample, followed by suspending the sample in 10 
volumes of a buffer containing 5 mmol/L 2-mercaptoethanol and 50 mmol/L 
potassium tetraborate (Seyoum & Selhub 1993). A chicken pancreas conjugase 
preparation was used to convert all the polyglutamates to their corresponding 
monoglutamate derivatives. The intra-assay CV of the analysis was 9.3%. 
Statistical analysis 
The response to treatment was calculated for each subject as the change in 
plasma folate from the start (average value for day 0 and day 1) to the end 
(average value for day 21 and day 22) of the dietary intervention period. The 
differences in mean plasma folate response between the pooled spinach groups 
and the control group and between the carotenoid supplement and the control 
group were compared using Student's t-test. The Tukey method for multiple 
comparisons among the various spinach groups was used after a significant F-
test. A general linear model was used to control for covariables, including age, 
sex, vegetarianism, and body mass index. Because differences among spinach 
groups were not significantly different, the plasma folate response in further 
processed spinach products (pooled minced and liquefied spinach groups) was 
compared with whole-leaf spinach. The effect of adding fibre back to liquefied 
spinach and the effect of a pure carotenoid supplement on plasma folate 
responses was tested using a t-test for independent samples. Differences with P 
< 0.05 were regarded as statistically significant (SPSS Advanced Statistics 7.5., 
1997, SPSS Inc., Chicago, IL). Results are expressed as means ± SD. Assuming 
a SD of 3.0, the power of the study to detect a difference in plasma folate 
concentration of 2.9 nmol/L was > 80%. 
Ethical considerations 
The protocol and aims of the study were fully explained to the subjects who all 
gave their written consent. Approval of the study was obtained from the Medical 
Ethical Committee of the Division of Human Nutrition and Epidemiology. 
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RESULTS 
Characteristics of the subjects are given in Table 1. At baseline the experimental 
groups did not differ in age, body mass index, plasma vitamin B12 concentration 
and plasma folate concentration (see Table 3). Folate and vitamin B12 status were 
within the normal range in all subjects (Herbert & Das 1994). The total daily intake 
of energy, macronutrients, dietary fibre and folate for a subject in the energy 
group providing 11 MJ is described in Table 2. There were no significant 
differences in macronutrient and fibre intake among the groups or among the 
three weeks of dietary intervention. The control diet, excluding the free choice 
products, provided on average daily 22.4 ± 3.9 (n = 5) u.g folate per MJ on 
average daily 22.4 ± 3.9 (n = 5) u.g folate per MJ. The daily folate intake in the 
spinach groups was approximately twice that of the control group. There were no 
significant differences in folate intake among the spinach groups. The whole-leaf, 
minced, liquefied, and liquefied plus added dietary fibre spinach products 
contained 113.5 ± 0.1, 118.8 ± 1.4, 109.1 ± 2.0, and 122.7 ± 18.0 u.g folate per 
100 g spinach, respectively. Plasma folate concentrations increased in all groups, 
including the control group, during the first week of intervention (Table 3). The 
Table 1. Characteristics of subjects participating in a study to determine the 
bioavailability of folate from differently processed spinach products* 
Group 
Men, women; 
n, n 
Vegetarians, 
Control 
3,7 
3 
Carotenoid 
supplement 
5,7 
1 
Whole-leaf 
spinach 
5,7 
3 
Minced 
spinach 
5,7 
7 
Liquefied 
spinach 
5,7 
3 
Liquefied 
spinach 
plus dietary 
fibre 
5,7 
3 
n 
Age, yearst 21(18,25) 21(18,24) 20(18,58) 21(18,42) 21(18,38) 20(18,54) 
Energy 11.4±2.6 12.8 ±3.4 11.5± 2.3 11.3 ± 2.1 11.4 ±2.1 11.4 ±2.3 
intake, MJ/d 
Body mass 21 ±2.1 22 ±2.3 22 ± 2.0 22 ± 2.4 23 ±2.1 22 ±1.8 
index, kg/m2 
Plasma 250 ±91 230 ±83 206 ± 57 250 ±49 268 ± 76 215 ±93 
vitamin B12, 
pmo//L 
* Data collected at beginning of study except for energy intake, which is the estimated mean 
over the intervention period. Values are means ± SD. 
tValues are expressed as medians (ranges). 
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Table 2. Mean total daily intake of energy, fibre and folate of subjects 
participating in a study to examine the bioavailability of folate from various 
spinach products* 
Energy (MJ/d) 
Dietary fibre (g/d) 
Folate C/jfir/cOt 
Control 
(A) =10) 
10.6 
27.4 
258 
Carotenoid 
supplement 
(n = 12) 
10.7 
25.2 
258 
Group 
Whole-leaf Minced 
spinach spinach 
(n = 12) (n=12) 
10.8 10.8 
32.4 32.3 
510 518 
Liquefied 
spinach 
(n = 12) 
10.8 
28.2 
495 
Liquefied 
spinach plus 
dietary fibre 
(« = 12) 
10.8 
31.3 
527 
* Results are based on the analysis of duplicate portions for a subject consuming approximately 
11 MJ together with an estimate calculated from the composition of the free items consumed. 
There were no significant differences in nutrient intakes among the groups or among the three 
weeks of dietary intervention. The mean daily intake was as follows: protein, 13.9 energy%; 
fat, 34.1 energy%; carbohydrate, 51.0 energy%; alcohol, 1.0 energy%. 
t Results are based on the analysis of duplicate portions of five week days for a subject in the 
control group consuming approximately 11 MJ together with an estimate calculated from the 
composition of the free choice food items consumed in each group and the analysed amounts 
of folate in each of the spinach products. 
pooled spinach groups had a statistically significant higher plasma folate 
response than the control group (2.4 nmol/L and -0.04 nmol/L, respectively; P < 
0.01). Multiple comparisons among the spinach groups revealed no significant 
differences between the various spinach products. When comparing the folate 
responses of the whole-leaf and the pooled minced and liquefied spinach groups, 
controlling for vegetarianism, the plasma folate response was higher in the pooled 
minced and liquefied spinach group than in the whole-leaf spinach group (P < 
0.03). Vegetarians (n = 20) had higher baseline (wk 0) plasma folate 
concentrations than non-vegetarians (18.0 ± 5.7, and 14.5 ± 3.2 nmol/L, 
respectively; P = 0.01), and their mean response was lower than that of the non-
vegetarians (0.9 ± 2.9 and 2.3 ± 2.6 nmol/L, respectively; P = 0.004). The 
response of the whole-leaf spinach group was small. If the trial was carried out 
with the whole-leaf spinach group and the control group only, we would not have 
been able to demonstrate a higher plasma folate response in the whole-leaf 
spinach group as compared to the control group (P = 0.3). 
Adding dietary fibre (10 g/kg wet weight) to the liquefied spinach group did not 
significantly reduce the plasma folate response relative to the response of the 
liquefied spinach group (P = 0.39; Table 3). The enzyme-treated spinach 
contained per 100 g dry matter 62 g MEIS and 9 g polygalacturonic acid as 
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compared to 71 g and 11 g, respectively, in the whole-leaf spinach. 
The plasma folate response did not differ between the carotenoid supplement 
group and the control group (P = 0.25), suggesting that the absorption of folates 
and carotenoids are independent processes and that there is no interaction 
between these nutrients. 
Table 3. Plasma folate concentrations in nmol/L (mean ± SD) at the start of 
the dietary intervention period (wk 0), after one week (wk 1), after two weeks 
(wk 2) and after three weeks of dietary intervention (wk 3) and response 
from begin to end of the dietary intervention period in healthy subjects fed 
various spinach products* 
WkO 
Wk1 
Wk2 
Wk3 
Response 
Control 
(n=10) 
15.4 ±3.1 
17.6 ±3.3 
16.6 ±2.2 
15.3 ±2.4 
-0.04 ± 2.4* 
Carotenoid 
supplement 
(n = 12) 
16.6 ±4.9 
18.7 ±4.6 
17.7 ±4.1 
17.9 ±4.0 
1.3 ±2.7 
Group 
Whole-leaf Minced 
spinach spinach 
(n = 12) (n =12) 
17.3 ±4.8 16.2 ±3.7 
20.8 ±5.5 19.8 ±3.7 
19.9 ±4.0 21.2 ±4.9 
18.6 ±3.4 19.4 ±4.1 
1.3 ±3.4+ 3.3 ±2.7 
Liquefied 
spinach 
0 = 1 2 ) 
13.1 ±4.1 
16.9 ±3.7 
17.2 ±4.2 
16.1 ±4.3 
2.9 ±1.7 
Liquefied spinach 
plus dietary fibre 
(n = 12) 
14.4 ±4.5 
18.3 ±4.2 
18.0 ±4.7 
16.5 ±3.6 
2.2 ±2.6 
* Significantly different from pooled spinach groups, P < 0.01 (independent samples t-test). 
t Significantly different, controlling for vegetarian diet, from pooled minced and liquefied spinach 
groups, P < 0.03 (ANOVA). 
DISCUSSION 
We found that consumption of 20 g/MJ of spinach daily for 3 wk significantly 
increased plasma folate concentration. Consumption of minced or liquefied 
spinach led to higher plasma folate responses than consumption of whole-leaf 
spinach, which suggests that the food matrix of spinach plays a role with regard to 
bioavailability of folate. Re-addition of dietary fibre did not significantly reduce the 
folate response in the liquefied spinach plus dietary fibre group compared to the 
liquefied spinach group. 
Our study suggests that folate from spinach consumed as part of a meal and 
mixed diet was absorbed and that further processing of spinach improved 
bioavailability. However, it should be noted that, perhaps due to the limited power 
of the study and the relative small amount of spinach served, the increase in 
plasma folate concentration in the whole-leaf spinach was small (8% or 1.3 
nmol/L). 
102 
Bioavailability of folate from spinach 
Few studies have examined the bioavailability of endogenous (polyglutamate) 
folate in foods. In an experiment with ten adult, non-pregnant women, who were 
maintained in a metabolic unit for 92 d, dietary folates appeared to be no more 
than 50% available when compared to pteroylmonoglutamic acid added to the 
diets (Sauberlich et al. 1987). This was confirmed by Cuskelly et al. (1996) in a 
long-term study, who found that the bioavailability of added folic acid was higher 
than the bioavailability of food folate. To our knowledge, there are no studies 
published that have examined the effect of food processing on improving folate 
bioavailability. We conclude that the bioavailability of folate in spinach products 
can be improved by further processing of the spinach, suggesting that the food 
matrix plays a role in folate bioavailability. Disruption of the food matrix by mincing 
or liquefying spinach resulted in a higher folate bioavailability. 
The plasma folate concentrations increased in all study groups, including the 
control group, after 1 wk and decreased after wk 2 and 3. We have no 
explanation for this finding. The plasma folate responses after wk 1 showed small 
increases in plasma folate concentrations for all spinach groups compared to the 
control group. Responses after wk 2 and 3 were consistent. 
In our study, 20 vegetarians participated and they were fed the same foods, 
except for the meat products, which were replaced by a vegetarian substitute with 
similar nutrient composition. The vegetarians had higher baseline plasma folate 
concentrations and smaller folate responses, which suggests that the vegetarians 
had higher intakes of folate before the start of the intervention period. During the 
run-in period subjects were instructed to avoid foods with a high folate content, 
but no restriction was given for cereal or meat products. To our knowledge, 
effects of baseline plasma folate concentrations on plasma folate responses to 
treatment with folate-rich foods have not been reported before. Lower plasma 
folate responses could also be due to differences in folate body stores, but we did 
not measure folate concentrations in erythrocytes. 
The difference in plasma folate response between liquefied spinach and 
liquefied spinach with added dietary fibre (0.7 nmol/L) was not statistical 
significant (P = 0.39). This suggests that dietary fibre (0.3 g/MJ) had no effect on 
folate bioavailability of spinach consumed as part of a mixed diet. Russell and co-
workers (1976) found no effect of cellulose or dietary fibre from wheat bran on 
folate absorption in humans of meals (breads) with increasing fibre contents (2.3 
to 8.2 g dietary fibre per meal). Addition of 30 g wheat bran to a formula meal had 
no effect on the absorption of heptaglutamyl folate whereas monoglutamyl folic 
acid absorption was increased (Keagy et al. 1988). On the other hand, Bailey et 
al. (1988) demonstrated in a short-term study that 34 g wheat bran, containing 19 
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g of dietary fibre, reduced the plasma folate response of polyglutamate relative to 
monoglutamyl or polyglutamyl folates consumed alone in solution. Brodribb & 
Humphreys (1976) showed that chronic ingestion of 24 g wheat bran daily to 
diverticular patients was associated with a small, but significant, decrease in 
serum folate concentrations. The mechanism behind a possible inhibitory effect of 
dietary fibre is not clear. In vitro data show a lack of effect of dietary fibre on brush 
border conjugase activity (Bhandari & Gregory 1990) and little or no effect on 
bioavailability of folic acid monoglutamate in a chick bioassay (Ristow et al. 1982). 
However, whether polyglutamyl folate binds to dietary fibre has not yet been 
investigated. In the present study, with the addition of 0.3 g/MJ dietary fibre to 
spinach no significant reduction of the plasma folate response was observed, but 
the intake of dietary fibre in the liquefied spinach plus dietary fibre group was only 
slightly higher than that in the liquefied spinach group (2.6 and 2.9 g dietary 
fibre/MJ, respectively). With the addition of higher amounts of dietary fibre the 
plasma folate response may further decrease and the difference between the two 
treatment groups may become statistically significant. 
Naturally occurring folates in foods are mainly in the form of polyglutamates, 
which are cleaved in the intestine by pteroylpolyglutamyl hydrolase (conjugase) to 
monoglutamates before absorption. Spinach and other vegetables contain 
endogenous folate conjugase (Leichter et al. 1979). When cell membranes are 
disrupted, endogenous folate conjugase, if still active, can act on polyglutamyl 
folates in spinach cells. Different ratios of polyglutamates to monoglutamates in 
the various spinach products could cause differences in folate bioavailability. 
However, all spinach products originated from one batch and all spinach was 
blanched to destroy all enzyme activity. Therefore, we assume that the 
inactivation of folate conjugase in all spinach products was complete. 
A limitation of the present study may be that plasma folate response was used 
as the criterion of response to bioavailable dietary folate. Although the plasma 
folate concentrations are often considered to be insensitive and highly variable, 
we think that measuring plasma folate concentrations after three weeks of fully 
controlled diets is a valuable method to examine the folate bioavailability. 
However, further research on the variability and sensitivity of plasma folate 
concentrations is needed. Another limitation to this study was the lack of a 
positive control group receiving synthetic folic acid. Therefore, we cannot relate 
the plasma folate responses of the spinach groups to the plasma folate response 
of a control group fed folic acid. 
We conclude that consumption of spinach (20 g/MJ) added to a mixed diet 
increased folate status in healthy volunteers. Our data suggest that the way foods 
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are processed influences folate bioavailability: consumption of minced and 
liquefied spinach increased plasma folate response more than consumption of 
whole-leaf spinach. The response to treatment may depend on the baseline 
plasma folate concentration, and the addition of dietary fibre (0.3 g/MJ added to 
2.6 g/MJ) did not reduce the plasma folate response. Consumption of a synthetic 
carotenoid supplement with a similar composition of carotenoids as present in 
spinach had no effect on the plasma folate concentration. 
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ABSTRACT 
In vitamin A-replete populations, increased concentrations of serum carotenoids 
have been associated with a decreased risk of degenerative diseases. The 
mechanism of action of carotenoids in determining antioxidant activity is largely 
unknown. The aim of the study was to examine the effect of carotenoid 
supplementation and spinach intake on erythrocyte enzyme antioxidant activities, 
serum or plasma non-enzymatic antioxidant concentrations, and concentrations of 
oxidatively damaged amino acids in plasma. Subjects received for 3 wk a basic 
diet (n = 10), a basic diet with a carotenoid supplement (n = 12) or with a spinach 
product (n = 12 per group), i.e., whole-leaf, minced, liquefied or liquefied spinach 
plus added dietary fibre. After 3 wk of dietary intervention, changes in serum or 
plasma concentrations of ascorbic acid, a-tocopherol, FRAP (ferric reducing 
ability of plasma) and uric acid and erythrocyte enzyme activities were assessed 
and differences among experimental groups were tested. Consumption of spinach 
resulted in greater (P < 0.01) erythrocyte glutathione reductase activity and lower 
(P < 0.05) erythrocyte catalase activity and serum a-tocopherol concentration 
compared to the control group. Consumption of the carotenoid supplement led to 
lower a-tocopherol responses (P = 0.02) compared with the basic diet only. Our 
data suggest that the short-term changes in erythrocyte glutathione reductase 
activity and serum a-tocopherol concentration can be attributed to an increased 
carotenoid (lutein and zeaxanthin) intake, but p-carotene is unlikely to be a 
causative factor. Lower erythrocyte catalase activity after intervention with 
spinach products may be related to other constituents in spinach such as 
flavonoids. 
KEY WORDS: carotenoids, antioxidants, a-tocopherol, humans, spinach 
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INTRODUCTION 
Carotenoids are naturally occurring compounds in plants, but only a limited 
number of carotenoids are found in human plasma and tissues. The major ones 
are p-carotene, lutein, a-carotene, zeaxanthin, cryptoxanthin and lycopene. A 
number of carotenoids are precursors of retinol and retinoids, but carotenoids 
also have several other functions in humans, including protecting against 
oxidation by quenching singlet oxygen (Stahl et al. 1997). In addition, p-carotene 
reacts chemically with peroxyl radicals to produce epoxide and apocarotenal 
products (Canfield 1992). A low level of carotenoids is associated with poor 
cognitive performance (Berr et al. 1998), and higher plasma p-carotene levels are 
associated with better memory performance in elderly people (Perrig et al. 1997). 
On the basis of intake or biomarkers of intake, carotenoids have been postulated 
to play a protective role in angina pectoris (Riemersma et al. 1991), 
cardiovascular disease (Gaziano et al. 1995, Kardinaal et al. 1993, Knekt et al. 
1994, Street et al. 1994) and cancer (Stahelin et al. 1991, van Poppel 1996), 
particularly cancer of lung (Dartigues et al. 1990, Knekt et al. 1990) and stomach 
(Chen et al. 1992). However, intervention studies have not borne this out (The 
ATBC Cancer Prevention Study Group 1994, Blot et al. 1993, Blot 1997, 
Greenberg et al. 1996, Omenn et al. 1996, Rapola et al. 1997). These 
intervention studies used p-carotene supplements rather than a mixture of 
carotenoids as present in fruits and vegetables. The positive effects on health 
postulated for the carotenoids have been attributed largely to their antioxidant 
actions. However, studies linking higher carotenoid intakes to better antioxidant 
defence and to a decrease in oxidative damage in the body are very few and 
have generally used indirect methods (Esterbauer 1996, Miller & Rice-Evans 
1997, Puhl et al. 1994). Therefore, we conducted a dietary controlled intervention 
study to investigate the effects of intake of a carotenoid supplement dissolved in 
oil and three differently processed spinach products on a range of enzymatic and 
non-enzymatic antioxidant parameters in human blood. The effect of consumption 
of the differently processed spinach products on the bioavailability of carotenoids 
has been published separately (Castenmiller et al. 1999). The primary aim of this 
study was to evaluate whether a spinach intervention had an effect on markers of 
antioxidative status and whether this effect could be contributed to carotenoids 
present in spinach. 
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MATERIALS AND METHODS 
Subjects 
The subjects were 72 healthy, non-smoking, normolipidemic volunteers; they 
were 42 women and 30 men, aged 18-58 y. The subjects, students of 
Wageningen Agricultural University and other inhabitants in the Wageningen 
area, were recruited through local advertisements. None of the subjects were 
taking oral medications, except for oral contraceptives, or supplements of any 
kind during the last three mo before the study started or during the study. The 
screening procedures included a test for elevated glucose and protein levels in 
urine and a check for abnormal haematology or low haemoglobin concentrations. 
All subjects completed a medical and a general questionnaire in addition to food 
frequency questionnaires to estimate their intakes of energy, and carotenoids and 
vitamin A. The subjects had normal body mass indices (18-28 kg/m2); their fasting 
serum cholesterol concentrations were lower < 6.5 mmol/L and triacylglycerol 
Table 1. Characteristics of subjects participating in a study to determine the 
effect of consumption of a carotenoid supplement or spinach products on 
antioxidant activity in human blood1 
Group 
Control Carotenoid Whole-leaf Minced 
supplement spinach spinach 
Liquefied Liquefied 
spinach spinach 
plus dietary 
fibre 
12 12 12 12 12 
5,7 5,7 5,7 5,7 5,7 
1 
n 10 
Men, women; 3, 7 
n, n 
Vegetarians, 3 
n 
Age, y 21(18,25)2 21(18,24) 20(18,58) 21(18,42) 21(18,38) 20(18,54) 
Energy 11.4 + 2.6 12.8 + 3.4 11.5 ±2.3 11.3 ±2.1 11.4 ±2.1 11.4 ±2.3 
(estimated), 
MJ/d 
Serum 4.14 ±0.65 4.07 ± 0.61 4.11 ±0.79 4.23 ±0.74 3.93 ±0.47 4.17 ±0.87 
cholesterol, 
mmolA. 
Serum 0.88 ± 0.41 0.87 ±0.32 0.92 ± 0.32 1.00 ±0.39 0.89 ± 0.27 1.00 ±0.34 
triacylglyce-
rol, mmolA. 
Body mass 21 ±2.1 22 ±2.3 22 ± 2.0 22 ± 2.4 23 ±2.1 22 ±1.8 
index, kg/m2 
1
 Data collected at beginning of study except for energy intake, which is the mean over the 
intervention period. Values are means ± SD. 
2
 Medians (ranges). 
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concentrations were < 2.8 mmol/L. During the study, two male subjects withdrew 
from the study for personal reasons. For characteristics of the subjects, see Table 
1. The protocol for this study was approved by the Medical-Ethical Committee of 
Wageningen Agricultural University and all subjects gave their written informed 
consent. 
Study design 
The study started in January 1997 with a 3-wk run-in period, during which 
subjects chose their own diets but were instructed to avoid foods rich in 
carotenoids and retinol. Then, subjects were stratified according to age, sex, 
cholesterol concentration and energy intake and assigned to six experimental 
groups. The six treatment groups were fed the same basic diet throughout the 
study and the menu was changed daily on a weekly cycle. The basic diet did not 
include fruits and vegetables with moderate or high amounts of carotenoids and 
met the requirements of the Dutch Recommended Daily Allowances (Netherlands 
Food and Nutrition Council 1992). In addition to the basic diet, four groups 
received daily a spinach product; one group received a supplement of a 
suspension in vegetable oil of microcrystalline p-carotene (40 g/kg; Hoffmann-La 
Roche, Basel, Switzerland) and crystalline lutein and zeaxanthin derived from 
marigold flowers (60 g/kg and 3 g/kg, respectively; FloraGLO, kindly supplied by 
Kemin Industries Inc., Des Moines, IA). The carotenoid supplement was 
suspended in sunflower oil; for the carotenoid supplement group, some of the 
sunflower oil used in salad dressing fed to the control and spinach groups was 
replaced by the carotenoid supplement suspension. The spinach groups received 
20 g/MJ of whole-leaf spinach, minced spinach, liquefied spinach or liquefied 
spinach to which dietary fibre was added. All spinach products originated from 
one batch and were provided, prepared and subsequently frozen by Langnese-
Iglo (Wunstorf, Germany) for Unilever Research (Vlaardingen, The Netherlands). 
Whole-leaf spinach was washed and blanched for 90 s and cooled down quickly; 
minced spinach was minced to 5 mm after blanching. An enzymatic preparation 
with pectinase, hemicellulase and cellulase activities (Rapidase LIQ+, kindly 
supplied by Gist-Brocades, Seclin, France) was used for the liquefaction of 
minced spinach. After the enzyme treatment, the spinach was boiled for 5-10 min 
to inactivate the enzymes. One group received the liquefied spinach plus fibre 
prepared from beetroot pulp (10 g/kg, Fibrex 600, kindly supplied by TEFCO Food 
Ingredients b.v., Bodegraven, The Netherlands). The energy content of the diets 
of the control group and carotenoid supplement group was adjusted to that of the 
spinach groups by extra amounts of appropriate foods. All frozen spinach was 
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thawed and heated by microwave before consumption. The spinach products 
contained no measurable nitrite and < 1000 mg nitrate/kg, thus ensuring that the 
nitrate intake of the subjects was below the Acceptable Daily Intake for nitrate 
(Joint FAO/WHO Expert Committee on Food Additives 1995). Microbiological 
counts showed normal values and confirmed that the spinach products were safe 
for human consumption. Subjects were supplied with total diets, except for a 
limited choice of free products (~10 energy%). Twenty vegetarians took part in the 
experiment. They received the same foods as the non-vegetarian subjects (n = 
50), except for the meat, which was replaced by a vegetarian substitute with 
similar nutrient composition. On week days, subjects received a hot meal at the 
Division of Human Nutrition and Epidemiology; foods for their other meals and 
snacks were packed to be taken home. For weekend days, all foods were packed 
together with instructions and suggestions for preparation and consumption. The 
daily selection of free-choice foods was recorded in a diary and the nutrient 
content was calculated (NEVO Foundation 1995). The free items did not contain 
carotenoids or retinol. A maximum of two alcoholic consumptions per day was 
allowed but was not to be consumed together with the hot meal. Individual body 
weights throughout the study were maintained at ± 2 kg. Subjects were asked not 
to change their usual pattern of activities. 
Blood measurements 
Blood was taken from fasting subjects at 715-1000 h by venipuncture on d 0, 1, 8, 
15, 21 and 22 of the intervention period for serum analyses of carotenoids and a-
tocopherol concentrations, on d 0, 8, 15, and 22 for plasma analysis of ferric 
reducing ability (FRAP)1, uric acid, and vitamin C concentrations and at d 0 and 
22 for analysis of erythrocyte enzyme activities and oxidatively modified amino 
acids in plasma proteins. 
Carotenoids and a-tocopherol 
Samples, to which no anticoagulant was added, were left to clot; within 1 h after 
being drawn, were centrifuged and stored at -80°C. Serum carotenoids and a-
tocopherol were measured by HPLC. To avoid day-to-day analytical variations, all 
samples from an individual were analysed as a set. After precipitation with 
ethanol, extraction followed with hexane twice, samples were evaporated under 
nitrogen and injected into the HPLC system (Craft et al. 1992). All sample 
1
 Abbreviations used: AAS, adipic semialdehyde; CAT, catalase; FRAP, ferric 
reducing ability of plasma; GPx, glutathione peroxidase; GR, glutathione reductase; 
SOD, superoxide dismutase. 
114 
P-Carotene and antioxidant activity 
preparations and extractions were carried out in duplicate and under subdued 
yellow light with minimal exposure to oxygen. The intra-assay CV for serum 
analysis of a-carotene, p-carotene, lutein, and zeaxanthin in control pools 
averaged 7.4, 3.9, 3.6 and 8.7%, respectively. 
Erythrocyte antioxidative enzymes 
Antioxidant enzyme activities were determined in erythrocyte lysates. Heparinised 
blood samples were centrifuged at 1500 x g for 10 min and plasma was removed. 
The erythrocytes were washed twice in 4 vol sterile physiological buffered saline, 
resuspended in 1 vol of sterile, deionised water for lysis and immediately frozen at 
-80°C. Automated assays were performed on a Cobas Mira analyser (Roche, 
Basel, Switzerland) to determine the activity of the antioxidant enzymes 
glutathione peroxidase (GPx), glutathione reductase (GR), superoxide dismutase 
(SOD) and catalase (CAT). The activities of the enzymes were related to the 
amount of haemoglobin in the blood haemolysates. SOD (Randox cat. no. SD 
125, Ardmore, UK), GPx (Randox cat. no. RS 05) and haemoglobin (Randox cat. 
no. HG 980) were determined using commercially available kits. GR activity and 
CAT activity were determined according to methods described previously 
(Wheeler et al. 1990). All analyses were conducted within 20 d. The intraday CV 
of SOD, CAT, GR and GPx averaged 1.9, 1.4, 3.1 and 1.9%, respectively. 
NADPH, glutathione, FAD, purpald and potassium periodate were purchased 
from Sigma Chemical (St. Louis, MO). 
Determination of adipic semialdehyde (AAS) 
Oxidatively modified amino acids in plasma proteins were analysed by HPLC 
(Daneshvar et al. 1997). The protein fractions were reacted with fluoresceinamine 
before the hydrolysis, and the decarboxylated fluoresceinamine derivatives of 
adipic and glutamic semialdehydes were measured by HPLC using a diode array 
detector. The intraday CV for this determination was 5.2%. 
FRAP, uric acid and vitamin C 
The antioxidant activity of samples, to which EDTA was added as an 
anticoagulant, was assessed as their ferric reducing ability (FRAP) (Benzie & 
Strain 1996). Uric acid concentration was measured in plasma samples using 
enzymatic colorimetric methods (Boehringer Mannheim, Germany). Vitamin C 
concentration in plasma treated with trichloroacetic acid was determined 
fluorimetrically as ascorbate plus dehydroascorbate (Vuilleumier & Keck 1996). 
The intra-assay, interday CV for plasma analysis of FRAP, uric acid and vitamin C 
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was 3.5, 2.0 and 5.6%, respectively. 
Food measurements 
The duplicate portions of the daily food intake of one subject collected throughout 
the study were mixed thoroughly as weekly portions; subsequently pooled 
samples were stored at -20°C until analysis. The moisture level and the ash 
content in each weekly portion were determined using a vacuum oven at 85°C 
and a muffle furnace at 550°C. The protein concentration was determined by the 
Kjeldahl method using a conversion factor of 6.25. The method of Folch et al. 
(1957) was used to extract fat. Dietary fibre was analysed according to the AOAC 
(1996) Official Method 992.16 for total dietary fibre. Digestible carbohydrate was 
calculated by difference. Carotenoids were extracted from wet material after 
homogenisation using tetrahydrofuran (THF), redissolved in THF/methanol (1:1 
v/v) and injected into the HPLC system (Hulshof et al. 1997). The CV within runs 
of a-carotene, p-carotene and lutein in control pools averaged 5.7, 6.8 and 8.8%, 
respectively. Samples for vitamin C determination, to which metaphophoric acid 
was added, were collected from a number of daily-homogenised duplicate 
portions and immediately frozen. Vitamin C was determined fluorimetrically, after 
extraction with metaphosphoric acid/acetic acid (60:80, wt/v), as ascorbate plus 
dehydroascorbate (CV was 5.6%, Vuilleumier & Keck 1996). 
Statistical analysis 
Responses to the dietary intervention were averaged for carotenoids and a-
tocopherol for d 0 and 1 and for d 21 and 22 for each subject. All other variables 
were measured once at the beginning and end of the dietary intervention period. 
The response to treatment was calculated for each person as the change in 
serum or plasma concentration or enzyme activity from the start to the end of the 
dietary intervention period. ANOVA was used to test equality of mean elevation 
for the different treatment groups, thereby controlling for several factors and 
covariables (SPSS Advanced Statistics, Chicago, IL). When all significant 
predictors of antioxidant levels are included in a model, it can be shown whether a 
particular variable is an independent predictor of the response after treatment. For 
example, for the ferric reducing ability of plasma (FRAP), uric acid should be 
included as a covariable because the uric acid concentration determines -60% of 
the antioxidant activity of plasma (Benzie & Strain 1996). To evaluate the effect of 
one of the erythrocyte enzyme activities, all other activity responses were 
included in the model as covariables. Because initial values may have affected 
the magnitude of changes, effects of treatment were also assessed after 
116 
p-Carotene and antioxidant activity 
adjustment for baseline values by analysis of covariance, where applicable. 
Significant F-tests were followed by Tukey studentised range tests of pair-wise 
differences and Least Significant Difference (LSD) tests to evaluate differences 
among the four means of each spinach treatment. Pearson's correlations were 
calculated for the responses of several variables. P-values < 0.05 were regarded 
as significant. Values are means ± SD. 
RESULTS 
Results of the composition of the diets are presented in Table 2 and results of 
analyses of various erythrocyte enzymatic activities and non-enzymatic, 
antioxidant concentrations in serum or plasma are described in Table 3 for the 
control, carotenoid supplement and pooled spinach groups. At baseline (wk 0), 
there were no significant differences among the erythrocyte antioxidant enzyme 
activities or serum or plasma antioxidant concentrations of the various 
experimental groups, except for erythrocyte SOD and GR activities. Results of the 
consumption of differently processed spinach products on the bioavailability of 
Table 2. Total daily intake of energy and nutrients of subjects participating 
in a study to examine the effect of consumption of a carotenoid supplement 
or spinach products on antioxidant activity in human blood1 
Energy, MJ/d 
P-Carotene, mg/d 
Lutein, mg/d 
Zeaxanthin, mg/d 
Retinol, mg/d 
Vitamin C, mg/d2 
Dietary fibre, g/d3 
Control 
10.6 
0.5 
0.5 
0.1 
0.4 
100 
27.4 
Group 
Carotenoid supplement 
10.7 
9.8 
6.6 
0.3 
0.3 
83 
25.2 
Spinach products 
10.8 
9.3 
11.5 
0.1 
0.4 
63 
31.1 
1
 Results are based on the analysis of duplicate portions for a subject consuming -11 MJ 
together with an estimate calculated from the composition of the free items consumed. The 
free items did not contain carotenoids or retinol. There were no significant differences in 
nutrient intake among the groups or the 3 wk of dietary intervention. The daily intake was as 
follows: protein, 14 energy%; fat, 34 energy%; carbohydrate, 51 energy%; and alcohol, 1 
energy%. 
2
 Includes estimated amounts of vitamin C from free choice foods (2.0 - 3.1 mg/d). The vitamin 
C content of whole-leaf, minced, liquefied, and liquefied spinach plus added dietary fibre 
groups was 75, 61, 68 and 48 mg/d, respectively. 
3
 The dietary fibre content of whole-leaf, minced, liquefied and liquefied spinach plus added 
dietary fibre groups was 32.4, 32.3, 28.2 and 31.3 g/d, respectively. 
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Table 3. Variables of antioxidant activity in human blood: concentrations 
and activities of the control, carotenoid supplement and pooled spinach 
groups at baseline (wk 0), after 3 wk of dietary intervention (wk 3) and 
responses from begin to end of the dietary intervention period1 
n 
Adipic semialdehyde, pmol/mg protein 
WkO 
Wk3 
Response 
Glutathione peroxidase, U/g Hb 
WkO 
Wk3 
Response 
Glutathione reductase, U/g Hb 
WkO 
Wk3 
Response 
Superoxide dismutase, U/g Hb 
WkO 
Wk3 
Response 
Catalase, U/g Hb 
WkO 
Wk3 
Response 
FRAP, mmol/L 
WkO 
Wk3 
Response 
Uric acid, mmol/L 
WkO 
Wk3 
Response 
Vitamin C, \imol/L 
WkO 
Wk3 
Response 
a-Tocopherol, nmol/L 
WkO 
Wk3 
Response 
Control 
10 
23.8 ±3.9 
27.3 + 4.3 
3.5 ±6.5 
61.3 ±27.7 
61.8 ±26.5 
0.5 ±8.9 
9.7 ±2.1 
8.8 ±1.8 
-0.9 ±1.3 
1299 ±312 
1295 ±248 
-4 ±181 
17.2 ±3.1 
22.1 ±9.0 
4.8 ±7.1 
1.01 ±0.134 
1.02 ±0.28 
0.02 ± 0.22 
242 ± 42" 
247 ±102 
5 ±73 
57.0+11.5 
67.8 ±4.0 
11.8 ± 11.9 
18.8 + 3.9 
21.9 ±4.5 
3.1 ±2.5 
Group 
Carotenoid 
supplement 
12 
25.7 ±4.0 
28.1 ±8.8 
2.4 ±9.1 
54.6 ±8.5 
59.2 ± 9.2 
4.6 ±7.9 
7.7 ±1.4 
8.1 ±1.9 
0.4±1.62 
1082 ±155 
1143± 101 
61 ± 133 
17.5 ±8.5 
20.1 ±5.5 
2.6 + 5.0 
1.03 ±0.22 
1.01 ±0.19 
-0.02 ±0.10 
253 + 70 
244 ±63 
-9 ±21 
58.3 ±14.5 
69.8 ±12.7 
11.4± 15.2 
21.1 ±4.5 
22.6 + 4.1 
1.5 ± 2.12 
Pooled spinach 
48 
24.8 ±4.5 
27.2 ±4.6 
2.3 ±6.1 
51.7 ±10.8 
54.3 ± 9.7 
2.5 ±9.3 
8.5 ±1.7 
8.7 ±2.1 
0.2±1.93 
1152 ±180 
1190 ±130 
38 ±162 
16.2 ±3.3 
18.1 ±4.5 
1.9±5.23 
1.06 ±0.17 
1.05 ±0.12 
-0.01 ±0.12 
266 ± 55 
254 ± 43 
-12 ±36 
60.5 ±14.6 
70.2 ±10.3 
9.7 ±13.6 
20.5 ±4.2 
21.5 ±4.4 
1.0 ±2.93 
Values are means ± SD. U/g Hb: units per gram haemoglobin. FRAP: ferric reducing ability of 
plasma. 
!
 Significant difference between control group and carotenoid supplement group, P = 0.02. 
' Significant difference between control group and pooled spinach groups, P < 0.05. 
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carotenoids are described elsewhere (Castenmiller et al. 1999). The serum 
concentration of 0-carotene increased from 0.253 ± 0.130 ^mol/L to 2.608 ± 1.06 
p.mol/L in the carotenoid supplement group and from 0.283 ± 0.141 \imo\IL to 
0.445 ±0.172 nmol/L in the pooled spinach groups. For lutein, the increase was 
from 0.218 ± 0.064 nmol/L to 0.983 ± 0.287 ^mol/L in the carotenoid supplement 
group and from 0.216 ± 0.072 nmol/L to 0.915 ± 0.272 ntnol/L in the pooled 
spinach groups. The serum zeaxanthin response was higher in the carotenoid 
supplement group than in the control group (P = 0.006) or the pooled spinach 
groups (P < 0.001; independent f test) but was not different between the pooled 
spinach and control groups (P = 0.07). The serum triacylglycerol and cholesterol 
concentrations did not change over the experimental period or among the 
experimental groups (data not shown). 
Diets 
Duplicate portions of the food provided to the participants were analysed as 
pooled weekly portions; results of chemical analysis are shown in Table 2. For 
macronutrients and p-carotene, the concentrations measured were consistent 
among the treatment groups and for the 3 wk; the intake of lutein in the 
carotenoid supplement group (0.6 mg/MJ) was lower than in the spinach groups 
(1.1 mg/MJ). The vitamin C content of the diets with a carotenoid supplement, 
whole-leaf spinach, minced spinach, liquefied spinach and liquefied spinach plus 
added dietary fibre were 83, 75, 61, 68 and 48%, respectively, that of the control 
group. The a-tocopherol content of the diets was not measured. However, we 
expected that the supply of a-tocopherol would have been similar for all treatment 
groups, but may have been different for the vegetarian diet, in which meat was 
replaced by a vegetarian product. Therefore, when analysing the a-tocopherol 
responses, an adjustment was made for the factor vegetarian diet. 
Spinach products and carotenoid supplement vs. control diet 
The erythrocyte GR activity response, adjusted for responses of SOD and CAT, 
was higher (P < 0.01) whereas the CAT, adjusted for responses of GR, GPx and 
SOD, and a-tocopherol responses, adjusted for vegetarian diet (P = 0.02 and P = 
0.04, respectively), were lower in the pooled spinach groups than in the control 
group. The response of erythrocyte GR activity, adjusted for responses of CAT 
and SOD, was higher (P = 0.02), whereas the serum a-tocopherol response was 
lower (P = 0.02) in the carotenoid supplement group than in the control group. 
Introducing the baseline value into the model, the difference between GR activity 
of the control and carotenoid supplement group was no longer significant, 
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whereas the difference between the control and spinach groups remained 
significant. The change in serum a-tocopherol concentration in the control group, 
which had the lowest mean baseline (wk 0) serum a-tocopherol concentration, 
was greater than that for the carotenoid and pooled spinach groups. These data 
are difficult to interpret. Adjustment of serum a-tocopherol concentrations for 
concentrations of cholesterol and triacylglycerol may provide a better reflection of 
dietary intake (Willett et al. 1983). The relative serum a-tocopherol concentration 
is the concentration of a-tocopherol in serum related to that of the sum of the 
concentrations of cholesterol and triacylglycerol in serum. The relative serum a-
tocopherol responses also showed significant differences between the control and 
pooled spinach groups (P < 0.001) and tended to be different between the control 
and carotenoid supplement group (P = 0.06; P = 0.006 when adjusted for 
vegetarian diet). Analysis of covariance with baseline values (wk 0) and 
vegetarian diet as covariable and the serum concentration at wk 3 as dependent 
variable showed that the difference between the pooled spinach group and the 
control group was no longer significant, but the difference between the control 
and carotenoid supplement group remained significant. This study could not 
demonstrate any effect of intake of spinach or the carotenoid supplement on 
plasma concentrations of MS, vitamin C, FRAP or uric acid. 
Carotenoid supplement vs. spinach products 
Although the bioavailability of p-carotene from the carotenoid supplement was 
much higher than that from the spinach products, no significant differences could 
be detected for any of the responses in enzymatic erythrocyte activities, plasma 
AAS, FRAP, uric acid and vitamin C concentrations or serum a-tocopherol 
concentration between carotenoid supplement and pooled spinach groups. 
Results among various spinach products 
The differences among the four spinach groups tended to be different (P = 0.07) 
only for uric acid responses (see Table 4). Whole-leaf spinach resulted in a higher 
uric acid response than consumption of liquefied spinach (Tukey method, P = 
0.06; LSD method, P = 0.01). These results indicate that consumption of whole-
leaf spinach, which resulted in lower serum carotenoid responses than 
consumption of other spinach products, may enhance oxidative defence more 
than consumption of liquefied spinach. 
Relationship between responses 
Pearson correlation coefficients for significant correlations of responses among 
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Table 4. Variables of antioxidant activity in human blood: concentrations 
and activities at baseline (wk 0), after 3 wk of dietary intervention (wk 3) and 
responses from begin to end of the dietary intervention period for each 
spinach group1 
Adipic semialdehyde, pmol/mg 
protein 
WkO 
Wk3 
Response 
Glutathione peroxidase, U/g Hb 
WkO 
Wk3 
Response 
Glutathione reductase, U/g Hb 
WkO 
Wk3 
Response 
Superoxide dismutase, U/g Hb 
WkO 
Wk3 
Response 
Catalase, U/g Hb 
WkO 
Wk3 
Response 
FRAP, mmol/L 
WkO 
Wk3 
Response 
Uric acid, mmol/L 
WkO 
Wk3 
Response 
Vitamin C, ymol/L 
WkO 
Wk3 
Response 
a-Tocopherol, \imol/L 
WkO 
Wk3 
Response 
Whole-leaf 
spinach 
25.5 ±4.8 
27.3 ±4.4 
1.8 ±7.3 
50.1 ±8.5 
52.5 ±10.4 
2.4 ±6.8 
9.4 ±1.6 
9.9 ±2.9 
0.6 ±2.6 
1167 ±150 
1173 ±86 
6 ±182 
16.5 ±3.2 
20.5 ±6.5 
4.0 ±6.6 
1.04 ±0.14 
1.07 ±0.12 
0.03 ±0.10 
264 ± 46 
268 ± 43 
5 ±34 
67.3 ±15.2 
72.4 ±9.0 
5.0 ±14.3 
21.0±4.7 
22.6 ± 5.4 
1.6 ±3.1 
Group 
Minced 
spinach 
25.2 ±4.2 
27.0 ±4.7 
1.8 ±5.8 
50.6 ±13.2 
52.2 ± 9.6 
1.6 ±9.1 
8.2 ±1.2 
8.4 ±1.5 
0.2 ±1.3 
1131 ±194 
1211 ±180 
80 ±170 
16.7 ±3.2 
16.3 ±2.6 
-0.4±1.12 
1.02 ±0.21 
1.04 ±0.12 
0.02 ±0.13 
249 ± 63 
244 ± 45 
-5 ±32 
60.4 ±14.9 
71.4± 11.2 
11.0± 12.3 
21.1 ±4.5 
21.3 ±4.3 
0.2 ±4.0 
Liquefied 
spinach 
23.8 ± 4.6 
25.3 ±3.9 
1.6 ±6.0 
52.5 ±13.4 
57.3 ±8.0 
4.8 ±10.6 
7.6 ±1.8 
8.0 ±1.2 
0.4 ±1.8 
1096+187 
1133 ±120 
37+172 
15.1 ±2.7 
17.3 ±3.7 
2.3 ±4.0 
1.11 ±0.16 
1.05 ±0.10 
-0.06 ±0.12 
284 ± 50 
252 ± 40 
-32 ± 312 
54.7 ±12.0 
66.4 ± 7.9 
11.7 ± 12.7 
20.4 ± 3.4 
21.6 ±3.9 
1.3 ±3.4 
Liquefied 
spinach plus 
dietary fibre 
24.8 ± 4.7 
29.0 ± 5.2 
4.2 ± 5.6 
53.7 ±8.0 
55.0 ±11.0 
1.3 ± 11.1 
8.7 ±2.0 
8.4 ± 2.0 
-0.3 ±1.8 
1213± 187 
1242 ±102 
29 ±132 
16.6 ±4.0 
18.2 ±3.7 
1.6 ±5.7 
1.07±0.17 
1.03 ±0.15 
-0.04 ±0.12 
268 ± 61 
253 ± 46 
-15 ±39 
59.6 ±15.0 
70.8 ±12.8 
11.2 + 15.6 
19.8 ±4.3 
20.7 ±3.9 
0.9 ±1.2 
Values are means ± SD, n = 12. U/g Hb: units per gram haemoglobin. FRAP: ferric reducing 
ability of plasma. 
:
 Significant differences for uric acid response between whole-leaf spinach and liquefied 
spinach: Tukey studentised range test after ANOVA (P = 0.07), P = 0.06. 
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variables of antioxidant activities and concentrations were calculated. Significant 
and meaningful correlations (r > 0.30, P < 0.05) were observed among the 
responses of erythrocyte enzymatic antioxidant activities of GPx, GR, SOD and 
CAT (all positive), with an exception for the correlation between SOD and CAT. 
Positive correlations existed between plasma responses of FRAP and uric acid, 
plasma FRAP responses and serum a-tocopherol concentrations, plasma AAS 
and vitamin C responses. The serum zeaxanthin responses were positively 
correlated with responses in serum concentrations of a-tocopherol (r = 0.39), and 
a positive correlation was observed between erythrocyte GR responses and 
serum lutein responses (r = 0.29). There were no significant correlations between 
the serum p-carotene response and that of any of the other markers of 
antioxidative status measured. 
DISCUSSION 
The present study showed that consumption of spinach resulted in greater 
responses of erythrocyte GR activity and lower erythrocyte CAT and serum a-
tocopherol responses compared with the control group. Consumption of the 
carotenoid supplement increased erythrocyte GR activity response and 
decreased the serum a-tocopherol response compared with the control group. 
However, evidence for the lower a-tocopherol response in the spinach groups 
and greater GR response in the carotenoid supplement group is not conclusive. 
Because the diets supplied to the carotenoid supplement group and the control 
group were similar except for the carotenoid supplement, differences between 
these groups, as were found for responses of erythrocyte GR activity and serum 
a-tocopherol, can be attributed to the intake of p-carotene, lutein and a small 
amount of zeaxanthin as a carotenoid supplement dissolved in oil. It should be 
noted that the lutein is obtained from a natural source (marigold) and may thus 
contain some flavonoids and other phytochemicals. A small but significant 
correlation was observed between the responses of GR activity and serum lutein 
concentrations (Pearson correlation coefficient: 0.29; P < 0.05), suggesting that 
the greater responses of GR in the carotenoid supplement and spinach groups 
compared with the control group were related to the greater responses of serum 
lutein concentrations. The antioxidant responses in the pooled spinach group 
were not significantly different from those in the carotenoid supplement group. 
This suggests that the observed changes in antioxidant activities or 
concentrations were not caused by the increased absorption of p-carotene 
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because the p-carotene response, but not that of lutein, was much higher in the 
carotenoid supplement group than in the spinach groups. In cases in which 
significant differences between the pooled spinach and control group were 
present but not between the carotenoid supplement and the control group, as we 
found for the response in erythrocyte CAT activity, the difference was probably 
due to constituents other than carotenoids present in spinach (Dragsted et al. 
1997). 
Antioxidant enzyme activities 
GR activity increased after 3 wk of dietary intervention with carotenoids. 
Diminished degradation of the antioxidant enzymes because of a protective role 
of carotenoids, known to deactivate singlet oxygen, could explain the relative 
increase in enzyme activity in the carotenoid supplement and spinach groups 
compared with the control group. Alternatively, carotenoids might act by inducing 
the enzymes. Although induction of an antioxidant enzyme theoretically cannot 
occur in erythrocytes, induction may occur during erythropoiesis. Moreover, 
activity of enzymes located in erythrocytes has been reported to change within 
hours after eating (Saghir et al. 1997). 
GPx catalyses the degradation of peroxides with concomitant oxidation of 
glutathione. In the presence of GR and NADPH, the oxidised glutathione is 
immediately converted to the reduced form. Thus, it is not surprising that we 
found that the activities of GPx and GR were correlated. SOD catalyses the 
dismutation of superoxide anion radicals and CAT catalyses the reduction of 
hydrogen peroxide to water. From a kinetic point of view, CAT and GPx are both 
able to destroy hydrogen peroxide, but GPx has a much higher affinity for 
hydrogen peroxide than does CAT, suggesting that hydrogen peroxide is mainly 
degraded by GPx under normal conditions (Delmas-Beauvieux et al. 1996). 
In a study conducted in France, elderly hospitalised subjects were supplied 
daily with a placebo; 20 mg zinc plus 100 \xg selenium (mineral group); 120 mg 
vitamin C and 6 mg p-carotene and 15 mg vitamin E (vitamin group); or 20 mg 
zinc, 100 |ig selenium, 120 mg vitamin C, 6 mg p-carotene and 15 mg vitamin E 
(mineral and vitamin group). After 6 mo of supplementation (Monget et al. 1996), 
significant effects of vitamin supplementation on GPx and SOD activities were 
reported whereas after 1 y of supplementation (Galan et al. 1997), significant 
increases were observed in GPx activity in the groups receiving minerals alone or 
in combination with vitamins, but there was no effect on SOD activity or 
thiobarbituric acid-reactive substances production. Omaye and co-workers (1996) 
fed nine women a low-carotenoid diet, followed by the same diet supplemented 
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with 15 mg p-carotene daily for 28 d and found a positive correlation between 
CAT and GPx activities; they concluded that p-carotene deficiency does have an 
effect on erythrocyte antioxidant status. In our study, a correlation between CAT 
and GPx activities was also found. Dixon et al. (1994) reported that erythrocyte 
SOD activity was depressed in carotene-depleted women, but it recovered with 
repletion. In a later study (Delmas-Beauvieux et al. 1996), supplementation of 60 
mg p-carotene daily for 1 y did not result in a significant difference in SOD activity 
compared with baseline, whereas GPx activity slightly increased, and a significant 
increase in glutathione status values was observed after 12 mo compared with 
baseline. Thus, there is some previous evidence that p-carotene might influence 
the activity of antioxidant enzymes. Our study now suggests that not only p-
carotene but also lutein has an effect on antioxidant enzyme activities. 
Antioxidant vitamins 
After 3 wk of dietary intervention, the serum a-tocopherol response was lower in 
the groups given the carotenoid supplement or spinach products than in the 
control group. The evidence for this was not completely conclusive for the 
difference between the pooled spinach and control groups. The lower response of 
a-tocopherol may reflect its increased utilisation as an antioxidant, in combination 
with the lower vitamin C content of the diets in the spinach groups. Furthermore, a 
significant correlation was found between serum a-tocopherol and zeaxanthin 
responses. 
Xu and co-workers (1992) supplied subjects with a placebo or 15 to 60 mg p-
carotene daily for 9 mo and found that all p-carotene doses resulted in similar 
decreases in plasma levels of a-tocopherol after 6 mo. On the other hand, the 
CARET study, after up to 6 y of supplementation, found a small but significant 
increase in the serum concentration of a-tocopherol in the participants taking 30 
mg p-carotene and 7.5 mg retinyl palmitate (as retinol) per day (Goodman et al. 
1994). Other studies have suggested that oral supplements of p-carotene do not 
change serum levels of a-tocopherol. The Polyp Prevention Study Group 
(Nierenberg et al. 1994) supplied 505 patients with a placebo or 25 mg p-carotene 
daily and found serum concentrations of vitamin E were not altered after 9 mo. 
The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study Group (Albanes 
et al. 1997) studied 491 men in Helsinki. After an average of 6.7 y, the group 
supplemented with 20 mg p-carotene/d did not have different a-tocopherol 
concentrations than the control group. Nierenberg et al. (1997) conducted a 
supplementation study in which subjects received a placebo (n = 54) or 25 mg p-
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carotene daily (n = 54) for 4 y and found that supplementation with p-carotene 
given orally did not alter serum concentrations of a-tocopherol. In an experiment 
in New Zealand (Zino et al. 1997), increased dietary intake of fruit and vegetables 
in the intervention group for 8 wk did not change concentrations of a-tocopherol. 
We conclude that most studies in which synthetic p-carotene is given as a 
supplement observe no effect on serum concentrations of a-tocopherol. Our study 
now suggests a relationship between serum zeaxanthin and a-tocopherol 
responses. 
Other antioxidants 
The higher response of plasma uric acid in the whole-leaf spinach group 
compared with the liquefied spinach group is noteworthy. Urate not only behaves 
as a radical scavenger but also stabilises ascorbate in biological fluids, e.g., 
human serum. This effect is due largely to iron chelation by urate. Unlike radical-
scavenging reactions, this protective effect of urate is not associated with its 
depletion because a stable, non-catalytic urate-iron complex is formed (Sevanian 
et al. 1991). This phenomenon may explain why we did not find changes in 
responses of plasma vitamin C. The antioxidative effect of spinach and carotenoid 
supplement consumption could not be observed by measurements of FRAP. A 
study on the effect of juice intervention on markers of antioxidative status found 
that after 1 wk of intervention with increasing amounts of black currant and apple 
juice, only GPx activity had significantly increased with dose and FRAP remained 
unchanged (Young et al. 1999). 
Conclusions 
Consumption of a supplement of p-carotene, lutein and zeaxanthin, and spinach 
products resulted in changes in erythrocyte enzyme activities of GR and CAT and 
serum a-tocopherol concentrations. Antioxidants and antioxidant enzyme systems 
play key roles in the protection of biological membranes, lipoproteins, and DNA 
and in the prevention of protein damage. However, these defence systems are 
very complex, and changes in one antioxidant may result in changes in 
concentrations of other antioxidants or erythrocyte enzymes. We have 
documented the changes that occur after intake of a pure carotenoid supplement 
containing p-carotene and lutein, and a small amount of zeaxanthin, during a 3-
wk controlled human dietary intervention study. The results were compared with 
those obtained after consumption of spinach products during the 3-wk study. The 
consumption of spinach resulted in greater responses of erythrocyte GR activity 
and lower erythrocyte CAT and serum a-tocopherol responses. Consumption of 
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the carotenoid supplement increased erythrocyte GR activity and lowered the 
serum a-tocopherol response. Our data suggest that carotenoid intake of lutein 
and zeaxanthin, but not p-carotene, is positively associated with erythrocyte GR 
activity and negatively with serum a-tocopherol concentration, respectively. The 
effect of spinach consumption on CAT activity is most likely not related to its 
carotenoid content. If analytical assays are improved in the near future and more 
information on antioxidant enzyme activity becomes available, we may be able to 
achieve a better understanding of the kinetics and mechanisms of the complex 
antioxidant defence systems. 
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ABSTRACT 
The antioxidant activity of differently processed spinach products (whole-leaf, 
minced and enzymatically liquefied spinach) and its relation with carotenoids (J5-
carotene and lutein) and total phenolic compounds were determined. In an 
autoxidative methyl linoleate (MeLo) system the inhibition of formation of 
hydroperoxides, measured by HPLC after three days of oxidation at a level of 10 
ppm was in descending order: whole-leaf > liquefied > minced spinach. The 
inhibition of formation of thiobarbituric acid-reactive substances (TBARS) and 
hexanal by spinach was determined in cooked meat with added spinach or water 
after two days of storage at 4°C. The formation of TBARS was inhibited by 
liquefied spinach at 200 g/kg meat; all other tested spinach products at 100 and 
200 g/kg were prooxidative. The formation of hexanal was inhibited by both 
minced and liquefied spinach at 100 and 200 g/kg meat. The differently 
processed spinach products behaved differently when tested for their antioxidant 
activity (MeLo) or oxidative stability (meatballs). For the inhibition of TBARS 
formation, differences between whole-leaf and liquefied spinach were significant. 
For the inhibition of hexanal formation, activities among all spinach products were 
significantly different. We conclude that the antioxidant capacity of spinach is 
dose-dependent and affected by processing. 
KEY WORDS: antioxidant; p-carotene; lutein; phenolics; food processing 
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INTRODUCTION 
In vitamin A replete populations, the incidence of cancer and of coronary heart 
disease has been found to be correlated negatively with the consumption of fruits 
and vegetables (Ness et al. 1997, World Cancer Research Fund/American 
Institute for Cancer Research 1997). This correlation has been attributed in part to 
the antioxidant properties of (3-carotene. However, recent trials indicate that (3-
carotene supplements are not effective in disease prevention and raise questions 
about the biological significance of carotenoid antioxidant actions (Kritchevsky 
1999). The beneficial effect of a high intake of fruits and vegetables may rely not 
only on the effect of the well characterised antioxidants, such as vitamins C and E 
and p-carotene, but rather on some other antioxidants or non-antioxidant 
constituents or on a concerted action of various compounds present in these 
foods (Cao et al. 1998). In general, more than 80% of the total antioxidant 
capacity in fruits and vegetables comes from ingredients other than vitamin C, 
indicating the presence of other potentially important antioxidants in these foods 
(Cao et al. 1996, Wang et al. 1996). In those studies, total antioxidant capacity 
was quantitated by using the oxygen radical absorbance capacity (ORAC) assay. 
Spinach is one of the vegetables that showed high ORAC activity (Cao et al. 
1996, Wang et al. 1996). Flavonoids and other phenolic compounds appear to be 
antioxidants that contribute to the high antioxidant capacity observed in certain 
fruits and vegetables (Guo et al. 1997, Singleton et al. 1981). The antioxidant 
capacity of a food per se is important because it provides protection against loss 
of organoleptic properties. 
The antioxidant activity of several plant materials has been reported (Al-
Saikhan et al. 1995, Kanner et al. 1994, Mallet et al. 1994, Pietta et al. 1998, Prior 
et al. 1998, Velioglu et al. 1998), however information on the effect of processing 
on the antioxidant activity of plant foods is not available. Haila (1999) reviewed 
recently the antioxidant/prooxidant chemistry of carotenoids and summarised the 
available data on the action of carotenoids in different lipid systems. 
The purpose of this work was to determine the effect of differently processed 
spinach products (whole-leaf, minced and enzymatically liquefied spinach) on 
inhibiting oxidation of food lipids. The antioxidant activity was tested using two 
oxidation systems: a methyl linoleate system and cooked meat. In the methyl 
linoleate system, the inhibition of formation of hydroperoxides was measured by 
HPLC after three days of oxidation. Inhibition of the formation of thiobarbituric 
acid-reactive substances (TBARS) and hexanal were determined in cooked meat 
after two days of storage at 4°C. Furthermore, the amounts of carotenoids, total 
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phenolics and some catechins, flavonols and flavones were measured in the 
spinach products tested. 
EXPERIMENTAL PROCEDURES 
Spinach products 
Three differently processed spinach products were tested: whole-leaf spinach, 
minced spinach, and enzymatically liquefied spinach. All spinach products 
originated from one batch and were provided, prepared and subsequently frozen 
by Langnese-lglo, Wunstorf (Germany) for Unilever Research Vlaardingen (The 
Netherlands). Whole-leaf spinach was washed and blanched for 90 sec and 
cooled down quickly and the blanched spinach was minced to 5 mm. An 
enzymatic preparation with pectinase, hemicellulase and cellulase activities 
(Rapidase® LIQ plus, kindly supplied by Gist-brocades, Seclin, France) was used 
for the liquefaction of minced spinach. After the enzyme treatment, the spinach 
was boiled for 5-10 min to inactivate enzymatic activities. 
Chemicals 
Pure grades of all-frans-a-carotene, all-frans-p-carotene, all-frans-lycopene and 
gallic acid were obtained from Sigma Chemical Co. (St Louis, MO) and a\\-trans-
lutein, all-frans-zeaxanthin, and all-frans-p-cryptoxanthin from Hoffmann-La 
Roche Ltd (Basel, Switzerland). Myricetin, quercetin dihydrate, kaempferol and 
apigenin were obtained from Fluka (Buchs, Switzerland). Methyl linoleate (MeLo) 
was purchased from Nu-Check-Prep, Inc. (Elysian, Ml). All organic solvents and 
other chemicals used were of HPLC or reagent grades. 
Analysis of phenolics 
The concentration of total phenolics in spinach was determined by the method 
described by Satue et al. (1995). Spinach samples (2 g) were extracted with 70% 
acetone (2x10 mL), evaporated to dryness and taken up to 10 mL in methanol. 
The concentrations of flavonols and flavones of the various spinach products 
were analysed by reversed phase HPLC, after acid hydrolysis of glycosides 
(Hertog et al. 1992). Catechins were measured by gradient reversed phase HPLC 
after methanol/water extraction (Arts et al. 1998). 
Analysis of dry matter, dietary fibre and carotenoids 
The moisture level and the ash content in each spinach product were determined 
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using a vacuum oven at 85°C and a muffle furnace at 550°C. The dietary fibre 
content of the various spinach products was determined as methanol-ether 
insoluble solids (MEIS) and the amount of pectin (polygalacturonic acid) in the 
spinach products was measured by hydrolysing pectic substances to water-
soluble galacturonic acid using an enzyme preparation (Katan & van de 
Bovenkamp, 1981). Carotenoids and retinol were extracted from wet material 
after homogenisation, using tetrahydrofuran (THF) and redissolved in 
THF/methanol (1:1 v/v) and injected into the HPLC system (Craft et al. 1992). The 
coefficients of variation (CV) within runs for food analysis of a-carotene, p-
carotene and lutein in control pools averaged 5.7, 6.8 and 8.8%, respectively. All 
sample preparations and extractions were carried out in duplicate and under 
subdued yellow light with minimal exposure to oxygen (Hulshof et al. 1997). 
Methyl linoleate (MeLo) model 
Spinach extracts in methanol containing either 10 or 40 ppm (10 or 40 mg of total 
phenolics/kg spinach) were added to MeLo (1 g). Subsequently methanol was 
evaporated under nitrogen. Oxidation of MeLo was carried out in the dark at 40°C 
(Hopia et al. 1999). After 3 days of oxidation, the amount of hydroperoxides was 
measured as the formation of conjugated diene hydroperoxides by HPLC (Hopia 
et al. 1996a). The antioxidant activity of the spinach extract was expressed as 
inhibition (%) of the formation of MeLo hydroperoxides in the control sample, a-
Tocopherol (20 ppm) was used as a reference antioxidant. 
Meatballs model: inhibition of thiobarbituric acid-reactive substances 
(TBARS) and hexanal formation 
These were measured at 100 and 200 g wet weight of spinach added to 1 kg 
meatballs. As a control, 100 or 200 g water/kg was added to the meat. Meat and 
spinach or water were mixed for approximately 1 min in a blender. Meatballs, 
made from pork meat (fat, 300 g/kg fresh weight; fatty acid composition was as 
follows: C14:0, 2.9%; C16:0, 51.4%; C16:1, 2.3%; C18:0, 18.7%; C18:1, 21.1%; 
C20:0, 1.1%; and C22:0, 0.8%) of 45 g weight were formed and heated in a 
microwave oven for 2 min. After cooling to room temperature, water loss was 
determined by weighing. Subsequently, the meatballs were stored in a plastic box 
for 48 h at 4°C. The antioxidant activity of the spinach extract was expressed as 
inhibition (%) of the formation of thiobarbituric acid-reactive substances (TBARS) 
and hexanal in the control sample. The meat sample (1 g) was homogenised 
(Ultra Turrax) with 5 mL trichloroacetic acid (35 g/100 mL) and 1 mL of the filtrate 
was mixed with 2 mL of TBARS reagent (20 mM 2-thiobarbituric acid) and heated 
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for 15 min in a water bath (100°C). The colour was measured at 532 nm. The 
blank consisted of 1 mL trichloroacetic acid and 2 mL thiobarbituric acid; samples 
were assayed in duplicate. The hexanal concentration was determined from 0.5 g 
meat mixed with 1 mL water in a headspace vial (NS20-vials, 10 mL). After 
incubating at 60°C for 15 min, 1 mL of the headspace was injected into the GC-
Headspace (Carlo Erba 4130). The retention time of hexanal was approximately 
4.5 min. The column was J &W DB1701 30 m x 0.32 mm with 1.0 urn film. The 
temperatures for the injector, oven and FID-detector were 180°C, 65°C, and 
210°C, respectively. The gas flow was as follows: N2, 140 kPa/7.5 mL/min; H2, 50 
kPa; and 02, 100 kPa. A headspace autosampler (Carlo Erba HS 250) was used. 
The injection volume was 1000 u.l and the temperatures of water bath and syringe 
were both 60°C. These samples were assayed in triplicate. 
Statistical analysis 
Values represent the mean of two (carotenoids, total phenolics, hydroperoxides, 
TBARS) or three (hexanal) replications. Data were analysed by analysis of 
variance (ANOVA) followed, when appropriate, by a Tukey or Dunnett test (P < 
0.05). Pearson correlation coefficients were calculated (P < 0.05; two-tailed). 
RESULTS 
Characteristics of the spinach products are given in Table 1. 
Table 1. Characteristics of differently processed spinach products (based 
on wet weight) 
Type of 
spinach 
Whole-leaf 
Minced 
Liquefied 
3
 Mean 
bMEIS 
Dry matter, 
g/kg 
67 
59 
89 
p-Carotene", 
mg/kg 
47 + 6 
40 ± 0.3 
45 ±7 
Lutein3'", 
mg/kg 
101 ±12 
89 ±1 
79 ±3 
+ SD, n = 2. 
= methanol-ether insoluble solids. 
MEIS", 
g/kg 
47.2 
39.4 
54.8 
Polygalacturonic 
acid, g/kg 
7.2 
5.9 
7.9 
Total phenolics3, 
mg/kg 
430 ± 35 
470 + 25 
390 ±10 
c
 p-Carotene/total phenolics (mg/mg) is for whole-leaf, minced and liquefied spinach 0.109, 
0.085 and 0.115, respectively. 
d
 Lutein/total phenolics (mg/mg) is for whole-leaf, minced and liquefied spinach 0.235, 0189 
and 0.203, respectively. 
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Antioxidant activity of spinach products 
Inhibition of formation of hydroperoxides 
At the level of 40 ppm, all samples completely inhibited the formation of 
hydroperoxides, which is comparable to an inhibition capacity of 20 ppm a-
tocopherol. At the level of 10 ppm, the inhibition of hydroperoxide formation was 
highest for whole-leaf spinach (82 ± 3 %), followed by liquefied spinach (75 ± 2 
%) and minced spinach (72 ± 2 %). In this test system, whole-leaf spinach had 
the highest antioxidant capacity. 
Inhibition of formation of TBARS 
Corrected for water loss measured in the control sample, whole-leaf and minced 
spinach increased the formation of TBARS at 100 and 200 g/kg meat (Table 2 
and Figure 1). Thus, both the whole-leaf and minced spinach products were 
prooxidative at 100 and 200 g/kg, but with an increasing amount of spinach added 
to the meatballs, the whole-leaf spinach was less prooxidative (P = 0.022). The 
liquefied spinach showed antioxidant activity (inhibition of formation of TBARS) at 
200 g/kg and was slightly prooxidative at 100 g/kg. The difference in antioxidant 
activity between the whole-leaf spinach and the liquefied spinach at 200 g/kg was 
significant (P= 0.010). 
Table 2. Inhibition (% ± SD) of formation of TBARS (n = 2) and hexanal (n = 
3) with various spinach products added in amounts of 100 and 200 g/kg to 
cooked meat after 48 hours of storage at 4°Ca,b 
Type of spinach 
Whole-leaf 
Minced 
Liquefied 
Whole-leaf 
Minced 
Liquefied 
Amount 
g^g 
100 
100 
100 
200 
200 
200 
Mean inhibition of formation 
TBARS 
-75.4 ± 0.5W 
-47.1 ±9.0 
-15.6 ± 11.1 
-22.4 ± 3.1c w 
-12.3 ±13.0 
32.3±4.5C 
Hexanal 
-30.7 ± 5.9ax 
9.8 ± 5.6d'y 
29.2 ± 3.0dJ 
-12.1 ± 3.7ex 
32.3±5.1e 'y 
54.8 ± 1 . 8 " 
3
 The control samples contained 100 or 200 g water/kg meat, respectively. The loss of water 
differed between the samples containing spinach and the controls and the data in the Table 
are corrected for the loss of water. 
b
 Means within column with similar letter are significantly different (P < 0.05). 
c
 Significant difference in inhibition of TBARS formation at 200 g spinach/kg meat between 
whole-leaf and liquefied spinach (Dunnett test after ANOVA: P = 0.01). 
de
 Significant difference in hexanal inhibition (Tukey test after ANOVA, P < 0.01). 
™'
xyz
 Significant difference between inhibition at 100 and 200 g of each type of spinach 
tested/kg meat (independent samples f-test, P < 0.001). 
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Inhibition of formation ofhexanal 
With respect to the mean inhibition of hexanal formation, corrected for water loss 
in the control sample, the whole-leaf spinach was prooxidative at 100 g/kg and 
less prooxidative at 200 g spinach/kg meat (P = 0.010). The minced and liquefied 
spinach were antioxidative at 100 g/kg and the activity increased at 200 g/kg (P < 
0.01). The liquefied spinach was more active than the minced spinach and both 
spinach products were more active than the whole-leaf spinach (P < 0.01). 
Carotenoid content vs. antioxidant activity 
A correlation was observed between the inhibition of hydroperoxide formation and 
the calculated amount of lutein, but not of p-carotene, in the original spinach 
samples. Here we assume that the proportion of extracted carotenoids was 
similar for each sample. Whole-leaf spinach had the highest adjusted lutein 
concentration, followed by liquefied and minced spinach (Table 1). The Pearson 
correlation coefficient for adjusted lutein content was 0.999 (P = 0.02, n = 3). 
Correlations for p-carotene or total phenolic content or between carotenoid 
content of the spinach products and the inhibition of formation of TBARS and 
hexanal were not significant. 
• hydroperoxides 
• TBARS (100g/kg) 
• TBARS (200 g/kg) 
• hexanal (100 g/kg) 
• hexanal (200 g/kg) 
whole-leaf spinach minced spinach liquefied spinach 
Spinach product 
Figure 1. Prooxidant and antioxidant activity of spinach products. 
Inhibition (%) of formation of hydroperoxides (10 ppm), TBARS (100 
and 200 g spinach/kg meat) and hexanal (100 and 200 g spinach/kg 
meat) by whole-leaf, minced and liquefied spinach. 
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Amount of total phenolics, catechins, flavonols and flavones 
The amount of total phenolics ranged from 390 mg/kg in liquefied spinach to 470 
mg/kg in minced spinach (see Table 1). The spinach products did not contain 
measurable amounts of catechins (detection limits): catechin (< 0.05 mg/kg); 
epicatechin (< 0.05 mg/kg); epicatechingallate (< 0.2 mg/kg); 
epigallocatechingallate (< 0.2 mg/kg); epigallocatechin (< 2 mg/kg). Also neither 
flavonols nor flavones were detectable: quercetin (< 1 mg/kg); myricetin (< 1 
mg/kg); kaempferol (< 2 mg/kg); isorhamnetin (< 5 mg/kg); luteolin (< 1 mg/kg); 
apigenin (< 1 mg/kg). The amount of total phenolics was correlated with the MEIS 
on a wet weight basis of the different spinach products (P = 0.005, r = -1.0, n = 3). 
DISCUSSION 
The present study showed that frozen spinach products demonstrated prooxidant 
and antioxidant activity depending on the extent of processing and the amount of 
spinach used. In a lipid methyl linoleate (MeLo) model, at a level of 40 ppm of 
total phenolics, all spinach extracts had an inhibitory activity on the formation of 
hydroperoxides comparable to 20 ppm a-tocopherol. At a level of 10 ppm of total 
phenolics the antioxidant activity in descending order was as follows: whole-leaf > 
liquefied > minced spinach. Higher concentrations of spinach in the meatballs 
(200 g/kg meat vs. 100 g/kg meat) significantly improved the antioxidant activity 
or decreased the prooxidant activity of all spinach products (inhibition of hexanal 
formation) and whole-leaf spinach (inhibition of formation of TBARS), 
respectively. Processing had a significant effect on the antioxidant activity of the 
spinach products. Differences in oxidant activity became significant for the 
difference between whole-leaf and liquefied spinach (inhibition of TBARS 
formation at 200 g/kg) and for all spinach products with respect to the inhibition of 
hexanal formation at all concentrations tested. An effect of processing has been 
reported before: strawberry extracts pre-treated with pectinase inhibited hexanal 
formation significantly less and blueberry extracts pre-treated with pectinase more 
than acetone extracts (Heinonen et al. 1998b). 
None of the vegetables studied by Cao et al (1996), including spinach, showed 
prooxidant activity. Chopra et al. (1993) demonstrated that, at atmospheric 
oxygen concentrations, (3-carotene slightly augmented the peroxidation of linoleic 
acid, whereas the xanthophyll carotenoids caused inhibition against peroxidation. 
However, experiments in the MeLo model with spontaneously autoxidised lipids, 
showed constantly increasing prooxidant activity (formation of hydroperoxides) of 
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p-carotene at concentrations of 5, 20, and 200 ppm, oxidised at 40°C in the dark 
and of lutein at concentrations of 5, 20, 30, and 40 ppm both in dark and light, at 
40°C and 25°C, respectively (Haila et al. 1999). Minor amounts of tocopherol 
protected carotenoids from destruction and thus inhibited the prooxidant action of 
carotenoids (Haila et al. 1996). Tsuchihashi et al. (1995) used a MeLo model with 
a radical initiator and found that p-carotene suppressed methyl linoleate oxidation 
in benzene solution in a dose-dependent manner. The antioxidant activity in our 
MeLo model was positively related to the lutein content of the original spinach 
samples, adjusted for their total phenolics content. Carotenoids, if not in an a-
tocopherol-free environment, reduce the rate of autoxidation of lipids by such 
processes as decomposing hydroperoxides to nonradical products. 
The concentration of total phenolics and lutein per 100 g spinach was lowest in 
the liquefied spinach. Nevertheless, the liquefied spinach had the highest 
antioxidant activity in the meatball model. It may be speculated that when using a 
whole food instead of an extract the following factors may play a role: 
bioavailability of phenolics and carotenoids: liquefied spinach had the highest 
amounts of bioavailable p-carotene per 100 g spinach (Castenmiller et al. 1999); 
the polarity of the carotenoids; or other food components such as phenolic acids 
with a high antioxidant activity. The spinach samples did not contain detectable 
amounts of catechins, flavonols (quercetin, myricetin, kaempferol or isohamnetin) 
or flavones (luteolin and apigenin). This is in line with the analysis of Hertog et al. 
(1992) who also did not find measurable amounts of quercetin, kaempferol, 
luteolin, apigenin or myricetin in spinach. Nevertheless, the total amount of 
phenolics ranged from 390 to 470 mg/kg spinach. Possible other reducing 
compounds in spinach giving a response in the total phenolics analysis may 
include phenolic acids such as ferulic acid, caffeic acid and coumaric acid. A 
direct relationship exists between antioxidant capacity and the amount of phenolic 
compounds of wines and grapes (Abu-Amsha et al, 1996, Fogliano et al. 1999, 
Heinonen et al. 1998a, Kanner et al. 1994), different berries (Prior et al. 1998), 
medicinal plants (Pietta et al. 1998), and a number of fruit and vegetables and 
grain products (Velioglu et al. 1998). However, the relationship between phenolics 
and antioxidant activity was not significant for potato cultivars (Al-Saikhan et al. 
1995) and anthocyanin-rich materials, including blueberry (Velioglu et al. 1998). 
The total phenolic content of berry and fruit wines and liquors did not correlate 
with the antioxidant activity in a MeLo system (Heinonen et al. 1998a). Our study 
showed that the total phenolic content, i.e., the reducing capacity of spinach, did 
not alone predict the antioxidant response. However, to explain the differences in 
antioxidant activity of various spinach products when tested under different 
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conditions, differences in the activities of the phenolic compounds and their 
antagonistic and synergistic reactions with other phenolics and other compounds 
present in spinach may be of importance. 
Ascorbate was not a significant contributor to the antioxidant activity measured 
in a study of berries (Prior et al. 1998, Wang et al. 1996). Prior et al. (1998) 
observed that if the skin of the blueberry was broken, ascorbate may be oxidised 
and the concentration may be significantly reduced. We expect to find the lowest 
vitamin C content in the liquefied spinach due to its prolonged processing (matrix 
disruption and heat treatment) and thus conclude that vitamin C in spinach is 
indeed not a significant contributor to antioxidant activity. In calculations with 
other fruits, ascorbate has generally contributed less than 10% of the total 
antioxidant capacity (Wang et al. 1996). a-Tocopherol, a phenolic compound, is 
the major liposoluble antioxidant found in leaves. Because bioactive compounds 
can act synergistically, antioxidative effects of fruits and vegetables may reflect a 
combined mechanism of antioxidant defence (Wise et al. 1996). Several studies 
have shown that the serum or blood lymphocyte antioxidant capacity increased 
following consumption of fruits and vegetables (Cao et al. 1998) or dried spinach 
powder and lutein (Pool-Zobel et al. 1997). These studies support the hypothesis 
that carotenoid containing plant products, but not synthetic carotenoids tested as 
single compounds, exert a cancer protective effect via a decrease in oxidative 
and other damage to DNA in humans (Pool-Zobel et al. 1997). 
Apparently conflicting results have been obtained in our study under different 
testing conditions, using different models. In general, it is critical to establish the 
influence of the methodology used to evaluate natural antioxidants: the conditions 
of oxidation and the analytical method used to determine the extent and endpoint 
of oxidation must be taken into account. The degree of oxidation should be 
determined by more than one method and by measuring different types of 
products, including initial and decomposition products of lipid oxidation, such as 
hydroperoxides and volatiles by GC (Frankel 1993). Lipid peroxidation is a radical 
chain reaction that generates conjugated diene hydroperoxides as the initial main 
product (Abuja et al. 1998). Various types of antioxidants affect the formation of 
hydroperoxides and their decomposition quite differently. Antioxidant activity can 
be monitored by measuring the formation of conjugated diene hydroperoxides 
and the decomposition of hydroperoxides can be monitored by measuring 
hexanal, the major volatile product of linoleic acid hydroperoxides. The 
thiobarbituric acid (TBA) method is based on the colour reaction between TBA 
and oxidation products of polyunsaturated lipids. This simple test is sensitive and 
very precise, but the test is not specific because many secondary oxidation 
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products form TBARS. The test is more sensitive when used with polyunsaturated 
fatty acids containing three or more double bonds (Frankel 1993). It should be 
noted that linoleic acid is perhaps not the best substrate to evaluate natural 
antioxidants since food lipids are mainly triglyceride in nature (Frankel 1993). In 
conclusion, prooxidant and antioxidant properties of carotenoids, and other 
substances, depend on the conditions and the partners in the reaction (Buettner 
1993, Gazzani et al. 1998), including partial oxygen pressure, carotenoid 
concentrations, interactions with other carotenoids, solvents, type of radical 
initiator, and type and polarity of the lipid system used (Britton 1995, Hopia et al. 
1996b, Palozza, 1998, Tsuchihashi et al. 1995). 
Our study may contribute to a better understanding of the antioxidant and 
prooxidant activity of spinach products and their carotenoid and total phenolics 
content. Of importance is the finding that spinach can have a prooxidative activity, 
which can become antioxidative by further processing of the spinach or by 
increasing the spinach concentrations. The results of this study are somewhat 
contradictory. Therefore in future studies the measurements made should be 
related to organoleptic and keeping qualities, which would be comparatively easy. 
They could also be related to health consequences once the food is eaten but this 
would be more difficult. 
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In this thesis two aspects of spinach have been examined, namely the 
bioavailability of carotenoids and folate and the antioxidant activity of spinach 
products when consumed and in food products. This Chapter evaluates the 
contribution of the studies described in this thesis to present scientific knowledge. 
Conclusions and suggestions for future research are also presented. 
FACTORS AFFECTING BIOAVAILABILITY AND BYCONVERSION OF 
CAROTENOIDS (SLAMENGHI FACTORS) 
The SLAMENGHI factors were used to examine the knowledge and information 
available on the bioavailability and bioconversion of carotenoids (Chapter 2). 
Each carotenoid appears to have an individual pattern of absorption, plasma 
transport, and metabolism. Data on each SLAMENGHI factor is necessary to fill 
the gaps in our knowledge about carotenoids and their metabolism and actions, 
so that food-based strategies and interventions with specific foods to control 
vitamin A deficiency and to reduce the risk for chronic diseases can be properly 
devised. We conclude that the data available are not sufficiently comparable to 
allow a systematic comparison of results. However, a number of conclusions can 
be drawn. The bioavailability and bioconversion of various carotenoids and 
geometrical isomers of carotenoids differ; molecular linkage does not play a role; 
a positive relationship exists between intake and response of p-carotene; p-
carotene supplementation increases serum a-carotene concentrations and 
decreases serum concentrations of lutein, lycopene and canthaxanthin; the 
bioavailability of p-carotene from foods is low, particularly from dark-green leafy 
vegetables; intake of dietary fat has a positive and intake of dietary fibre a 
negative effect on bioavailability; alcohol interferes with the bioconversion of p-
carotene; and that nutrient status and genetic factors related to the host may 
explain some of the differences observed. There is a need for more carefully 
designed studies in order to define the individual SLAMENGHI factors (West & 
Castenmiller1998). 
BIOAVAILABILITY OF CAROTENOIDS 
The most commonly applied methods to measure carotenoid bioavailability 
include measuring the increase in serum or plasma concentrations following long-
term administration of a controlled diet resulting in a new steady-state condition, 
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typically up to 17 days for p-carotene (Nierenberg et al. 1991), and use of 
postprandial chylomicron carotenoid response following a single dose of 
carotenoid (van den Berg & van Vliet 1998, van Vliet et al. 1995). In a three-week 
dietary controlled intervention study involving healthy subjects, the effect of the 
food matrix on the bioavailability of carotenoids was examined. Consumption of 
spinach (20 g/MJ), containing p-carotene and lutein, increased serum 
concentrations of all-frans-p-carotene, c/s-p-carotene (and consequently total p-
carotene), lutein, a-carotene and retinol and decreased the serum concentration 
of lycopene compared with the control group. Compared to a synthetic carotenoid 
supplement, the relative bioavailability of p-carotene was low, 5.1-9.5%, but much 
higher for lutein, 45-55%. This finding has been confirmed in a study by van het 
Hof et al. (1999a): they compared plasma responses of a mixed vegetable diet 
and found relative bioavailabilities for p-carotene and lutein of 14 and 67%, 
respectively. The low bioavailability of p-carotene from green vegetables (de Pee 
et al. 1995, Chapter 3) may partly be explained by the presence of 15-18% c/s-p-
carotene in the spinach products. All-frans-p-carotene is more readily absorbed 
than its cis isomers (Ben-Amotz & Levy 1996, Gaziano et al. 1995b, Jensen et al. 
1987, Tamai et al. 1995, Chapter 2). However, also the relatively high lutein:p-
carotene ratio in spinach may have negatively affected the bioavailability of p-
carotene (van den Berg 1998). Plasma lutein concentrations were significantly 
reduced after single (Kostic et al. 1995, Martini et al. 1995, White et al. 1994) and 
multiple (Micozzi et al. 1992) doses of p-carotene, and lutein had an inhibitory 
effect on p-carotene plasma response (Kostic et al. 1995). Combined dosage with 
lutein decreased the area-under-the-curve (AUC) of p-carotene and retinyl 
palmitate in the triacylglycerol-rich lipoprotein (TRL) fraction adjusted for the 
triacylglycerol response by 66 and 74% respectively, compared with the response 
for p-carotene alone, but had no effect on p-carotene cleavage (van den Berg & 
van Vliet 1998, van den Berg 1998). A combined dosage with lycopene had no 
significant effect on p-carotene and retinyl palmitate response (van den Berg & 
van Vliet 1998). In the long-term Alpha-Tocopherol Beta-Carotene (ATBC) 
intervention study on p-carotene supplementation, a slight (approximately 11%) 
but significant decrease in serum lutein concentrations were observed as 
compared with a placebo (Albanes et al. 1997), but no effects on other serum 
carotenoids were observed in other long-term intervention studies (Fotouhi et al. 
1996, Nierenberg et al. 1997). The increase in serum a-carotene levels after p-
carotene supplementation (Micozzi et al. 1992, Pappalardo et al. 1997, de Pee et 
al. 1995, Wahlqvist et al. 1994, Chapter 3) might also be due to reduced cleavage 
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of cc-carotene in the presence of excess p-carotene (van den Berg 1999). In 
conclusion, interactions or competition between carotenoids can occur during 
incorporation into mixed micelles in the intestinal lumen, during absorption into 
enterocytes, during p-carotene cleavage, or during chylomicron assemblage (van 
den Berg 1999). Van den Berg (1999) reviewed literature on carotenoid 
interactions and concluded that much of the evidence suggests an interaction 
between p-carotene and oxycarotenoids, such as canthaxanthin and lutein, and 
between the hydrocarbon carotenoids p-carotene and lycopene. These 
interactions needs further research because both of the effects reported, an 
interference of p-carotene on lutein uptake, and vice-versa, might have long-term 
health effects. 
Granado et al. (1998) observed the occurrence of ester forms in subjects 
having a serum lutein concentration of over 1.05 |i.mol/L. This may indicate a 
ceiling effect on or saturation of the transport capacity for lutein, which may be re-
esterified in vivo when it is supplied in excess of normal dietary intake. In our 
study, the mean serum lutein concentration per group was below 1 |imol/L 
(Chapter 3). 
The relative bioavailability of p-carotene in dark-green leafy vegetables is 
extremely low (de Pee et al. 1995, de Pee et al. 1998, Chapter 3). Pure p-
carotene is absorbed far more readily than that in foods. For example, the plasma 
response to pure p-carotene has been found to be about five times the response 
to a similar amount of p-carotene in carrots (Brown et al. 1989, Micozzi et al. 
1992). The serum response of p-carotene from fruits was four times that from 
vegetables (de Pee et al. 1998) and the bioavailability of p-carotene and lutein 
varied substantially among different vegetables (van het Hof et al. 1999b). The 
bioavailability of carotenoids in dark-green leafy vegetables, root vegetables (e.g., 
carrots), and fruits partly depends on the matrix in which the carotenoid is located 
in the unprocessed product. Processing, cooking or fine grinding increased the 
bioavailability of carotenes possibly because of the softening or disruption of plant 
cell walls and the disruption of carotenoid-protein complexes (Congdon et al. 
1981, Erdman et al. 1988, Hussein & El-Tohamy 1990, Torronen et al. 1996, van 
Zeben & Hendriks 1948). Disruption of the vegetable matrix also enhanced the 
bioavailability of lycopene from tomatoes (Gartner et al. 1997, Porrini et al. 1998, 
Stahl & Sies 1992). The effect of the food matrix on the lutein bioavailability has 
not been reported in the literature. Our study (Chapter 3) confirmed that disruption 
of the food matrix (cell wall structure) and loss of cellular structure had an effect 
on the bioavailability of p-carotene, whereas the bioavailability of lutein was not 
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affected. Serum (3-carotene responses differed significantly between the whole-
leaf and liquefied spinach groups and between the minced and liquefied spinach 
groups. 
Addition of dietary fibre to the liquefied spinach to compensate for the fibre that 
was broken down during liquefaction had no effect on serum carotenoid 
responses. Dietary fibre has an effect on lipid metabolism by interacting with bile 
salts, resulting in a possible decreased absorption of carotenoids, and other fat-
soluble substances. Rock and Swendseid (1992) reported that increases in 
plasma p-carotene in humans were significantly reduced by dietary pectin; in our 
study the proportion of dietary fibre added per mg p-carotene was much smaller. 
Other experimental approaches are required to estimate the absolute 
bioavailability of carotenoids and to study the mechanisms involved. These 
approaches could include studies with isotopically labelled carotenoids. 
BIOAVAILABILITY OF FOLATE 
Brouwer et al. (1999b) reviewed the literature and used the SLAMENGHI factors 
to describe the present state of knowledge on bioavailability and bioefficacy of 
folate and folic acid. They concluded that the food matrix and the amount of folic 
acid consumed are the major factors to influence folate bioavailability in healthy 
persons. These factors, in addition to the effectors of absorption, such as dietary 
fibre and the amount of fat, also play an important role in the bioavailability and 
bioconversion of carotenoids. 
Studies examining the effect of single foods on the bioavailability of dietary 
folate showed that folate was absorbed, but the relative bioavailability, as 
compared to synthetic folic acid, differed greatly between different foods (Brouwer 
et al. 1999a, Cuskelly et al. 1996, Gregory et al. 1995, Keagy et al. 1988, Tamura 
& Stokstad 1973). Few studies have examined the bioavailability of folate from 
mixed diets (Sauberlich et al. 1987). The most commonly applied methods 
include measuring the increase in serum or plasma concentrations following long-
term administration of a controlled diet resulting in a new steady-state condition. 
Plasma folate concentrations reached a steady state after four weeks of 
supplementation with 1 mg folic acid daily (Heseker & Schmitt 1987). In our 
controlled dietary human intervention study we examined the effect of 
consumption of spinach as part of a normal, mixed meal and destruction of the 
spinach food matrix (disruption of the cell wall and loss of dietary fibre) on plasma 
folate concentrations. Daily consumption for three weeks of 20 g/MJ of spinach 
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increased plasma folate concentrations significantly. Intake of minced and 
liquefied spinach resulted in greater plasma folate responses than consumption of 
whole-leaf spinach, which suggests that the food matrix of spinach plays a role 
with regard to bioavailability of folate (Chapter 4). 
In an experiment with ten women, who were maintained in a metabolic unit for 
92 d, dietary folates appeared to be no more than 50% available when compared 
to pteroylmonoglutamic acid added to the diets (Sauberlich et al. 1987). This was 
confirmed by Cuskelly and co-workers (1996) in a long-term study, who found that 
the bioavailability of added folic acid was higher than the bioavailability of food 
folate. Brouwer et al. (1999a) conducted a four-week controlled dietary 
intervention study and found that folate from vegetables and citrus fruits had a 
relative bioavailability, as compared to synthetic folic acid, of 60% based on 
plasma total homocysteine concentrations, 78% based on plasma folate 
concentrations, and 98% based on red blood cell folate concentrations. No 
studies have been published that have examined the effect of food processing on 
improving folate bioavailability. The consumption of the carotenoid supplement 
(see Chapter 3) had no effect on plasma folate concentrations compared with the 
control group. This implies that the study design could have been improved by 
supplying a synthetic folic acid supplement to a study group to estimate the 
relative bioavailability of folate from spinach. 
Re-addition of dietary fibre to the liquefied spinach to compensate for the fibre 
broken down during liquefaction did not reduce the plasma folate response. The 
effect of dietary fibre on plasma folate concentrations is not conclusive. No effect 
on folate absorption was observed for cellulose or wheat bran, up to 8.2 g dietary 
fibre per meal (Russell et al. 1976), or 30 g wheat bran in a formula meal (Keagy 
et al. 1988). In contrast, 30 g wheat bran increased the folic acid absorption of a 
formula meal (Keagy et al. 1988) and 34 g wheat bran (19 g dietary fibre) reduced 
the plasma folate concentration of folates consumed in solution (Bailey et al. 
1988). In our study, the total dietary fibre intake for the liquefied spinach and 
liquefied spinach plus added dietary fibre was 2.6 and 2.9 g/MJ, respectively. This 
difference was too small to become statistically significant. 
The effect of food processing and heat treatment on the composition of folate 
forms in spinach and other foods is not clear and needs further research. 
Differences in chain length of food folates may explain differences in 
bioavailability of differently processed spinach products. An experimental 
approach involving isotopically labelled folates could be developed to answer 
these questions. 
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ANTIOXIDANT ACTIVITY OF SPINACH IN MAN 
Antioxidants inhibit or delay the oxidation of molecules by inhibiting the initiation 
or propagation of oxidising chain reactions (Halliwell 1996). Carotenoids have 
been found to inhibit free radical-induced lipid peroxidation (Krinsky 1993, Krinsky 
& Deneke 1982) and to quench singlet oxygen (Stahl et al. 1997). 
The serum/plasma antioxidant concentrations, erythrocyte enzyme antioxidant 
activities, and concentrations of oxidatively damaged amino acids in plasma were 
measured in humans after consumption of spinach during a three-week period 
(Chapter 5). Consumption of spinach resulted in significantly greater erythrocyte 
glutathione reductase activity and lower erythrocyte catalase activity and serum 
a-tocopherol concentration compared with the control group. Consumption of the 
carotenoid supplement led to lower a-tocopherol responses and tended to 
increase the erythrocyte glutathione reductase activity. These changes may be 
related to increased serum lutein concentrations after carotenoid intake. 
Glutathione peroxidase catalyses the degradation of peroxides with concomitant 
oxidation of glutathione. In the presence of glutathione reductase and NADPH, 
the oxidised glutathione is immediately converted to the reduced form. 
Superoxide dismutase catalyses the dismutation of superoxide anion radicals and 
catalase catalyses the reduction of hydrogen peroxide to water. Thus, the 
removal of hydrogen peroxide (H202) is achieved by catalase, which is largely 
sequestered within the peroxisomal compartment of cells, and by the S-
dependent enzyme glutathione peroxidase (Diplock 1994), whereby the affinity for 
hydrogen peroxide is higher for glutathione peroxidase than for catalase. 
The increased glutathione reductase activity may be explained by decreased 
enzyme degradation due to a protective effect of carotenoids. Alternatively, 
carotenoids may induce the enzyme. The lower a-tocopherol concentrations in 
the spinach and carotenoid supplement groups may reflects its increased 
utilisation as an antioxidant, especially in combination with the lower ascorbic acid 
(vitamin C) contents of the diets in the spinach groups. In studies with synthetic |3-
carotene supplements, plasma a-tocopherol concentrations have been shown to 
decrease (Xu et al. 1992), increase (Goodman et al. 1994), or stay the same 
(Albanes et al. 1997, Nierenberg et al. 1994, Nierenberg et al. 1997). In our study 
a significant positive correlation was observed between serum responses of 
zeaxanthin and a-tocopherol and this finding may explain the inconclusive 
evidence for an effect of (3-carotene supplementation on a-tocopherol 
concentrations. 
A number of studies (Dugas et al. 1998, Romanchik et al. 1997) illustrate the 
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uncertainty that exists regarding the effects of p-carotene and other carotenoids 
on low-density lipoproteins (LDL) oxidative stability in vitro. Neither vegetable 
consumption (up to 490 g/d) nor a carotenoid supplement had effect on the 
resistance of LDL to oxidation ex vivo as compared to the control group (van het 
Hof et al. 1999a). Administration of p-carotene did not reduce oxidation of LDL 
particles, which actually carry p-carotene in the lipid phase of plasma, in vivo 
(Gaziano et al. 1995a, Reaven et al. 1994, Reaven et al. 1993). Recent studies 
(Bowen & Omaye 1998) even suggest that p-carotene participates as a 
prooxidant in the oxidative degradation of LDL (see Introduction for discussion of 
possible mechanisms) and that elevated LDL concentrations may counteract the 
protective effects of a-tocopherol. Following supplementation with concentrated 
fruit and vegetable extracts, decreases in lipid peroxide levels were coincident 
with increases in carotenoids and a-tocopherol (Wise et al. 1996). Hininger et al. 
(1997) found that an increased intake of carotenoid rich food had an inhibitory 
effect on the susceptibility of LDL to oxidation. 
There are several methods to measure the prooxidant and antioxidant activity 
of p-carotene and other carotenoids, including measurements of cell damage, 
mainly as lipid peroxidation products, e.g., formation of thiobarbituric acid-reactive 
substances (TBARS) and hydroperoxides; non-enzymatic antioxidants 
concentrations and non-enzymatic antioxidant activity; and intermediate products 
of the reaction between free radical species and carotenoid molecules. Most 
studies on the ability of supplementary carotenoids to protect cells against 
oxidatively induced DNA damage have determined oxidatively induced DNA 
damage or protection against oxidation of LDL. However, by measuring activity of 
red blood cell antioxidative enzymes (Nielsen et al. 1998, Young et al. 1999), 
functional biomarkers for antioxidant activity could be developed. Measurements 
of erythrocyte enzyme antioxidant activities, serum or plasma non-enzymatic 
antioxidant concentrations and ferric reducing ability of plasma (FRAP) and uric 
acid concentrations can be considered biomarkers of defence in antioxidant 
research, whereas concentrations of oxidatively damaged amino acids in plasma 
is a biomarker for damage to proteins. Other biomarkers for damage include the 
determination of malondialdehyde (oxidation of fat) and the Comet assay (DNA 
damage). 
Our data (Chapter 5) suggest that serum lutein concentration, or lutein and 
zeaxanthin intake, is positively related with erythrocyte glutathione reductase 
activity and negatively with serum a-tocopherol concentration. Moreover, the 
antioxidant responses in the pooled spinach group were not significantly different 
from those in the carotenoid supplement group, suggesting that the observed 
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changes in antioxidant activities or concentrations were not caused by the 
increased absorption of p-carotene, because the p-carotene response, but not 
that of lutein, was much higher in the carotenoid supplement group than in the 
spinach groups. In vivo oxidative metabolites have been described in human 
subjects after lutein supplementation (Khachik et al. 1995, Khachik et al. 1997, 
Olmedilla et al. 1997), indicating that lutein has biological activity with the 
potential of providing protection against cancer. The presence of the direct 
oxidation product of lutein and 3'-epilutein (metabolite of lutein and zeaxanthin) in 
human retina suggests that lutein and zeaxanthin may act as antioxidants to 
protect the macula against short-wavelength visible light and these carotenoids 
may therefore play an important role in prevention of age-related macular 
degeneration and cataracts (Khachik et al. 1997). 
It is expected that in the near future analytical assays will be improved and 
more information on antioxidant enzyme activity will become available, thus 
enabling a better understanding of the kinetics and mechanisms of the complex 
antioxidant defence systems to be obtained. 
ANTIOXIDANT CAPACITY OF SPINACH IN FOOD 
Generally, antioxidant and prooxidant properties of any substance depend on the 
conditions and the partners in the reaction (Buettner 1993). Antioxidant, 
autoxidation and even prooxidant processes are possible, and the relative 
efficiency of these processes in any system will determine whether a compound 
has an antioxidant action. Carotenoids are generally found in foods complexed 
with either proteins or fatty acids, which protect them from oxidation. The 
breakdown of these complexes allows the prooxidant action of carotenoids in 
lipids to take place and leads to degradation of carotenoids, resulting in blanching 
or discoloration of the product. 
The effect of differently processed spinach products on inhibiting oxidation of 
food lipids, with special emphasis on the effect of total phenolics and carotenoids 
((3-carotene and lutein) present in spinach, was determined (Chapter 6). The 
antioxidant activity of spinach extracts and spinach products was tested using two 
oxidation systems: a methyl linoleate (MeLo) system and a cooked meat model, 
respectively. In the methyl linoleate system the inhibition of formation of 
hydroperoxides was measured after three days of autoxidation. The inhibition of 
thiobarbituric acid-reactive substances (TBARS) and hexanal concentrations was 
determined in cooked meatballs after two days of storage at 4°C. On the basis of 
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inhibition of hydroperoxide formation, the activity of oxidation, corrected for the 
content of phenolic compounds, decreased at 10 ppm in the descending order of 
minced (72% decrease) > liquefied (75% decrease) > whole-leaf spinach (82% 
decrease). Whole-leaf and minced spinach were more prooxidative and showed 
greater increased TBARS formation than the liquefied spinach. Minced and 
liquefied spinach were antioxidant active with respect to the mean inhibition of 
hexanal formation. Differences among the three spinach products (in descending 
order of inhibition of TBARS and hexanal formation: liquefied > minced > whole-
leaf spinach) were significant. A strong correlation was observed between the 
calculated amount of lutein, but not for (3-carotene, of the original spinach 
samples (amounts were adjusted for the content of phenolic compounds) and the 
inhibition of hydroperoxide formation. In contrast to this finding is the highest 
antioxidant activity of the liquefied spinach in the meatballs model: the liquefied 
spinach had the lowest content of total phenolics and lutein. 
In fruits and vegetables, more than 80% of the total antioxidant capacity comes 
from ingredients other than ascorbic acid, indicating the presence of other 
potentially important antioxidants in these foods (Cao et al. 1996, Wang et al. 
1996). There is evidence for a prooxidant activity of p-carotene in vitro (Haila et 
al. 1999) and in vivo (Lomnitsky et al. 1991, Reaven et al. 1993). Prooxidant 
means that the compound in question promotes oxidation. p-Carotene seems to 
act as a prooxidant when it is added to an a-tocopherol-deficient medium or diet 
(Haila et al. 1999, Lomnitsky et al. 1991). a-Tocopherol was the major liposoluble 
antioxidant found in leaves (Mallet et al. 1994). Even a minor amount of 
tocopherol protects carotenoid from destruction and thus inhibits the prooxidant 
action of carotenoids. It can be concluded that the naturally occurring combination 
of a carotenoid and a stabilising component such as tocopherol acts as a lipid 
antioxidant, whereas when tested as an isolated carotenoid, p-carotene, lutein 
and lycopene acted as lipid prooxidants (Haila et al. 1999, Haila et al. 1996, 
Palozza 1998). However, some of our spinach products, especially at low 
amounts, showed prooxidant activity. It must be assumed that the concentrations 
of carotenoids and co-antioxidants were too low in these cases to behave as 
antioxidants. 
The differently processed spinach products behaved differently when tested for 
antioxidant activity (MeLo) or stability (meatballs). In the methyl linoleate model 
extracts were tested that contained at least phenolic compounds, whereas the 
whole spinach product was tested in the meatballs model. The thiobarbituric acid 
method has been widely used to evaluate the effectiveness of potentially 
antioxidative compounds to prevent lipid oxidation. The main drawback of this 
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method is that only an advanced oxidation status can be detected. A different 
approach is to measure the induction period before the rapid oxidation phase, 
which occurs in a lipid matrix exposed to conditions of accelerated oxidation. The 
methyl linoleate lipid model used in Chapter 6 is suitable for mechanistic studies, 
but may be less appropriate to evaluate the antioxidant capacity of most foods or 
biological systems (Hopia et al. 1996). 
There is still much to be learned about the synergistic effects of potential 
antioxidants in foods and the effect of processing on the prooxidant or antioxidant 
activity of foods. 
HEALTH EFFECTS OF FRUITS AND VEGETABLES 
Epidemiological studies strongly suggest that high intakes of fruits and 
vegetables, foods rich in p-carotene and other carotenoids and ascorbic acid, are 
associated with a reduced risk of heart disease and cancer. Whether this risk 
reduction is due to the action of one or several carotenoids, to other plant-based 
substances, or is secondary to confounding factors is at this point unclear. 
Evidence from clinical trials shows that supplemental p-carotene does not prevent 
coronary heart disease or cancer, though the benefits of other carotenoids has 
not been ruled out. The serum levels reported from the observational 
epidemiological studies, showing that p-carotene protects against cancer, were 
much lower than the levels achieved in the various intervention trials. Typical 
intakes of p-carotene in most populations are less than 5 mg/d (Russell 1998). 
The Finnish trial provided 20 mg, while the CARET trial supplemented men with 
30 mg p-carotene and 8000 RE retinol each day. The p-carotene levels achieved 
were 5.6 u.mol/L in the ATBC study, 3.9 u.mol/L in the CARET study and 2.2 
u,mol/L in the Physicians Health Study. In the USA, the 95th percentile of serum 
carotenoid levels in the general population was only 0.9 u.mol/L (Russell 1998). It 
is possible that beneficial effects of p-carotene might be seen only at 
physiological and not pharmacological levels. For example, there could be local 
accumulation of p-carotene and its metabolic products in lung tissue, or it could 
be that the high doses used in the intervention trials had a negative impact on one 
or more dietary protective factors (Russell 1998). The following working 
hypothesis has been introduced by Russell (1998): low doses of p-carotene can 
give rise to low levels of eccentric cleavage products, which can be converted to 
retinoic acid and thus have a beneficial effect in preventing cancer; high-dose p-
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carotene supplements can give rise to high levels of eccentric cleavage products 
in oxidative conditions. This could especially be seen, for example, in the lung 
exposed to smoke. Such eccentric cleavage products in high concentrations 
could have biological activity per se, or compete with the biological functions of 
retinoic acid. Another explanation for the lack of beneficial effect of p-carotene 
could be the possibility that the prooxidant behaviour of carotenoids prevailed 
over the antioxidant behaviour because of carotenoid concentration, oxygen 
tension of tissues, and/or inadequate pre-existing antioxidant defences (Palozza 
1998). In contrast, prooxidant activity could induce beneficial effects in already 
transformed cells, inhibiting tumour growth. 
The results of the studies described in this thesis (Chapters 5 and 6) support 
the finding that p-carotene is not a good antioxidant in vivo or in vitro, but indicate 
that lutein may play a role as an antioxidant. Among the explanations for the 
disparity between epidemiological and intervention studies is the possibility that p-
carotene may be a surrogate marker for other protective dietary factors. In 
addition, there are several other potentially beneficial micronutrients in fruits and 
vegetables. In many cases, it is not possible to separate the influence of these 
other dietary factors from that of carotenoids because data on these food 
components are not currently included in nutrient databases. Furthermore, the 
relation between carotenoid intake and disease risk may not be linear and 
carotenoid-related variables in disease outcomes may occur largely at the lower 
end of the intake spectrum, especially in women (Tribble 1998). 
We are not aware of any other study that has determined effects of intake of 
fruits or vegetables on biomarkers of antioxidant activity in vivo and has 
measured antioxidant capacity in vitro. The studies described in Chapters 5 and 6 
suggest that there is a direct relationship between in vitro and in vivo results of 
antioxidant activity from spinach. The antioxidative activity of spinach products in 
vitro could be confirmed in vivo as changes in certain biomarkers of antioxidative 
enzyme activity. It should be noted that spinach consumption decreased serum 
lycopene concentrations. Lycopene is an effective in vitro antioxidant that may 
have protected p-carotene from oxidation (Stahl et al. 1997). Clearly more 
research is needed to establish and validate good markers or biomarkers to 
measure antioxidant activity in human blood and in foods. 
The finding that p-carotene as a single nutrient is not responsible for the health 
effects of fruits and vegetables supports the hypothesis that the synergistic effect 
of a number of nutrients and perhaps nonnutrients promotes health. Examples of 
synergistic effects include the formation of a complex of retinol and p-carotene 
with iron, keeping the iron soluble in the intestinal lumen and preventing the 
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inhibitory effect of phytates and polyphenols on iron absorption (Garcia-Casal et 
al. 1998) and the synergism between antioxidants. No controlled dietary trials 
have been conducted to study the effect of fruits and vegetables intake on 
endpoints for degenerative diseases. The DASH-trial assessed the effect of fruit 
and vegetable intake on blood pressure and found that a fruit and vegetable diet 
had a significant effect on systolic blood pressure. However, a diet of fruit and 
vegetables, low-fat diary foods and with reduced saturated total fat was much 
more effective in reducing both the systolic and diastolic blood pressure (Appel et 
al. 1997). 
Gey (1995) concluded after reviewing complementary observational data, that 
these data consistently suggest that optimal, i.e., potentially protective plasma 
levels, should be > 0.4 umol/L p-carotene (> 0.5 umol/L total carotene). Russell 
(1998) suggests that it may well be that once serum levels exceed 1.5 mg/L (ca. 
2.8 umol/L), harmful effects ensue. Lin et al. (1998) measured carbonyl 
production by CuS04-challenged LDL from healthy women on a controlled diet 
plus a mixed carotenoid supplement and concluded that LDL seemed fully 
protected with 2.3 umol p-carotene/L plasma. 
In conclusion, optimal health and protection against oxidative damage and 
related diseases is best served by the variety of bioactive substances found in 
fruits and vegetables, which act together, instead of a single component. There is 
insufficient or inconclusive evidence regarding carotenoids, although p-carotene 
per se is unlikely to be a causative factor. The combination of a-tocopherol, p-
carotene and ascorbic acid may be effective in inhibiting oxidative damage, 
especially in vivo where oxygen concentration is low (Niki et al. 1995). 
FUTURE STUDIES 
A number of suggestions for further studies are set out below. 
• Future studies on nutrient bioavailability and bioconversion should be 
designed in such manner that the results between studies can be compared 
and that they provide information to contribute to the quantification of one or 
more SLAMENGHI factors influencing bioavailability and bioconversion of 
carotenoids and the bioavailability of folate. Food composition databases used 
for observational studies should provide information on the bioavailability of 
carotenoids and of folate. 
• New methods should be developed to study the bioavailability and 
bioconversion of nutrients. Until now, most studies have measured p-carotene, 
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retinol or folate concentrations in serum or plasma. One complicating factor in 
comparative studies that include provitamin A carotenoids and use the serum 
or plasma response as a measure of absorption is that provitamin A 
carotenoid cleavage is not accounted for and, thus, absorption of these 
carotenoids is underestimated. Another complication of postprandial plasma 
responses is the presence of endogenous carotenoids and resecretion of 
absorbed carotenoids by the liver (van den Berg 1999). For example, by 
feeding labelled p-carotene and retinol with 10 13C-atoms at predetermined 
positions to participants the degree of labelling of these compounds can be 
measured in serum using liquid chromatography/mass spectrometry (LC-MS) 
(van Breemen et al. 1998, van Lieshout et al. 1999). This enables the 
bioavailability of p-carotene and retinol to be estimated. Alternatively, 
measuring carotenoid responses in the triacylglycerol-rich lipoprotein or 
chylomicron plasma fractions can be advantageous because the carotenoid 
content in these fractions reflects newly absorbed carotenoids and accounts 
for effects of intestinal p-carotene cleavage. 
There is a need for validated and good biomarkers to measure antioxidant 
activity in humans. Methodologies to measure biomarkers of impact of fruit 
and vegetable consumption should be improved. This includes the 
development and provision of certified reference materials for the analytical 
methods used. 
Studies should be directed at obtaining a better understanding of the 
mechanisms underlying the effect of individual fruit and vegetable components 
on antioxidant activity and stability in foods. The synergistic effects of potential 
antioxidants in foods and the effect of processing on the prooxidant or 
antioxidant activity of foods should be further explored. 
CONCLUSIONS 
In order to better understand the potential role of carotenoids and folate in foods, 
their relative bioavailability is a critical factor. This thesis has evaluated a number 
of studies on factors affecting the bioavailability and bioconversion of carotenoids. 
It is not yet possible to accurately quantify these factors due to a lack of 
comparable studies, but factors affecting bioavailability and bioconversion have 
been identified. A carefully designed study was carried out to examine the effect 
of the food matrix on carotenoid and folate bioavailability. The consumption of 
spinach (Spinacea oleracea L), a green, leafy vegetable containing carotenoids 
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(p-carotene and lutein) and folate, increased after three weeks the serum or 
plasma concentrations of p-carotene, lutein, ct-carotene, retinol, and folate, and 
decreased the serum concentration of lycopene. The bioavailability of lutein was 
higher than that of p-carotene and the disruption of the food matrix (cell wall 
structure) enhanced the bioavailability of p-carotene from whole-leaf and minced 
spinach, but had no effect on lutein bioavailability. The processing method of 
spinach also had an effect on the bioavailability of folate. Processing methods, 
such as mincing or liquefaction may increase the plasma folate response. The 
effect of disruption of the food matrix on carotenoid and folate bioavailability could 
not be reversed by adding dietary fibre in an amount comparable to that lost in the 
cell wall structure. 
Blood samples were collected to determine enzyme and non-enzyme 
antioxidant activities. Spinach consumption significantly increased responses of 
erythrocyte glutathione reductase activity and decreased responses of erythrocyte 
catalase activity and serum a-tocopherol concentrations. p-Carotene was unlikely 
to be a causative factor for changes in erythrocyte glutathione reductase activity 
or serum a-tocopherol concentrations in vivo. Our data suggest that these 
changes can be attributed to an increased intake of lutein (and zeaxanthin). This 
finding is further supported by in vitro measurements of antioxidant capacity of the 
spinach products. Frozen spinach products possessed prooxidant or antioxidant 
activity, depending on the extent of processing and the amount of spinach used. 
In a lipid methyl linoleate model, at a level of 10 ppm total phenolics the 
antioxidant activity was descending as follows: whole-leaf > liquefied > minced 
spinach. Differences among the spinach products tested in the meatball model 
were significant: the inhibition of the formation of thiobarbituric acid-reactive 
substances (TBARS) and hexanal was in the following descending order: 
liquefied > minced > whole-leaf spinach. Of importance is the finding that spinach 
can have prooxidative activity, which can become antioxidative by further 
processing of the spinach or by increasing the amount of spinach present. 
We used the same dietary intervention trial to study a number of aspects of 
spinach consumption. The major advantage of this approach is that the results of 
measurements of various parameters can be related to each other. A 
complication is that it is difficult to design a study with multiple aims. For example, 
subjects could not be stratified according to their baseline concentrations of 
serum or plasma antioxidant vitamins or enzyme antioxidant activities. This 
complicated the statistical analysis. 
Antioxidants and antioxidant enzyme defence systems are very complex and 
changes in one antioxidant may result in changes in serum/plasma 
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concentrations of other antioxidants or erythrocyte enzyme activities. It is 
concluded that a severe lack of knowledge on the bioavailability and antioxidant 
activity of carotenoids hampers adequate suggestions for human 
supplementation. We support the statement of Vainio et al. (1998) that, pending 
further research, supplemental p-carotene, a-carotene, lutein, and other 
carotenoids should not be recommended as an approach to prevent cancer in the 
general population. 
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SUMMARY 
Fruits and vegetables are generally considered important contributors to a healthy 
diet and, for some years now, health professionals have been advising the 
general public to increase their intake of fruits and vegetables to reduce the risk of 
specific cancers, cardiovascular disease, neural tube defects, and cataracts. 
Although the mechanisms are not fully understood, carotenoids, folic acid and 
dietary fibre appear to play important roles in the prevention of these diseases. 
The hypothesis that p-carotene plays a role in cancer prevention is based on 
studies suggesting that carotenoids function as antioxidants, as enhancers of 
immune function, as precursors of retinoids and/or by stimulation of cell-cell 
communication. Epidemiological studies reveal associations but cause and effect 
have not been demonstrated. In order to determine whether p-carotene is the 
active phytochemical in the prevention of cancer and cardiovascular disease, four 
major intervention trials in humans have been completed, all of which included p-
carotene supplementation with or without other nutrients. Two studies, provided 
evidence suggesting that p-carotene increased the risk of lung cancer in high-risk 
groups: one study was in male Finnish smokers and the other was in smokers or 
workers who had been occupational^ exposed to asbestos. Another study 
showed no effect on the incidence of cancer in a healthy population 
supplemented for 12 years with p-carotene. A further study, which involved 
combined supplementation of p-carotene with vitamin E and selenium to 
marginally malnourished people, showed lower mortality from gastric and total 
cancers in the supplemented group. With respect to cardiovascular disease, the 
clinical trials, in which p-carotene was given without other antioxidants, no 
evidence was found that supplementation had a protective effect. Thus, with 
respect to the chemopreventive effect of fruits and vegetables, these intervention 
trials indicated that p-carotene alone is not the active phytochemical in the 
prevention of cancer and cardiovascular disease. Another candidate contributing 
to the positive effects of fruit and vegetable intake on degenerative diseases is 
folate. Folates are abundant in many of the same fruits and vegetables that are 
rich in carotenoids. A low intake of folate is associated with increased plasma 
homocysteine levels, cardiovascular disease, colon cancer and neural tube 
defects. No intervention studies have yet been conducted to examine the effect of 
fruit and vegetable intake on endpoints of degenerative diseases. 
In this thesis two aspects of spinach, a dark-green, leafy vegetable are 
examined. The first aspect is the bioavailability of the carotenoids and folate 
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present in spinach. The second aspect is the antioxidant activity of spinach 
consumption in humans and the antioxidant capacity of spinach products. 
Bioavailability is defined as the fraction of an ingested nutrient that is available for 
utilisation in normal physiological functions or for storage. Accurate information on 
the bioavailability of nutrients and nonnutrients is needed in order to devise food-
based strategies for long-term alleviation of deficiency and/or to devise food or 
supplement-based interventions to reduce risk for chronic diseases, which appear 
linked to these food constituents. The term bioconversion is used to refer to the 
conversion to the active form of a nutrient. The overall process from ingestion to 
the formation of an active form of a nutrient is termed bioefficacy although this is 
often referred to as bioconversion. 
We refer to the factors that affect nutrient and nonnutrient bioavailability, and 
bioconversion, as SLAMENGHI factors derived from the capitalised letters in the 
following description: Species of the constituent; molecular Linkage; Amount of 
constituent consumed in a meal; Matrix in which the constituent is incorporated; 
Effectors of absorption and bioconversion; Nutrient status of the host; Genetic 
factors; Host related factors; and Interactions. Current knowledge of each of the 
SLAMENGHI factors for the bioavailability and bioconversion of carotenoids is 
discussed in Chapter 2. From the literature review, we concluded that each 
carotenoid appears to have an individual pattern of absorption, plasma/serum 
transport, and metabolism. We further concluded that although data are at 
present not sufficiently comparable to allow a systematic comparison of results, a 
number of conclusions can be drawn. The bioavailability and bioconversion of 
various carotenoids and geometrical isomers of carotenoids differ; molecular 
linkage does not play a role; a positive relationship exists between intake and 
response of p-carotene; p-carotene supplementation increases serum a-carotene 
concentrations and decreases serum concentrations of lutein, lycopene and 
canthaxanthin; the bioavailability of p-carotene from foods is low, particularly from 
dark-green leafy vegetables; intake of dietary fat has a positive and intake of 
dietary fibre a negative effect on bioavailability; alcohol interferes with the 
bioconversion of p-carotene. Nutrient status and genetic factors related to the 
host may explain some of the differences observed. 
We conducted a dietary intervention study with 70 healthy human subjects, 42 
women and 28 men, to examine the effect of the food matrix on the bioavailability 
of carotenoids and folate and to evaluate the effect of spinach intake on 
biomarkers of antioxidant activity. The study started with a three-week run-in 
period, in which subjects chose their own diets but were instructed to avoid foods 
rich in carotenoids, vitamin A and folate. The run-in period was followed by a 
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three-week dietary intervention period. During the intervention period, subjects 
were supplied with total diets, except for a limited choice of free products, and 
divided over six treatment groups. Four groups received a basic diet plus a 
spinach product (whole-leaf, minced, enzymatically liquefied, and liquefied 
spinach plus added dietary fibre), one group received the basic diet plus a 
carotenoid supplement of p-carotene, lutein and a small amount of zeaxanthin 
dissolved in oil, and one group received the basic diet only. Consumption of 
spinach (20 g/MJ), containing p-carotene and lutein, increased serum 
concentrations of all-frans-p-carotene, c/s-p-carotene (and consequently total p-
carotene), lutein, a-carotene and retinol and decreased the serum concentration 
of lycopene compared with the control group. Compared with the synthetic 
carotenoid supplement, the relative bioavailability of p-carotene was low, 5.1-
9.5%, but much higher for lutein, 45-55% (Chapter 3). The low bioavailability of p-
carotene from spinach products can partly be explained by the presence of 15-
18% c/s-p-carotene, which is less readily absorbed than all-frans-p-carotene. 
Furthermore, the relatively high lutein:p-carotene ratio in spinach may have 
negatively affected the bioavailability of p-carotene. Combined intake of lutein and 
P-carotene has been shown to have an inhibitory effect on serum p-carotene 
concentrations. Another factor that contributed to the low bioavailability of p-
carotene is the food matrix, because p-carotene dissolved in oil is absorbed far 
more readily than that in plant foods. Our study (Chapter 3) showed that 
disruption of the food matrix (cell wall structure) and loss of cellular structure had 
an effect on the bioavailability of p-carotene, whereas the bioavailability of lutein 
was not affected. Serum p-carotene responses differed significantly between the 
whole-leaf and liquefied spinach groups and between the minced and liquefied 
spinach groups. Addition of dietary fibre to the liquefied spinach to compensate 
for the fibre that was broken down during liquefaction had no effect on serum 
carotenoid responses. The plasma folate response was significantly greater in the 
spinach groups compared with the control group. Intake of minced and liquefied 
spinach resulted in greater plasma folate responses than consumption of whole-
leaf spinach, which suggests that the food matrix of spinach plays a role with 
regard to bioavailability of folate (Chapter 4). Also in the folate study the amount 
of dietary fibre added to the liquefied spinach was too small to have a significant 
effect on the plasma folate response compared with that of the liquefied spinach 
group. The folate response in the carotenoid supplement group was similar to that 
in the control group, suggesting that there is no interaction between the 
absorption of carotenoids and folate. 
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Foods and the human body are under constant oxidative stress from free 
radicals, reactive oxygen and nitrogen species and other prooxidants. Cells have 
intact prooxidant/antioxidant systems that function continuously to generate and 
to detoxify oxidants during normal aerobic metabolism. The first line of defence is 
largely enzymatic and prevents the generation of radical species derived from 
molecular oxygen. The enzymes superoxide dismutase, catalase, glutathione 
reductase and glutathione peroxidase are free radical control biomolecules that 
are present in most tissues. Superoxide dismutase prevents the accumulation of 
superoxide anion (02*) by converting it to hydrogen peroxide (H202). Hydrogen 
peroxide is metabolised by catalase or glutathione peroxidase to water. Although 
these endogenous antioxidant enzymes are very effective, they do not provide 
(sufficient) defence against some reactive oxygen species such as singlet oxygen 
or hydroxyl radicals. Food-derived derived antioxidants, such as vitamins C and 
E, uric acid, glutathione, carotenoids and flavonoids, form the second line of 
defence. There is no doubt that antioxidants are of great importance in the 
aetiology of a number of different human diseases. However, it is critical to 
provide evidence that a diet containing a high antioxidant activity from fruits and 
vegetables can either increase the overall antioxidant capacity or change the 
relative balance between individual antioxidant components in the human body; 
otherwise, an antioxidant hypothesis related to the protection of fruits and 
vegetables against diseases cannot be sustained. 
Thus, we examined the effect of consumption of spinach after three weeks on 
several enzymatic antioxidant activities in erythrocytes as well as antioxidants 
concentrations in serum/plasma and concentrations of oxidatively damaged 
amino acids in plasma (Chapter 5). Consumption of spinach resulted in 
significantly greater erythrocyte glutathione reductase activity and lower 
erythrocyte catalase activity and serum a-tocopherol concentration compared with 
the control group. Consumption of the carotenoid supplement led to lower a-
tocopherol responses and tended to increase the erythrocyte glutathione 
reductase activity. Serum lutein concentration was positively related with 
erythrocyte glutathione reductase activity and negatively with serum a-tocopherol 
concentration. Moreover, the antioxidant responses in the pooled spinach group 
were not significantly different from those in the carotenoid supplement group, 
suggesting that the observed changes in antioxidant activities or concentrations 
were not caused by the increased absorption of p-carotene, because the p-
carotene response, but not that of lutein, was much higher in the carotenoid 
supplement group than in the spinach groups (Chapter 3). The antioxidant 
capacity of the differently processed spinach products was determined (Chapter 
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6). The antioxidant activity was tested using two oxidation systems: a methyl 
linoleate system and a cooked meat model. In the methyl linoleate system the 
inhibition of formation of hydroperoxides by spinach extracts was measured after 
three days of oxidation. The inhibition of thiobarbituric acid-reactive substances 
(TBARS) and hexanal concentrations by spinach samples was determined in 
cooked meat after two days of storage at 4°C. On the basis of inhibition of 
hydroperoxide formation, the activity of oxidation, corrected for the total phenolics 
content of the spinach, decreased at 10 ppm in the descending order of minced 
(72% inhibition) > liquefied (75% inhibition) > whole-leaf spinach (82% inhibition). 
Whole-leaf and minced spinach were more prooxidative and showed greater 
increased TBARS formation than the liquefied spinach. Minced and liquefied 
spinach were antioxidatively active with respect to the mean inhibition of hexanal 
formation, whereas whole-leaf spinach showed prooxidant activity. Differences 
among the three spinach products (in descending order: liquefied > minced > 
whole-leaf spinach) were significant. A correlation was observed between the 
calculated amount of lutein, but not for p-carotene, in the original spinach samples 
(amounts were adjusted for the total phenolics content of spinach) and the 
inhibition of hydroperoxide formation. The results of the studies described in this 
thesis (Chapters 5 and 6) support the finding that p-carotene is not a good 
antioxidant in vivo or in vitro, but indicate that lutein may play a role as 
antioxidant. 
Among the explanations for the disparity between observational 
epidemiological and dietary intervention studies is the possibility that p-carotene 
may be a surrogate marker for other protective nutrients and nonnutrients in fruits 
and vegetables. In many cases, it is not possible to decipher the influence of 
these other dietary factors because they are not currently included in databases. 
The finding that p-carotene as a single nutrient is not responsible for the health 
effects of fruits and vegetables supports the hypothesis that the synergistic effect 
of a number of nutrients and perhaps nonnutrients promotes health. Furthermore, 
the relation between carotenoid intake and disease risk may not be linear: 
beneficial effects of p-carotene might only be seen at physiological and not at 
pharmacological levels. 
Controlled dietary trials should be conducted to study the effect of fruit and 
vegetable intake on endpoints for degenerative diseases. More research is 
needed to establish and validate good markers or biomarkers to measure 
antioxidant activity in human blood and in foods. It should be taken into account 
that the most effective antioxidant in oxidative stress depends on the specific 
molecules causing the stress and the cellular or extracellular location of the 
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source of these molecules. 
In conclusion, the bioavailability of p-carotene from differently processed 
spinach products is low and can be improved by mincing or liquefaction of whole-
leaf spinach. The food matrix also has an effect on the bioavailability of folate 
from spinach. Optimal health and protection against oxidative damage and related 
diseases is best served by the variety of bioactive substances found in fruits and 
vegetables, which act together, instead of a single component. Consumption of 
spinach or a carotenoid supplement changed erythrocyte enzyme activities and 
non-enzymatic serum/plasma antioxidant concentrations, but p-carotene is 
unlikely to be a causative factor. Lutein may play a role in the antioxidant defence 
of human blood. 
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Spinazie als bron van caroteno'fden, foliumzuur en antioxidantactiviteit 
Groenten en fruit leveren een belangrijke bijdrage aan een gezonde voeding. 
Nationale campagnes worden gericht op de gehele Nederlandse bevolking om de 
inneming van groenten en fruit te verhogen. Een hoge inneming van groenten en 
fruit wordt geassocieerd met een verlaagde kans op kanker, hart- en vaatziekten 
en andere negatieve gezondheidseffecten. Caroteno'iden, foliumzuur en 
voedingsvezel lijken een belangrijke rol te spelen in het voorkomen van deze 
ziekten, alhoewel de hierbij behorende reactiemechanismen niet volledig bekend 
zijn. De hypothese dat p-caroteen, een van de caroteno'iden die in het lichaam 
kunnen worden omgezet in vitamine A, een rol speelt bij de preventie van kanker, 
is gebaseerd op onderzoeken waarin de werking en functie van caroteno'iden zijn 
beschreven en op epidemiologisch onderzoek. CarotenoTden werken als 
antioxidanten, versterken de immuunfunctie, kunnen worden omgezet in retinol 
(vitamine A), en stimuleren de communicatie tussen cellen. Epidemiologische 
onderzoeken laten verbanden zien maar geen oorzaak en gevolg. Om te kunnen 
vaststellen of p-caroteen inderdaad een actieve verbinding is in de preventie van 
kanker en hart- en vaatziekten, zijn een viertal interventie-onderzoeken 
uitgevoerd met vrijwilligers. Tijdens deze onderzoeken kregen de deelnemers 
synthetisch p-caroteen zonder of in combinatie met andere voedingsstoffen. 
Twee onderzoeken toonden aan dat het toedienen van p-caroteen de kans op 
longkanker verhoogde bij mensen met een hoog risico, namelijk Finse rokers en 
werknemers, die blootgesteld waren geweest aan asbest. Een derde onderzoek 
liet geen effect zien op de incidentie van kanker bij een gezonde populatie, die 
werd gesuppleerd met p-caroteen gedurende 12 jaren. Een vierde onderzoek 
omvatte het toedienen van p-caroteen in combinatie met vitamine E en selenium 
aan marginaal gevoede mensen in China. Dit leidde tot een verlaagde sterfte aan 
maagkanker en kanker in het algemeen. Met betrekking tot hart- en vaatziekten, 
werd in de klinische onderzoeken waarin alleen p-caroteen of p-caroteen in 
combinatie met andere antioxidanten werd gegeven, geen bewijs gevonden voor 
een beschermend effect van p-caroteen. Uit deze onderzoeken kan worden 
geconcludeerd dat p-caroteen in groenten en fruit niet de actieve component is, 
die een beschermend effect heeft op het ontstaan van kanker en hart- en 
vaatziekten. Een mogelijke andere kandidaat voor een positieve bijdrage van 
groenten en fruit aan ziekten, is foliumzuur. Foliumzuur is aanwezig in veelal 
dezelfde groenten- en fruitsoorten die ook veel caroteno'iden bevatten. Een lage 
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foliumzuurinneming wordt geassocieerd met het optreden van verhoogde 
homocyste'i'neconcentraties in plasma, hart- en vaatziekten, darmkanker en 
neurale buis-defecten. Tot heden zijn er nog geen interventie-onderzoeken 
uitgevoerd om het effect van de inneming van groenten en fruit op harde 
eindpunten van chronische ziekten te bestuderen. 
In dit proefschrift zijn twee aspecten van spinazie, een donkergroene 
bladgroente, onderzocht. Het eerste aspect is de biobeschikbaarheid van 
carotenoTden en foliumzuur in spinazie. Het tweede aspect is tweeledig, namelijk 
het effect van de consumptie van spinazie op de antioxidantactiviteit in het bloed 
en de antioxidantcapaciteit van spinazieproducten. 
Biobeschikbaarheid wordt gedefinieerd als het gedeelte van een ingenomen 
voedingsstof, dat beschikbaar is voor normale fysiologische functies of voor 
opslag in het lichaam. Accurate informatie over de biobeschikbaarheid van 
voedingsstoffen en andere stoffen in voedingsmiddelen is nodig om 
voedselgerichte strategieen te kunnen ontwerpen ter voorkoming van 
voedingstekorten en/of om strategieen te ontwerpen gebaseerd op voedsel- of 
suppletie-interventies om het risico van chronische ziekten, gerelateerd aan deze 
voedingsstoffen, te verminderen. De term bioconversie wordt gebruikt om de 
omzetting naar een actieve vorm van een voedingsstof aan te geven. Het gehele 
proces van inneming tot de formatie van een actieve vorm van een voedingsstof 
wordt 'bioefficacy' (biodoeltreffendheid) genoemd, maar wordt vaak verward met 
bioconversie. 
De factoren, die van invloed kunnen zijn op de biobeschikbaarheid en 
bioconversie van stoffen, zijn de zogenaamde SLAMENGHI factoren, waarbij elke 
letter staat voor een bepaalde factor. De factoren zijn de volgende: soort stof 
(Species); moleculaire verbinding (Linkage); hoeveelheid van een stof aanwezig 
in een maaltijd (Amount); Matrix waarin de stof zich bevindt; verbindingen die de 
absorptie of bioconversie bewerkstelligen of bevorderen (Effectors); 
Nutrientenstatus van de gastheer; Genetische factoren; individuele (Host-related) 
factoren; en Interacties. De hedendaagse kennis over elk van de SLAMENGHI 
factoren voor de biobeschikbaarheid en bioconversie van carotenoTden wordt 
besproken in hoofdstuk 2. Uit het literatuuronderzoek kon worden geconcludeerd 
dat elk van de carotenoTden een individueel patroon van absorptie, plasma of 
serum transport, en metabolisme lijkt te volgen. Alhoewel de gegevens niet 
voldoende vergelijkbaar waren om tot een systematisch vergelijk van resultaten te 
komen, konden toch een aantal conclusies worden getrokken uit de resultaten 
van gepubliceerde onderzoeken. De biobeschikbaarheid en bioconversie van de 
verschillende carotenoTden en geometrische isomeren van carotenoTden zijn 
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verschillend; moleculaire verbindingen spelen geen rol; er bestaat een positieve 
relatie tussen de inneming en de p-caroteenconcentratie in serum of plasma; p-
caroteensuppletie verhoogt a-caroteenconcentraties in serum en verlaagt 
serumconcentraties van lute'ine, lycopeen and canthaxantine; de 
biobeschikbaarheid van p-caroteen uit voedingsmiddelen, met name uit 
donkergroene bladgroenten, is laag; vetinname heeft een positief effect terwijl 
inname van voedingsvezel een negatief effect heeft op de biobeschikbaarheid; 
alcohol be'i'nvloedt de bioconversie van p-caroteen. De voedingsstatus en 
genetische factoren van een individu kunnen een gedeelte van de waargenomen 
verschillen in biobeschikbaarheid verklaren. 
Om de invloed van de voedselmatrix op de biobeschikbaarheid van 
carotenolden en foliumzuur te onderzoeken en om het effect van consumptie van 
spinazie op biomerkers van antioxidantactiviteit te evalueren, werd een 
voedingsinterventie-onderzoek uitgevoerd. Aan dit onderzoek namen 70 gezonde 
vrijwilligers deel (42 vrouwen en 28 mannen). Het onderzoek begon met een drie 
weken durende inloopperiode, waarin alle deelnemers zelf hun voeding 
samenstelden, maar instructies ontvingen om voedingsmiddelen rijk aan 
caroteno'iden, vitamine A en foliumzuur te vermijden. De inloopperiode werd 
gevolgd door een voedingsinterventieperiode van drie weken, waarin de 
deelnemers werden verdeeld over zes onderzoeksgroepen. Gedurende de 
interventieperiode werden alle deelnemers voorzien van een volledige 
dagvoeding met een beperkte keuze aan vrije producten. Vier 
onderzoeksgroepen kregen naast de basisvoeding een van de volgende 
spinazieproducten: heel-blad, gehakte, enzymatisch vervloeide, of enzymatisch 
vervloeide spinazie waaraan voedingsvezel was toegevoegd. De vijfde groep 
kreeg naast de basisvoeding een supplement van p-caroteen, lute'ine en een 
kleine hoeveelheid zeaxantine, opgelost in olie. De laatste groep (controlegroep) 
kreeg alleen de basisvoeding. De spinazie bevatte de caroteno'iden p-caroteen en 
lute'ine. Spinazieconsumptie (20 g/MJ) verhoogde de serumconcentraties van all-
frans-p-caroteen, c/s-p-caroteen (en dus van totaal p-caroteen), lute'ine, a-
caroteen en retinol en verlaagde de serumconcentratie van lycopeen vergeleken 
met de controlegroep. Vergeleken met het synthetische carotenoidensupplement, 
was de relatieve biobeschikbaarheid van p-caroteen laag (5,1-9,5%), maar was 
veel hoger voor lute'ine (45-55%) (hoofdstuk 3). De lage biobeschikbaarheid van 
p-caroteen uit spinazieproducten kan gedeeltelijk worden verklaard door de 
aanwezigheid van 15-18% c/'s-p-caroteen in de spinazieproducten, dat minder 
makkelijk wordt geabsorbeerd dan het alkrans-p-caroteen waaruit het 
supplement bestond. Voorts kan de relatief hoge verhouding tussen lute'ine en p-
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caroteen in spinazie de biobeschikbaarheid van p-caroteen negatief hebben 
beinvloed. Een gecombineerde inneming van lute'ine en p-caroteen verlaagt de 
serum p-caroteenconcentraties. Een andere factor, die bijgedragen heeft aan de 
lage biobeschikbaarheid van p-caroteen is de voedselmatrix. p-Caroteen opgelost 
in olie wordt veel beter geabsorbeerd dan p-caroteen uit plantaardige 
voedingsmiddelen. Het onderzoek beschreven in hoofdstuk 3 laat zien dat het 
verbreken van de voedselmatrix (de celwandstructuur) en het verlies van de 
celstructuur een invloed hadden op de biobeschikbaarheid van p-caroteen, terwijl 
de biobeschikbaarheid van lute'ine hierdoor nauwelijks werd beinvloed. De 
verschillen in p-caroteenconcentraties in serum tussen het begin en eind van de 
proefperiode waren statistisch significant voor het verschil tussen de heel-blad en 
vervloeide spinaziegroepen en tussen de gehakte en vervloeide spinaziegroepen. 
Het toevoegen van voedingsvezel aan de vervloeide spinazie om de 
voedingsvezel, die verloren is gegaan tijdens het vervloeien, te compenseren, 
had geen invloed op de serumcaroteno'idenconcentraties. Na drie weken spinazie 
te hebben gegeten, was de foliumzuurconcentratie in plasma statistisch 
significant hoger in de spinaziegroepen dan in de controlegroep. De inneming van 
gehakte en vervloeide spinazie resulteerde in een groter verschil in 
foliumzuurconcentraties in plasma dan de inneming van heel-blad spinazie. Dit 
suggereert dat de voedselmatrix ook een rol speelt bij de biobeschikbaarheid van 
foliumzuur (hoofdstuk 4). Ook in het foliumzuuronderzoek bleek de hoeveelheid 
voedingsvezel, die was toegevoegd aan de vervloeide spinazie, een te klein 
verschil in foliumzuurconcentraties te veroorzaken om een statistisch significant 
verschil aan te tonen tussen de groepen die vervloeide spinazie en vervloeide 
spinazie met toegevoegd voedingsvezel ontvingen. De foliumzuurconcentraties in 
plasma van de controle- en supplement-groepen reageerden hetzelfde, hetgeen 
suggereert dat er geen interactie is tussen de absorptie van caroteno'iden en 
foliumzuur. 
Het menselijk lichaam en voedingsmiddelen ondervinden een continue 
oxidatieve druk van vrije radicalen, reactieve zuurstof- en stikstofverbindingen en 
andere pro-oxidanten. Cellen bezitten intacte pro-oxidant/antioxidant-systemen, 
die tijdens het normale aerobe metabolisme continu functioneren om oxidanten te 
genereren of te ontgiften. Een eerste afweermechanisme is voornamelijk 
enzymatisch en voorkomt de vorming van radicalen afgeleid van moleculair 
zuurstof. De enzymen superoxidedismutase, catalase, glutathionreductase en 
glutathionperoxidase zijn aanwezig in bijna alle weefsels en deze biomoleculen 
reageren met vrije radicalen. Superoxidedismutase voorkomt de accumulatie van 
het superoxide-anion (02") door het om te zetten in waterstofperoxide (H202). 
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Waterstofperoxide wordt gemetaboliseerd door catalase of glutathionperoxidase 
tot water (H20). Alhoewel deze endogene antioxidantenzymen effectief zijn, 
voorzien ze niet in een (voldoende) afweer tegen sommige reactieve 
zuurstofsoorten, zoals 102 of hydroxylradicalen. Antioxidanten afkomstig uit 
voedingsmiddelen, zoals bijvoorbeeld de vitamines C en E, urinezuur, glutathion, 
carotenoiden en flavono'iden vormen een tweede afweermechanisme. Er bestaat 
geen twijfel over dat antioxidanten een belangrijke rol spelen in het ontstaan van 
een aantal ziekten. Echter, het is van essentieel belang om het bewijs te leveren 
dat een voeding rijk aan groenten en fruit, en dus met een veronderstelde hoge 
antioxidantactiviteit, inderdaad de algehele antioxidantactiviteit kan verhogen of 
een verandering teweeg kan in de relatieve balans tussen individuele 
antioxidantcomponenten in het lichaam. Als deze relatie niet gestaafd kan worden 
met bewijs, kan de antioxidanthypothese met betrekking tot het beschermende 
effect van groenten en fruit niet worden gehandhaafd. 
De invloed van inneming van spinazie gedurende drie weken op verschillende 
enzymatische antioxidantactiviteiten in erytrocyten (rode bloedcellen), 
antioxidantconcentraties in serum/plasma en concentraties van oxidatief 
beschadigde aminozuren in plasma is onderzocht (hoofdstuk 5). De consumptie 
van spinazie resulteerde in een statistisch significant grotere glutathionreductase-
activiteit en lagere catalase-activiteit in de erytrocyten. Ook werden lagere a-
tocoferolconcentraties in serum gemeten vergeleken met de controlegroep. De 
inneming van het carotenoTdensupplement leidde tot lagere a-
tocoferolconcentraties en vertoonde een net niet statistisch significante toename 
in de glutathionreductase-activiteit in de erytrocyten. De luteineconcentraties in 
serum waren positief gecorreleerd met de erytrocyt-glutathionreductase-activiteit 
en negatief met de a-tocoferolconcentratie in serum. Bovendien waren de 
gemeten antioxidantactiviteiten en -concentraties in de samengevoegde 
spinaziegroepen niet statistisch significant verschillend van die in de 
caroteno'idensupplementgroep. Dit geeft aan dat de waargenomen veranderingen 
niet werden veroorzaakt door een verhoogde absorptie van p-caroteen, omdat de 
absorptie van p-caroteen in tegenstelling tot de absorptie van luteine, veel hoger 
was in de caroteno'idensupplementgroep dan in de spinaziegroepen (hoofdstuk 
3). Vervolgens is de antioxidantactiviteit van de verschillend bewerkte 
spinazieproducten bepaald (hoofdstuk 6). De antioxidantactiviteit werd getest in 
twee oxidatiesystemen: in een methyl-linoleaatsysteem en in een model van 
gekookte gehaktballen. In het methyl-linoleaatsysteem werd de remming van de 
formatie van hydroperoxiden door spinazie-extracten gemeten na drie dagen van 
oxidatie. De remming van de vorming van thiobarbituurzuur-reactieve substanties 
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(TBARS) en hexanal door de spinaziemonsters werd bepaald in gekookt gehakt 
na opslag van twee dagen bij 4°C. Op basis van de remmende werking op de 
formatie van hydroperoxiden, nam de oxidatie-activiteit, gecorrigeerd voor de 
totale hoeveelheid fenolische verbindingen in de spinazieproducten, bij 10 ppm 
het sterkst af voor gehakte spinazie (72% remming), gevolgd door vervloeide 
spinazie (75% remming) en heel-blad spinazie (82% remming). In het gekookte 
vlees-model, waren de heel-blad en gehakte spinazieproducten pro-oxidatiever 
(de vorming van TBARS werd minder geremd) dan de vervloeide spinazie. Wat 
betreft de gemiddelde remming van de hexanalvorming, bleken de gehakte en 
vervloeide spinazieproducten een antioxidatieve activiteit te hebben, terwijl de 
heel-blad spinazie een pro-oxidatieve activiteit vertoonde. De verschillen tussen 
de drie spinazieproducten (afnemend naar antioxidantactiviteit: vervloeid > gehakt 
> heel-blad spinazie) waren statistisch significant. De berekende hoeveelheid 
lute'ine in de originele spinaziemonsters, gecorrigeerd voor de totale hoeveelheid 
fenolische verbindingen, was gecorreleerd met de remming van de 
hydroperoxidevorming. De resultaten van de onderzoeken die beschreven zijn in 
dit proefschrift (hoofdstukken 5 en 6) steunen de bevinding dat p-caroteen geen 
goede antioxidant is in de mens of in voedingsmiddelen, maar geven aan dat 
lute'ine een rol zou kunnen spelen als antioxidant. 
Een van de verklaringen voor de uiteenlopende bevindingen van 
observationeel epidemiologisch onderzoek en voedingsinterventie-onderzoek is 
de mogelijkheid dat p-caroteen het effect van andere voedingsstoffen en andere 
stoffen in groenten en fruit maskeert. In vele gevallen is het niet mogelijk om de 
invloed van een groot aantal (voedings)stoffen die voorkomen in groenten en fruit 
te bestuderen, omdat informatie over hun hoeveelheden (nog) niet zijn 
opgenomen in voedingsmiddelenbestanden. De bevinding dat p-caroteen als 
enkelvoudige voedingsstof niet alleen verantwoordelijk is voor de 
gezondheidseffecten, die worden toegeschreven aan een hoge inneming van 
groenten en fruit, ondersteunt de hypothese dat een synergistisch effect van een 
aantal (voedings)stoffen gezondheidsbevorderend werkt. Ook kan het zo zijn dat 
de relatie tussen de inneming van carotenoi'den en het ziekterisico wellicht niet 
lineair is: het zou kunnen zijn dat een heilzaam effect van p-caroteen alleen 
optreedt bij fysiologische en niet bij farmacologische hoeveelheden. 
Gecontroleerde voedingsproeven dienen uitgevoerd te worden om de invloed 
van inneming van groenten en fruit op harde eindpunten voor chronische ziekten 
te bestuderen. Meer onderzoek is nodig naar het vaststellen en valideren van 
goede (bio)merkers om de oxidantactiviteit te bepalen in bloed en in 
voedingsmiddelen. Hierbij dient rekening gehouden te worden met het feit dat de 
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meest effectieve antioxidant in een bepaalde situatie afhankelijk is van de 
specifieke moleculen, die de balans van de oxidanten verstoren, en de cellulaire 
of extracellulaire herkomst van deze moleculen. 
Conciuderend kan gesteld worden dat de biobeschikbaarheid van (3-caroteen 
uit verschillend verwerkte spinazieproducten laag is maar kan worden verbeterd 
door het hakken of vervloeien van heel-blad spinazie. De voedselmatrix heeft ook 
een invloed op de biobeschikbaarheid van foliumzuur uit spinazie. Een optimale 
gezondheid en bescherming tegen oxidatieve schade en gerelateerde ziekten kan 
worden bereikt door het eten van groenten en fruit met een verscheidenheid aan 
bioactieve stoffen in plaats van een enkel bestanddeel. 
De inneming van spinazie of een caroteno'idensupplement leidde tot 
veranderingen in de gemeten enzymactiviteiten in de erytrocyten en in 
antioxidantconcentraties in serum en plasma. Echter, het is onwaarschijnlijk dat 
deze veranderingen werden veroorzaakt door p-caroteen; wel zou het kunnen zijn 
dat lute'ine een rol speelt in de antioxidatieve afweer van het bloed. 
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